Expression and functional analysis of the Notch signaling pathway within the thymus microenvironment by García León, María Jesús
  
Universidad Autónoma de Madrid 
Facultad de Ciencias 
Departamento de Biología Molecular 
 
 
 
TESIS DOCTORAL 
 
 
 
Expression and functional analysis of the 
Notch signaling pathway within the thymus 
microenvironment 
 
 
 
 
MARÍA JESÚS GARCÍA LEÓN 
Madrid, 2015 
 
Directora: Dra. María Luisa Toribio García 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work was performed at the Center of Molecular Biology “Severo Ochoa” (CBM-
SO) from the Spanish Research Council (CSIC) and the Autónoma University of 
Madrid (UAM) with the following funding: SAF2010-15106, PLE2009-0110 and 
SAF2013-44857-R projects, from the Spanish Ministry of Science and Innovation and 
Spanish Ministry of Economy and Competitiveness; S-SAL/0304/2006 project from 
the Community of Madrid; and HEALTH-F4-2013-602587 THYMISTEM project 
from the 7 Program of the European Union; and also by institutional funding from the 
Ramón Areces Foundation. María Jesús García León was supported by a phD 
fellowship from the Spanish Ministry of Science and Innovation (FPU Program).  
 
 
 
 A mis padres,  
 
 
 
“There is no energy in matter other than that received from the environment” 
 
“No hay mas energía en la materia que aquella recibida del entorno”. 
 
–Nikola Tesla– 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 I
Preface 
 
On the cover: Logos, Eros and Thumos. 
 
Plato famously divided the human Psyche into three parts by using the allegory of a 
charioteer driving two winged horses. The charioteer is Logos (the Reason), the black horse is 
Eros (the Desires) and the white horse is Thumos (the Emotions). Thus, the task of Logos is to 
balance human desires and emotions, as both must be guided by rationality (1, 5, 6).  Eros is a 
dark wild horse, hedonist and stubborn. He constitutes our appetites at our lowest level, 
embracing the desire to eat, sleep, reproduce, and live just for pleasure. Conversely, Thumos 
(also commonly spelled as "Thymos"; θυµός: anger) is bright and beautiful, governable, ruled 
by the command of Logos, and helps the reasonable Charioteer to control the passionate dark 
horse (4). Thumos is known to us from the herb thyme, which exudes a strong aroma. 
“Thyme” is the cognate word of “Fume” in latin (as Th and f is the same Indo-European 
consonant) thus its original meaning is smoke, “breath”, exhalation, “Spirit” or “soul”. In the 
Homeric epics the Greek philosopher Empedocles often used Thumos as the vital principle, 
the “breath of life”, “the site for the soul” (3, 4). Thumos is also known by the primary 
lymphoid organ, named as “thymus” by Galen (Pergamum, c.130 A.D.) due to its histologic 
resemblance with the thyme herb (Fig. I) (3) and its anatomic location at the upper chest 
where strong emotions are physically felt (no, it’s not at the heart, it’s at the thymus) (4). As 
being the site for the soul the thymus involutes with age along with our strengths, passions 
and wishes. 
 
Thumos takes several emotions as pride, indignation, competitiveness and ambition, 
although its fundamental manifestation is anger, but of a special kind. Anger is not a pure 
emotion as it is usually accompanied by and idea, some conviction about our rights, our 
privileges, or our status (6). Thus, Thumos arises when your honor or reputation is questioned 
or when your efforts, rights or qualities are not recognized. Thumos constitutes the 
fundamental human need for recognition. Lack of recognition turns into anger and drives a 
person to stand up for itself. Thumos is, in modern psychology, our self-stem or self-worth, 
and thus it names several mood disorders as dysthymia, athymia or cyclothymia (4). Thumos 
also can make you angry with yourself when you fail to live up to your own principles and 
code of honor (dictated by Logos, the Reason) and make you indignant of your own desires, if 
those oblige you to do something contrary to the dictates of Reason. In contrast to the lower 
desires of the dark horse, moved for pleasure, Thumos seeks independence over wealth, and 
recognition and honor over security. This drive for recognition will motivate him to risk 
much, for his reputation an also for the reputation of a group to which he is devoted (4, 6). 
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Thumos pushes you to despise mediocrity and to want to excel your fellows, to dominate, and 
to seek glory and legacy. Thumos is courage and self-confidence, and it will keep you in a 
fight that your Reason (Logos) has decided is indeed a worthy one (1). Great primates know 
that their courage and confidence comes from their Thumos, as before a fight they stimulate it 
by beating their chest above the heart. But just like the dark horse of our appetites, the White 
Horse of Thumos can be harmful, as being ruled by emotions is dangerous if they usurp the 
role of Reason, the Charioteer. Conversely, extreme retention of your white horse by the 
Reason will make you susceptible to external insults and to be ruled by the desires and 
emotions of others (4). Intriguinly, the thyme oil obtained from the thyme herb helps to 
encourage a drained white horse against external insults as it is an effective antiseptic (7) and 
antinflamatory (8). 
 
Altogether, the whole ancient knowledge about the Thumos, draw a picture of an 
holistic force that protects and encourages human individuality. Thumos is the force that 
arises to vindicate ourselves and draw a line, based in our unique experiences and dictates of 
the Reason, that external insults must not cross. Indeed, the cells generated in the thymus can 
be found from our nose tip to our toes, and are always ready to fight against external threats, 
thus perfectly materializing the global and individually unique protective force described by 
the ancient Greeks.  
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Summary 
 
The thymus provides a specialized environment for T cell development, but the 
identity of the thymus niche components involved in this process and the nature of their 
functional interactions with developing thymocytes are still not well understood, specially in 
humans. The Notch pathway is one of the critical signalling pathways that make the thymus a 
unique site for T cell development. Notch signalling is delivered by thymic epithelial cells 
(TECs) expressing distinct Notch ligands to thymus-seeding T cell progenitors expressing 
several Notch receptors, mainly Notch1. As T-cell development implies the migration of 
developing thymocytes throughout distinct thymic niches, we ought to determine whether a 
differential distribution of Notch ligands and receptors in the thymus could define discrete 
microenvironments with specific developmental functions, paying special attention to a 
critical check-point that controls the split of developing thymocytes into αβ and γδ T cells. To 
this end, we performed immunohistochemistry and confocal microscopy analyses focussing 
on the regulation of the expression of Notch pathway components during human ontogeny in 
comparison with mouse ontogeny. The study provided information about the localization of 
human early CD34+ intrathymic progenitors receiving Notch1 signals in vivo. In addition, 
they provided evidence of an spatio-temporal regulation of the expression of Notch ligands 
and receptors and confirmed that this expression defines particular intrathymic niches, which 
are dynamically regulated during thymus ontogeny and involution, but differ between mouse 
and human. Notably, functional in vitro assays showed that the opposite pattern of expression 
observed for Jag1 and Jag2 ligands in the human thymus correlated with divergent functional 
roles, as they differentially regulate the αβ versus γδ T cell output from human intrathymic 
progenitors, and also the process of γδ T cell expansion and functional maturation. In fact, 
Jag1 and Jag2-expressing niches host different γδ maturation stages in the human thymus, 
thus defining the intrathymic γδ T cell developmental dynamics. Finally, the study provides 
evidence that Notch signalling may play a key role also in human TEC biology, as not only 
thymic progenitors, but also TECs express active Notch1 and Hes1. Particularly, the finding 
that Notch1 activation increases with age in TECs located in the thymus medulla suggests a 
role for Notch signalling on the natural process of thymic involution. By using a conditional 
loss of function murine model we show that thymi of mice with impaired Notch activation in 
the TEC compartment have a disturbed medullary microenvironment, support a defective T-
cell development, and allow for aberrant B-cell generation. Altogether the study reveals a 
crucial role for Notch signalling in a dynamic crosstalk between thymus components, and 
highlights the importance that specific microenvironments defined by spatio-temporal 
regulation of Notch ligand expression may have not only in T-cell fate specification, but also 
in γδ T cell development, TEC biology and thymus involution. 
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Resumen 
 
  El timo proporciona un microambiente especializado para el desarrollo de las células 
T, pero ni la identidad de los nichos responsables de este proceso, ni la naturaleza de sus 
interacciones funcionales con los timocitos en desarrollo se conocen bien, especialmente en 
humanos. La vía de Notch es una de las vías de señalización que hacen del timo un nicho 
único para la generación de los linfocitos T. Los progenitores hematopoyéticos, que 
principalmente expresan principalmente el receptor Notch1, reciben señales activadoras de las 
células epiteliales del timo (TECs) que expresan diversos ligandos. Como el desarrollo de las 
células T implica la migración de los timocitos a través de distintos nichos intratímicos, 
hemos querido determinar si una distribución diferencial de receptores y ligandos de Notch en 
el timo podrían definir microambientes discretos con funciones específicas en el desarrollo T, 
prestando especial atención al punto de control crítico que determina la bifurcación de los 
progenitores intratímicos en células de linaje αβ o γδ. Para ello, y mediante 
inmunohistoquímica y microscopía confocal, hemos analizado la regulación de la expresión 
de los componentes de la vía Notch durante la ontogenia humana y la de ratón. El estudio ha 
proporcionado información acerca de la localización in vivo de los progenitores CD34+ 
humanos, los que se activa el receptor Notch1. Además, hemos obtenido evidencia de una 
regulación espacio-temporal de la expresión de ligandos y receptores Notch, confirmando que 
Notch define nichos específicos regulados de forma dinámica durante la ontogenia y la 
involución del timo, que difieren entre ratón y humanos. Adicionalmente, ensayos funcionales 
in vitro han mostrado que el patrón opuesto de expresión de Jag1 y Jag2 observado in vivo, 
correlaciona con funciones divergentes en la regulación de los linajes T γδ y αβ, así como en 
el proceso de expansión de células T γδ y en su maduración funcional. De hecho, los dos 
nichos definidos por la expresión de Jag1 y Jag2, albergan diferentes etapas de la maduración 
de los timocitos γδ,  definiendo así la dinámica de diferenciación intratímica de las células T 
γδ. Por último, nuestro el estudio demuestra que la activación de Notch1 también desempeña 
un papel clave en la biología del estroma tímico, ya que no sólo los progenitores del timo, 
sino también las TECs expresan Notch1 activo y Hes1 in vivo. En concreto, el hallazgo de 
que la activación de Notch1 en TECs aumenta con la edad sugiere su implicación en la 
involución natural del timo. Mediante el uso de un modelo de pérdida de función en ratón, 
hemos demostrado que los timos de ratones defectivos en la activación de Notch en TECs, 
presentan alteraciones en el microambiente medular, así como un desarrollo defectuoso de 
linfocitos T, y una generación aberrante de células B. Por tanto, nuestro estudio revela un 
papel crucial de Notch en la dinámica de interacciones entre diversos componentes celulares 
del timo, y pone de relieve la importancia que los nichos específicos definidos por la 
regulación espacio-temporal de la expresión de los ligandos de Notch pueden desempeñar, no 
sólo en la especificación del linaje T, sino también en el desarrollo de las células T γδ, en la 
biología de las TECs y en la involución del timo. 
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Introduction 
 
1. The thymus: a specialized environment for T cell development. 
 
The environment is the master driver of development in any biological system. In 
multicellular organisms, the development of any cellular lineage is dependent on the niche 
that hosts the pluripotent stem cell. In their niche, stem cells receive complex and well-
ordered signals that develop their inner potential or allow their self-renewal.  
 
For the hematopoietic system, all hematopoietic linages derive from a common 
progenitor that resides in primary sites of hematopoiesis such as the yolk sac, AGM and liver 
in the fetus, and the bone marrow in the adult (Marcos et al., 1997) (Cumano et al., 2000). 
Most of the hematopoietic lineages mature in those primary sites (Adolfsson et al., 2005) 
(Luc et al., 2008) (Bell and Bhandoola, 2008) (Graf, 2008), with the exception of T cell 
lymphocytes (Fig. 1). T cell progenitors need to migrate to an specialized environment for 
their development, namely the thymus. The thymus provides specific and step-wise signals to 
developing thymocytes that induce their proliferation, differentiation and migration through 
different thymic microenvironments (TMEs) (Takahama, 2006) (Petrie and Zuniga-Pflucker, 
2007). Little is known about the identities and functional interactions of the thymic niche 
components in vivo with thymic progenitors and developing thymocytes. The characterization 
and understanding of complex molecular signals that make the thymus the unique niche for T 
cell development, is the main goal of this PhD thesis. 
 
1.1. Anatomy and development of the human and murine thymus. 
 
The thymus is a primary lymphoid organ of endodermal origin (Manley and 
Blackburn, 2003) (Gordon et al., 2004) (Hollander et al., 2006) located at the mediastinum 
and formed by two symmetrical lobules. Comprehension of thymic development will help to 
understand postnatal thymic anatomy and its specialized niches.  
 
Thymic development can be divided into two phases: pre-vascular and post-vascular 
development (Boehm, 2008). In the first one, thymic development depends exclusively on 
epithelial-mesenchymal interactions, while in the later thymic development is dependent also 
on lympho-stromal interactions (Anderson et al., 1993). Human thymic development starts at 
the 4th week of gestation (Ed 9.5 - 10.5 in mice), when the thymus is an avascular epithelial 
rudiment attached to the 3rd pharyngeal pouch, devoid of hematopoietic cells and surrounded 
by a thick capsule of mesoderm-derived mesenchymal tissue (Fig. 2).  
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Figure 1. Hematopoietic cell lineages differentiation.  BM progenitors give rise to all 
hematopoietic lineages. T cells are only generated in the thymus. The phenotype of human 
intrathymic precursor is noted. LT-HSC: Long-term self-renewing stem cell; ST-HSC: Short-term 
self-renewing stem cell. LMPP: Lympho-myeloid pluripotent progenitor; MkEP: Megakariocyte-
erythroid progenitor; GMP: Granulocyte-monocyte progenitor; TLMP: Thymic lymphomyeloid 
progenitor. ETP: Early thymic progenitor; LP: Intrathymic lymphoid progenitor; MP: Intrathymic 
myeloid progenitor. Adapted from (Luc et al., 2008). 
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At the beginning of the 8th week of gestation, both left and right thymic rudiments 
move caudally and fuse, forming the two characteristic thymic lobules (Lobach and Haynes, 
1987). The expression of the epithelial transcription factor FoxN1 by thymic epithelial cells 
(TECs) in late 8th week (Ed11,5 in mice) initiates the process of hematopoietic colonization 
and the vascularization of the thymic anlage. Indeed, FoxN1-deficient (nude) thymic anlages 
fail to vascularize (Mori et al., 2010). But it is not until the 10th week of gestation (Ed12 in 
mice), when the mesenchymal connective tissue begins to invaginate into the thymic 
epithelial anlage along with blood vessels, forming the characteristic discrete lobules of the 
thymic tissue (fig. 2.3). Additionally, the hematopoietic capacity of the thymus also depends 
on the activity of the FoxN1 transcription factor (Corbeaux et al., 2010; Nehls et al., 1994). 
FoxN1 up-regulates the expression of the thymus expressed chemokine (TECK or CCL21) 
(Liu et al., 2006) and of Notch ligands (Xiao et al., 2008), mostly Dll4 (Tsukamoto et al., 
2005). The former attracts the hematopoietic progenitor cells (HPCs) resident in the fetal yolk 
sac and liver into the thymic anlage (Bleul and Boehm, 2000), and the latter specifies T cell 
lineage fate on them (Lefort et al., 2006); (Koch et al., 2008) (Hozumi et al., 2008). In 
FoxN1-deficient animals (nude) no hematopoietic cells can be found in the thymus 
(Blackburn et al., 1996), although their progenitors are produced normally in the bone 
Figure 2. Development of the thymus. Image represents different stages of thymic ontogeny. (1) 
The thymic anlage develops from the 3rd pharyngeal pouch. (2) Induction of FoxN1 expression and 
homing of the first wave of TLMPs that enter the thymic anlage by active migration throughout the 
perithymic mesenchyme. (3) Detachment from the pharinx, vascularization and lobulation. (4) 
Definitive postnatal anatomy of the thymus; second and successive waves of TLMPs enter thought 
the blood vessels. cp: thymic capsule. c: cortex; m: medulla; asterisks: perivascular spaces (PVS); 
TLMP: thymus lymphomyeloid progenitor. 
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Figure 3. Compared developmental kinetics of thymic development in humans and mice. 
Table represents human and murine ontogeny divided by thirds. Capital developmental events 
occurring on each range of time and phenotype of T-lineage cells hosted in the thymus are noted. 
 
marrow (Nehls et al., 1996) (Wortis et al., 1971). Importantly, while hematopoietic 
colonization of the murine thymus occurs in the 2nd third of gestation (Ed11,5), the human 
thymus is colonized by HPCs during the 1st third (Fig. 3). As early as the 7th week, CD7+ 
CD45+ HPCs are found throughout the perithymic mesenchyme and other mesenchymal 
areas, and by the 8th week the first HPCs colonize the epithelial parenchyma (Lobach and 
Haynes, 1987) (Haynes et al., 1988). At 8.2 weeks, human thymocytes already express CD8, 
CD4 and intracellular TCR-β, while in mice, most thymocytes at the equivalent stage 
(Ed11,5) are CD8- CD4- (DN). By the 10th week, CD3 and CD8β membrane expression is 
present in fetal thymocytes, and definitive corticomedulary organization of thymocyte 
populations in cortical immature (CD1a+) and medullary mature (CD1a-) populations is 
achieved by week 13th. Thus, postnatal histologic configuration of the thymus in cortical and 
medullary TMEs, is already established in humans by the end of the first trimester (14 wks) 
(Lobach and Haynes, 1987) (Haynes and Heinly, 1995).  
 
Once mature, each thymic lobule is histologically divided into three main 
compartments: an epithelial cell-rich medulla, surrounded by a lymphocyte-rich cortex, with a 
perivascular space (PVS) between both. The PVS derives from the early fetal perithymic 
mesenchymal tissue that penetrates into the thymic parenchyma around the blood vessels 
during vascularization (Lobach and Haynes, 1987). Additionally, the thymic cortex can be 
divided in other three functional subregions: subcapsular cortex (SCC), inner cortex (IC) and 
  17
Introduction 
 
corticomedulary junction (CMJ) (Griffith et al., 2009) (Fig. 4). In the postnatal thymus, early 
T cell progenitors (ETPs) are located at the CMJ (Lind et al., 2001), suggesting that, in the 
vascularized thymus, ETPs enter through the vasculature and PVS. ETP entrance to the 
thymus is temporarily regulated in colonization waves, coincident with space availability in 
limited niches (Donskoy et al., 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The thymus architecture. A, Schematic view of 
histologic and functional thymic regions. Cortex, medulla and 
perivascular space are the three formal compartments of the 
thymus, but the cortex is subdivided in three functional subregions 
(dashed lines): the subcapsular cortex (SCC), the inner cortex (IC) 
and the corticomedulary junction (CMJ).  B, Human postnatal 
thymus stained for the T cell maturation marker CD1a (red). 
Thymic regions are limited by brackets.  
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The functionally mature medullary compartment is histologically defined by the 
appearance of terminally differentiated medullary TECs (mTECs). These cells are highly 
keratinized and form rounded swirls known as Hassall's corpuscles (HCs), which are known 
to be a source of a cytokine known as thymic stroma-derived lymphopoietin (TSLP) (Ziegler 
and Liu, 2006) that plays a role in dendritic cell (DC) maturation and regulatory T cell (Treg) 
generation (Watanabe et al., 2005). Additionally, HC’s mTECs express the chemokine SDF-1 
and the CD30L, a membrane-associated glycoprotein involved in T-cell signaling (Zaitseva et 
al., 2002) (Romagnani et al., 1998). CD30-deficient mice show a gross defect in negative but 
not positive selection (Amakawa et al., 1996), suggesting that HCs are capital to negative 
selection. In the mice, keratinized mTECs form analogous small structures but much more 
infrequent. This ultimate postnatal thymic structure is not steady, as TECs are in continuous 
homeostasis during postnatal life (see 3.3). 
 
1.2. The thymic stromal cells. 
 
Early studies in vertebrates demonstrated that the non-lymphoid components of the 
thymus play critical roles in thymic development and T cell generation (Haynes, 1984). In 
addition to thymocytes, the thymus contains epithelial cells, fibroblasts, macrophages, 
dendritic cells (DCs), and vascular endothelial cells, as well as minor populations of myoid 
cells, B cells, basophils, and eosinophils (Boyd et al., 1993) (Jablonska-Mestanova et al., 
2013), which all in conjunction are referred to as “thymic stroma”. Mesenchymal cells are 
important supporters of thymus development and T cell differentiation in the fetal thymus 
(Itoi et al., 2007b). Myeloid cells, mainly macrophages and DCs, are necessary for apoptotic 
thymocyte clearance and central tolerance establishment, respectively (Surh and Sprent, 
1994) (Oh and Shin, 2015). But the epithelial component of the thymic stroma, composed by 
TECs, is the essential element for T cell development (Anderson and Jenkinson, 2001) (Gray 
et al., 2005). TECs are responsible of progenitor homing to the fetal thymic anlage and of T 
cell specification via Notch signaling (Harman et al., 2003) (Koch et al., 2008); as direct 
contact of Notch ligand-expressing TECs with thymocytes is necessary to activate and sustain 
Notch signaling in developing thymocytes (Anderson et al., 2001) (Schmitt et al., 2004). 
Importantly, Notch signaling delivery by TECs is only sustainable when they are organized 
three dimensionally (3D) (van Ewijk et al., 1999), and disruption of the 3D architecture of 
TECs immediately results in downregulation of Notch ligand expression (Mohtashami and 
Zuniga-Pflucker, 2006). TECs comprise an heterogeneous population of cells (de Maagd et 
al., 1985) and 3D TEC organization allows their compartmentalization in specific niches, 
each responsible for specific stages of T cell development (Ladi et al., 2006). In general 
terms, TECs comprise two major populations, cortical (cTECs) and medullary (mTECs), both 
  19
Introduction 
 
derived from a common thymic epithelial progenitor cell (TEPC) (Bennett et al., 2002) (Rossi 
et al., 2006) (Bleul et al., 2006) (Baik et al., 2013) (Alves et al., 2014) of endodermal origin 
(Le Douarin and Jotereau, 1975). cTECs drive the early stages of T cell development, while 
mTECs are required for central tolerance establishment (Mizuochi et al., 1992) (Farr and 
Rudensky, 1998). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The development and maturation of TECs and thus their hematopoietic capacity 
depends on the activity of the epithelial-specific transcription factor FoxN1 (Corbeaux et al., 
2010; Nehls et al., 1994) (Gordon et al., 2001) (Itoi et al., 2007a). FoxN1 is required for 
differentiation of TEPCs into cortical and medullary TECs (Blackburn et al., 1996) (Bleul et 
al., 2006), although it is not completely known if it is required for the generation of the 
bipotent TEPC itself, as the FoxN1 null thymic primordium is able to separate from the 
parathyroid primordium and form and epithelial alymphoid thymic anlage (Nowell et al., 
2011). But FoxN1 is not the only molecular cue required for TEC development. TECs support 
T cell development, but they are supported in turn by developing thymocytes. Indeed, 
although cTEC versus mTEC cell fate decision occurs in the absence of lymphocytes 
(Jenkinson et al., 2005), CD4+CD8+ double positive (DP) immature thymocytes are needed 
for successive cTEC differentiation. Likewise, mTECs require interaction with mature single 
positive (SP) cells for functional maturation (Philpott et al., 1992) (van Ewijk et al., 1994) 
(Shores et al., 1994) (Hollander et al., 1995) (van Ewijk et al., 2000). Such reciprocal 
interdependency between thymocytes and TECs is referred to as “thymic crosstalk” (Fig. 5). 
Unfortunately, the identity of the molecular signals derived from thymocytes to TECs remains 
Figure 5. Thymic crosstalk. Thymocytes and stromal cells (mainly TECs) signal 
to each other in other to promote their mutual development, maturation or 
homeostasis via Notch signalling or the TNF receptor family. 
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elusive. Recent studies showed that TNF receptor family signaling play a pivotal role in 
mTEC development (Rossi et al., 2007) (Akiyama et al., 2008) (Hikosaka et al., 2008), but 
little is known about the involvement of Notch signaling in this thymic crosstalk (see section 
3.3).  
 
 
2. T lymphocytes. 
 
Among the lymphoid cell populations of the hematopoietic system, T cells are the 
cells responsible for scanning the intracellular environment for foreign invaders, killing 
infected cells, eradicating cancer cells, activating other immune cells and remembering 
antigens challenged in the past. Their immunological features are also responsible for 
rejection of transplanted organs, tissues and cells, and for the generation of nearly all 
autoimmune diseases and allergies, so their essential role in human immunity is irrefutable.  
 
T cells can be divided into two major subtypes according to the polypeptide chains 
that form their T-cell antigen receptors: αβ T cells and γδ T cells (Fig. 6). Of them, γδ T cells 
recognize non-peptide antigens on intact proteins, while cells bearing the αβ TCR only 
recognize MHC-bound antigens presented by an antigen-presenting cell (APC). Both cell 
types are generated and mature within the thymus during a complex journey throughout 
specific intrathymic niches, which involves binary fate decisions orchestrated mainly by 
Notch signaling. However, little is known about the identity of in vivo niches that host 
TCRαβ and TCRγδ cells and their progenitors, the availability of Notch ligands and receptors 
in those niches, and the specific molecular requirements for their preferential generation and 
expansion. 
 
2.1. The intrathymic development of αβ T cells is niche- and Notch- dependent.  
 
T cells are generated in the thymus by a microenvironment-guided process in which 
thymocytes dynamically interacts with different thymic stromal cells that deliver Notch and 
other molecular cues at discrete steps of development (Ciofani and Zuniga-Pflucker, 2007) 
(Petrie and Zuniga-Pflucker, 2007) (Ladi et al., 2006). T cell development can be divided into 
two broad phases: an early phase, that takes place at the cortex, characterized by the 
expansion and differentiation of T cell precursors towards CD4+CD8+ double positive (DP) 
thymocytes, and a second late phase, that takes place at the medulla, in which immature DP 
thymocytes bearing the αβ TCR mature to CD4 or CD8 single positive (SP) T cells. During 
this process, each precursor that enters the thymus gives rise to approximately one million 
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progeny (Shortman et al., 1990). Five of the six major stages of T cell development occur at 
the cortex; and thus the cortex may contain several microenvironments different enough to 
promote sequential developmental changes. However, scarce reports have accounted for such 
cortical differences (Griffith et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T cell development at the cortex:  
 
 The first steps of the early phase of T cell development involve the commitment of 
HPCs to the T cell fate in the thymus. Data from different groups, including ours, define the 
earliest human T cell progenitors or ETPs as c-kit+ CD34hi CD38+ CD1a- IL7Rlo (LSK- 
CD44+CD25- in mice) multipotent cells (Galy et al., 1993) (Andrews et al., 1989) (Marquez 
et al., 1998) that comprise about 0.03% of neonatal thymocytes, which are included within the 
most immature DN intrathymic population (DN1). ETPs lack self-renewal capacity and thus 
differ from the HSC compartment present in the BM (Galy et al., 1993) (Galy et al., 1995) 
(Allman et al., 2003), but they are similar to BM lymphomyeloid multipotent progenitors 
(LMPPs), as they retain T, NK, and myeloid lineage potential, and even display some B cell 
lineage potential (Porritt et al., 2004) (Garcia-Peydro et al., 2006) (Weerkamp et al., 2006) 
Figure 6. Molecular structure of the human T cell receptors. The signalling 
strength model claim that αβ/γδ T cell fate is determined by the strength of the 
signal delivered by the preTCR or the γδTCR. There are differences between 
both TCR complexes that might confer them differential signalling capacities at 
early stages of T cell development. The preTCR possess the three CD3 
polypeptide chains (γ, δ, ε and ζ) and a pTα, while TCRγδ lacks pTα (Carrasco 
et al., 2001). In mice, TCRγδ also lacks CD3δ (Hayes and Love, 2002). 
Additionally, their expression levels at the plasma membrane differs notably, 
with the γδTCR being expressed in far greater numbers than the preTCR. 
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(Bell and Bhandoola, 2008) (Luc et al., 2012) (Adolfsson et al., 2005). Therefore, ETPs may 
derive from BM LMPPs that enter the thymus through the CMJ, where they briefly stay as 
DN1 cells (Lind et al., 2001) and rapidly migrate upwards to the subcapsular cortex while 
interacting with cortical thymic stroma (Fig. 7) (Witt and Robbins, 2005). During this 
process, ETPs further differentiate along two alternative pathways through separate 
intermediate lymphoid or myeloid progenitors, characterized by differential expression of 
CD44 and IL7R. The CD34+ CD44lo IL7Rhi lymphoid progenitor (DN2 stage) is devoid of 
myeloid potential and comprises a bipotent population able to generate NK and T cells 
(Marquez et al., 1995) (de Yebenes et al., 2002). Cortical transmigration coincides with loss 
of non-T lineage potential, accessibility of TCR-γ, -δ , and -β  loci (Petrie and Zuniga-
Pflucker, 2007), a proliferation boost (Lind et al., 2001), and a developmental progress along 
successive DN2 and DN3 stages, the latter including CD4+ immature single positive 
thymocytes (CD4ISP) in humans (Kraft et al., 1993) (Hori et al., 1991). The important 
proliferation burst at the DN1 and DN2 stages is the consequence of several molecular cues 
provided by the TME, including c-kit, Wnt, Hedgehog (Griffith et al., 2009) and, most 
importantly, Notch1 and IL-7 (Peschon et al., 1994) (Balciunaite et al., 2005). Notch1 induces 
cell proliferation at early stages of T cell differentiation by upregulating IL7R in developing 
thymocytes (Gonzalez-Garcia et al., 2009). But the most important role of Notch1 in early 
intrathymic development is the induction of T cell lineage specification and the blockade of 
non-T cell fates (Schmitt et al., 2004) (Petrie and Zuniga-Pflucker, 2007) (Sultana et al., 
2010). This occurs at the CMJ and is phenotypically characterized in humans by the 
downregulation of CD34 and CD44 (Marquez et al., 1995), the acquisition of the CD1a 
marker (Galy et al., 1993) and the transition to the DN3 stage (CD4ISP in humans; CD44-
CD25+ in mice) (Fig. 7). In the absence of ligand-induced Notch signaling, T cell generation 
is severely impaired, as either Notch1 or Dll4 knock-out (KO) leads to complete absence of T 
cells (Radtke et al., 1999) (Koch et al., 2008) (Hozumi et al., 2008). Conversely, 
overexpression of Notch1 constitutively active intracellular form (ICN1), allow the ectopic 
generation of T cells at the BM (Pui et al., 1999). Other Notch receptors such as Notch2 or 
Notch3 are also able to induce T cell development but they are not essential in vivo (Suliman 
et al., 2011) (Waegemans et al., 2014).  
 
Activation of Notch1 in human ETPs triggers the generation of CD34+ CD44lo 
IL7R+ lymphoid intermediates (DN2), while suppressing the generation of CD34+ CD44hi 
IL7R- CD123+ myeloid intermediate progenitors (Garcia-Peydro et al., 2006) (Martin-Gayo 
et al. submitted). According to current models, early Notch1 engagement by intrathymic 
Notch ligands blocks B cell potential in the earliest incoming LMPP progenitors (Harman et 
al., 2003), while other studies suggest that the T/B lineage choice occurs prior to 
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intrathymic Notch signaling, at least during fetal life (Harman et al., 2005) (Masuda et al., 
2005). In any situation, continuous Notch signaling is required for intrathymic progenitors to 
progress along the T cell lineage (Schmitt et al., 2004) (Billiard et al., 2011). 
 
Once thymocytes are committed to the T cell lineage, a first vawe of RAG gene 
upregulation (Wilson et al., 1994) initiates the rearrangements at the TCRγ, δ and β loci that 
finally result in the expression of either a mature γδ TCR or a pre-TCR (Groettrup et al., 
1993). Pre-TCR expression coincides with the arrival of developing thymocytes to the SCC 
(Fig. 7), the simultaneous acquisition of CD4 and CD8 (DP stage) (Lind et al., 2001) 
(Kreslavsky et al., 2012) and the accessibility of the TCRα locus to the recombinase (Petrie et 
al., 1995). Productive rearrangement and expression of a TCRβ chain represents a survival 
signal for developing thymocytes, which are rescued from cell death by means of expression 
of a surface preTCR complex composed of TCRβ and the invariant pTα chain associated with 
CD3 components (Fehling et al., 1995) (von Boehmer and Fehling, 1997) (Ciofani and 
Zuniga-Pflucker, 2005). Pre-TCR signaling also induces a second intrathymic proliferation 
burst (Penit, 1988).  These processes, known as β-selection also involve a directional change 
in the intrathymic migratory pathway of developing thymocytes, as β-selected thymocytes 
located at the SCC rapidly turn back inwards the cortex (Lind et al., 2001) (Fig. 7). Notch 
signaling also participates at this critical checkpoint, as pre-TCR-mediated β-selection 
critically requires Notch activation (Wolfer et al., 2002) (Balciunaite et al., 2005) (Maillard et 
al., 2006). Only after β-selection, thymocytes become independent of Notch signaling 
(Taghon et al., 2009), and immature DP thymocytes start to rearrange the TCRα locus 
(Carrasco et al., 1999) (Starr et al., 2003), which move randomly in the cortex as shown by in 
vitro real-time imaging of intact murine thymic lobes (Bousso et al., 2002) (Witt and Robbins, 
2005). This random motility represents the dynamic consequence of TCR engagement of 
MHC-II-peptide complexes displayed by TECs at the cortical microenvironment. TCR 
engagement results in rescue from programmed cell death of DP thymocytes and acquisition 
of their definitve CD4+ or CD8+ single positive (SP) phenotype, a process known as positive 
selection; while DP thymocytes with no affinity for the MHC-II-peptide complexes expressed 
by cTECs die by neglect. 
 
T cell development at the medulla: 
 
Once DP thymocytes have been positively selected, CCR7 is upregulated on the cell 
membrane. CCR7 expression induces a rapid and directed migration from the cortex to the 
thymic medulla (Fig. 7), where mTECs express the CCL19 and CCL21 ligands (Ueno et al., 
2004) (Witt and Robbins, 2005). At the medulla, positively selected TCRαβ+ thymocytes 
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undergo the process of negative selection by engaging self-antigens presented by mTECs and 
medullary DCs; therefore, the migration of positively selected thymocytes to the medulla is 
essential for the establishment of central tolerance. Finally, mature SP TCRαβ+ thymocytes 
egress the thymus from medullary and corticomedulary veins to the periphery. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Intrathymic dynamics of T cell development. The image represents the intrathymic journey 
of developing thymocytes and how Notch signalling regulates T cell development in a microenviroment-
dependent manner: (1) Notch-mediated inhibition of non-T cell lineages and proliferation; (2) Notch 
cooperates with the preTCR during β-selection. Double-pointed arrows at the left delimitate histologic 
thymic regions. Coloured boxes indicate the phenotype of each corresponding population. TLMP: 
Thymic lymphomyeloid progenitor; ETP: Early thymic progenitor; MP: myeloid progenitor; icTCRβ: 
intracellular TCRβ chain; SCC: subcapsular cortex; IC: inner cortex; CMJ: corticomedullary jucntion; 
MED: Medulla; PVS: perivascular space. Adapted from (Lind et al., 2001). 
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2.2. Models of in vitro T cell development. 
 
An efficient immune reconstitution of the T-lymphoid compartment in 
immunocompromised patients represents a major clinical challenge. De novo generation of T 
cells from donor BM stem cells may take up to 12 months in transplanted patients, period in 
which opportunistic infections, complications as GvHD and the need of continuous supply of 
cytokines, compromise the survival and/or expansion of the cellular allograft (Andre-Schmutz 
et al., 2009). Due to those limitations, in vitro development and large-scale expansion of 
TCRαβ and TCRγδ cells suitable for human immune reconstitution is one of the main goals 
of modern Immunology.  
 
With the exception of T cells, any hematopoietic lineage can be generated in vitro by 
cytokine stimulation or co-culture on stromal feeding layers (Rolink et al., 1995) (Vuckovic et 
al., 2002) (Luevano et al., 2012). But the complexity of T cell development established the 
idea of a compulsory requirement for an intact 3D thymic structure, as 2D TEC monolayers 
were incapable of mimicking the TME (Montecino-Rodriguez et al., 1996). Latter on, Notch 
signaling activation was identified as sufficient to induce T cell fate on HPCs. Nevertheless, 
additional stromal-derived signals were required to support full differentiation of T cells, as 
ETPs overexpressing ICN1 are unable to undergo β-selection unless co-cultured with stromal 
cells (Garcia-Peydro et al., 2006). Due to these limitations, fetal thymic organ culture (FTOC) 
was initially envisioned as the only culture system matching both requirements. But in 2001, 
elegant experiments initiated by Parreira and coworkers using S17 murine stromal cells 
(Jaleco et al., 2001) and followed by Zuñiga-Pfucker (Schmitt and Zuniga-Pflucker, 2002) 
using the murine bone marrow OP9 stromal cell line (Kodama et al., 1994), showed that those 
BM stromal cells, which efficiently support B (Vieira and Cumano, 2004) and NK cell 
generation  (Williams et al., 1999) from murine HPCs in vitro, acquire the ability of 
generating T cells when they ectopically express the Notch ligand Dll1 (Fig. 9) (Schmitt and 
Zuniga-Pflucker, 2002) (De Smedt et al., 2004) (La Motte-Mohs et al., 2005) (Zuniga-
Pflucker, 2004) (de Pooter and Zuniga-Pflucker, 2007). While this phD thesis was in progress 
other Notch ligands including Dll4, Jag1 and Jag2, were shown to display the ability to 
support in vitro T cell development, although with different efficiencies (see section 3.2 and 
Results II).  
 
While in general terms, the Notch ligand expressing-OP9 in vitro co-culture assay is 
currently envisaged as an efficient system for generating αβ T lineage cells, there are still 
some important limitations regarding MHC restriction and thus generation of mature T cell 
populations. Specifically, OP9 cells do not express MHC molecules (Gao et al., 2010), only 
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IFNγ stimulation induces endogenous MHC-I expression (Van Coppernolle et al., 2009), thus 
MHC-restricted human CD8+ T cells suitable for clinical purposes might not be generated in 
any case. Nevertheless, generation of innate-like T cells and minute amounts of functionally 
mature CD4+ and CD8+ TCRαβ cells has been reported to occur in OP9-Dll1 co-cultures, via 
MHC-I expressed by developing thymocytes (Van Coppernolle et al., 2009) (Awong et al., 
2011). Besides, more physiological approached using human TEC cell lines have been also 
considered. But TEC cell lines were able to support T cell development only when 
retrovirally transduced with the Dll1 ligand (Beaudette-Zlatanova et al., 2011), experimental 
procedure that discards the suitability of the mature T cell generated for the clinic. New 
approaches devoid of feeder layers might be the promise of large-scale in vitro T cell 
generation. Besides, αβ T cells, γδ T lineage cells can also be observed in these co-culture 
assays, but Notch requirements for large-scale in vitro expansion of γδ T cells are not well 
understood yet, and contradictory results have been obtained in mice and humans (see section 
2.4).  
 
 
 
 
 
 
 
 
 
 
 
 
2.3. Gamma-delta T cells.  
 
The relative “recent” discovery of T cells bearing a different antigen receptor than 
classical αβ T cells (Saito et al., 1984) (Pardoll et al., 1987), together with its rare occurrence 
in humans and mice have traditionally consigned γδ T cell research to a second place with 
respect to TCRαβ research. But in the last decade, immunologist have appreciated that γδ T 
cells represent a promising and intriguing new aspect of immunology by their unique antigen 
recognition patterns and special immunological properties. Notably, these special properties 
fit in none of the two classical branches of Immunology, the innate and the adaptive, being 
mostly a “bridge” between the two (Vantourout and Hayday, 2013). The γδ TCR directly 
recognizes antigens from intact proteins or non-peptide compounds, while αβ TCRs only 
Figure 8. Co-culture system of HPCs with Notch ligand-expressing OP9 stromal cells 
for in vitro T cell development. HPCs are seeded onto monolayers of Notch ligand-
expressing OP9 cells, and induced to differentiate in the presence of exogenous IL-7 and 
Fms-related tyrosine kinase 3 ligand (FLT3L). After 1 to 4 weeks of co-culture, resulting T-
lineage cells are harvested for further applications of phenotypic analysis. (*) The length of 
the culture period depends on the desired stage of T-cell differentiation that is to be 
studied. 
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recognize MHC-bound antigens on an APC. Indeed, αβ T cell development and maturation is 
MHC-dependent while γδ T cell development seems to be independent and γδ thymocytes 
mature just after high affinity engagement of the γδ TCR with a self ligand present in the 
thymus (Xiong and Raulet, 2007).  
 
Although both cell types emerge in peripheral blood (Campbell et al.) of most 
vertebrates, γδ T cells are rare in murine and primate PB, representing about 5% of 
mononuclear cells. Conversely, they constitute a major T-cell population at other anatomical 
locations such as the gut mucosa and other epithelial tissues (O'Brien et al., 2007) (Hua et al., 
2013). As αβ T cells, human γδ T cells differentiate in the thymus from pluripotent CD34+ 
ETPs (Dudley et al., 1995) (Kang and Raulet, 1997) (Garcia-Peydro et al., 2003), where they 
comprise about 1% of total thymocytes (Offner et al., 1997). As in mice, the particular γδ 
TCRs expressed by human fetal γδ thymocytes are distinct from those expressed in postnatal 
life (Garman et al., 1986) (Chien et al., 1987) (Havran and Allison, 1988), a finding that 
raised the confirmed idea that γδ T cells are produced in ordered waves that populate different 
anatomical sites. In humans, early fetal rearrangements at the TCRδ locus initially involve 
Vδ2 segments. Later, there is a switch to Vδ1, implying that Vδ1+ and Vδ2+ subsets arise via 
rearrangements occurring at distinct phases of thymic ontogeny (Krangel et al., 1990). In 
contrast with αβ T cells, a β-selection-like process for γ or δ chains has not been found, and 
selective rearrangements at different moments during ontogeny may represent a mechanism 
for γδ T cell diversity in specific tissues and PB (Lauritsen et al., 2006). 
 
The anatomical location of γδ lymphocytes has profound implications for their 
antigen specificity. For example, 50% to 90% of human γδ T cells in PB use a combination of 
Vγ9 and Vδ2 gene segments (Allison et al., 2001). These human Vγ9/Vδ2 T cells, are unique 
in that they specifically respond to a set of non-peptidic phosphoantigens, highly expressed by 
bacteria and cancer cells (Riganti et al., 2012), and by the secretion of IFN-γ and TNF-α. 
Their potent anti-tumor activities have prompted the development of protocols of adoptive 
immunotherapy of autologous in vitro-activated TCRγδ cells and new treatments in which 
TCRγδ-agonists are administered to cancer patients (Meraviglia et al., 2010) (Castella et al., 
2011) (Deniger et al., 2014). Similarly, TCRγδ Vδ1 cells are the object of recent interest 
(Bruno Silva-Santos, 4th European Congress of Immunology. September, 2015). They are 
more prevalent in tissues than in PB and interact mainly with MHC-related antigens, as 
CD1c, CD1d MIC-A, MIC-B and ULPBs (Spada et al., 2000) (Groh et al., 1998) (Cosman et 
al., 2001). Thus, it is well established that γδ T cells comprise heterogeneous subsets with 
different tissue-specific functions that increase their antigen recognition range. 
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Despite their functional importance, the intrathymic dynamics of γδ T cells and the 
several differentiation stages through which they develop remain unclear, especially in 
humans. In mice, several studies have demonstrated that γδ T cells differentiate in the thymus 
along a DN pathway (Fisher and Ceredig, 1991) (Pennington et al., 2005), in contrast with 
TCRab cells that differentiate along a DP pathway. Besides, the expression of other cell-
surface markers including CD24 (or heat-stable Ag; HSA), distinguishes immature from 
mature TCRγδ thymocytes, as CD24 becomes downregulated during γδ lineage maturation 
(Tatsumi et al., 1993). Similarly, the immature αβ lineage marker CD1a (Galy et al., 1993) 
(Res et al., 1997) that is expressed in 50 to 90% of human postnatal γδ thymocytes can be 
used to distinguish immature human γδ thymocytes from functionally mature γδ T cells 
(Offner et al., 1997) (Van Coppernolle et al., 2009) (Van Coppernolle et al., 2012). However, 
in contrast to mice, γδ T cells differentiate along a DP pathway in the human postnatal 
thymus. Accordingly, the human postnatal thymus contains DN, DP, CD4+ and CD8+ SP γδ 
T cell populations (Strominger et al., 1989) (Van Coppernolle et al., 2012), thus traditional 
characterization of human γδ T cells based on lack of CD4 and CD8 expression is not 
accurate. Indeed, DP and CD4+SP γδ populations represent the majority of human 
intrathymic γδ T cells. These subsets are only found in the thymus, as peripheral γδ T cells are 
either DN or CD8+SP (Groh et al., 1989). Nevertheless, γδ Τ cells expressing CD4 and/or 
CD8 can be seen in the periphery in pathological conditions, such as in patients with an 
atypical CD3δ immunodeficiency, in which CD4+ γδ T cells are 10-fold enriched in 
comparison with normal individuals (Garcillan et al., 2014). Also, the majority of γδ T cells 
found in the PB or BM of γδ T-ALL patients are heterogeneous in their CD1/CD4/CD8 
phenotype, and display either a CD4+SP or a DP phenotype (Falini et al., 1989) (Langerak et 
al., 1999).  
 
The progenitor-progeny relationships between all those four human intrathymic γδ 
developmental stages is still a matter of debate, although recently, Van Coppernolle et al. 
have demonstrated that immature CD1a+DP γδ thymocytes can give rise to mature CD1a-SP 
γδ T cells in vitro. However, the DP stage is not a compulsory developmental stage in the 
absence of Notch signaling, this implying that both populations may arise independently from 
a common CD1a+ DN TCRγδ+ precursor (Van Coppernolle et al., 2012). The observation 
that Notch signaling supports the differentiation of human γδ progenitors along a DP pathway 
in vitro, point to the importance that microenvironmental signals provided by intrathymic 
niches to γδ T cell progenitors may have during their development in the thymus. However, 
unlike αβ T cell development, the characterization of the intrathymic niches that host the 
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development of γδ thymocytes as well as their intrathymic dynamics are poorly understood. It 
is known that human γδ T cells are mainly located at the thymic medulla, although some are 
also found in the cortex (Falini et al., 1989), and that CCR7-directed migration through 
different intrathymic niches controls their development in mice (Reinhardt et al., 2014), so 
step-wise delivered signals from particular thymic miroenvironments may be important for 
human γδ T cell development, as they are for development of αβ T cells. 
 
2.4. αβ versus γδ lineage specification. 
 
Soon after T lineage commitment, developing thymocytes split from a DN bipotent 
precursor into αβ- or γδ-lineage T cells depending on productive rearrangements and 
expression of TCRG, TCRD and TCRB genes (Petrie et al., 1992). This choice is controlled at 
the transition between late DN2 and DN3 stage (Rothenberg, 2014) but the molecular 
mechanisms involved are still controversial. Two classical models of T cell fate determination 
were early proposed, the instructive and the stochastic model (Kang and Raulet, 1997) 
(MacDonald and Wilson, 1998). The instructive model gives a primary role to the TCR and 
proposes that successful expression of either TCRγ and TCRδ or TCRβ polypeptide chains 
determines specific lineage commitment (Alison and Lanier, 1987; Pardoll, 1987) (Livak et 
al., 1995). Alternatively, the stochastic (or selective) model proposes that cell fate is 
determined independently and prior to TCR rearrangements, giving a secondary role to the 
TCR in cell fate determination just as a driver of survival and proliferation of already pre-
commited thymocytes (Terrence et al., 2000). Although evidence exists to support either 
model (Kang et al., 1998) (Sherwood et al., 2011) (Ishida et al., 1990) (Schweighoffer and 
Fowlkes, 1996), a reviewed version of the instructive model, the “signaling potential” model 
(Fig. 9), posits that the strength of signal transduced by the TCR expressed by late DN2-DN3 
thymocyte dictates its lineage specification (Robey, 2005) (Pennington et al., 2005) 
(Kreslavsky et al., 2008). Consequently, strong signals, usually delivered by the gd TCR, 
drive commitment towards the gd lineage, while weak signals, usually delivered by the 
preTCR, promote the ab T cell fate (Hayes and Love, 2002) (Hayes et al., 2005) (Haks et al., 
2005) (Li et al., 2010) (Fig. 9). However, the identity of the expressed TCR in uncommitted 
progenitors is not important for fate outcome, as in vitro manipulation leading to a γδ TCR 
weakened signal may instruct the αβ T cell fate (Zarin et al., 2014), while an early expression 
of the αβTCR or a strong signal delivered by the preTCR can replace the γδ TCR in the 
development of γδ lineage cells in an Id3-dependent manner (Bruno et al., 1996) (Terrence et 
al., 2000) (Haks et al., 2005) (Lauritsen et al., 2006) (Kreslavsky et al., 2008). 
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Besides the apparently well-established dependency of the αβ/γδ lineage 
determination from the TCR, there are indications that the TCR is not the only player. Several 
evidences point to Notch and its IL7R target as important players in the process (Washburn et 
al., 1997). IL7R signaling regulates the accessibility to the TCRγ locus (Huang et al., 2001) 
(Ye et al., 2001), and T cell progenitors with high IL-7R expression levels seem to be biased 
towards the γδ lineage in mice (Kang et al., 2001). Conversely, absence of ligand engagement 
by Notch receptors favors γδ over αβ T cell generation, as the latter compulsory require 
Notch signaling (Ciofani et al., 2006) (Tanigaki et al., 2004) (Washburn et al., 1997) (Garbe 
et al., 2006). Indeed, BM progenitors heterozygous for a Notch1 inactivating mutation, or 
deficient in RBPjκ, develop almost exclusively to γδ T cells (Tanigaki et al., 2004; Wolfer et 
al., 2001); while constitutively active Notch1 induces murine γδ thymocytes to adopt the αβ T 
cell fate (Washburn et al., 1997). Intriguingly, γδ T cell numbers are 2-fold reduced in the 
fetal thymus of Jag2-deficient mice (Jiang et al., 1998), a finding that concurs with results in 
humans showing that Notch signaling favors γδ T cell generation at the expense of αβ T cells 
in fetal thymic organ culture (FTOC) (Garcia-Peydro et al., 2003) (De Smedt et al., 2002). 
Indeed, high Notch activity in human intrathymic progenitors increases DTX1, NRARP and 
RUNX3 gene expression, genes that are downregulated during αβ-lineate differentiation (Van 
de Walle et al., 2009). As a whole, these controversial results suggest that small differences in 
Notch signaling strength in particular contexts or developmental stages (Wolfer et al., 2001) 
Figure 9. Signalling potential model of αβ/γδ T cell lineage 
specification. Reviewed instructive model of αβ/γδ T cell fate 
specification considering the strength of the signal delivered by 
the TCR and the role of other instructive signalling pathways as 
Notch signalling. Lineage decision is made depending on TCR 
signal strength, no matter what kind of TCR is expressed by the 
T cell precursor. A strong TCR signal will drive γδ T cell 
development, while weak TCR signal will lead progenitors 
towards the αβ-lineage. Notch signalling pathway also instruct 
αβ/γδ T cell outcome at early time points when the TCR is not 
yet expressed. Modified from (Garbe and von Boehmer, 2007). 
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are translated into different cell fate outcomes as confirmed by modulation of Notch 
activation with a γ-secretase inhibitor (GSI) (Doerfler et al., 2001) (Van de Walle et al., 
2009), or as a result of different Notch receptor-ligand interactions (Van de Walle et al., 
2013). Importantly, these results may also reflect the non-redundant roles of individual Notch 
receptors and ligands, whose expression in particular thymic niches may differ from human to 
mice (Van de Walle et al., 2013) (Jaleco et al., 2001). Therefore, one of the aims of this study 
has been to assess whether context-specific changes in Notch-signaling activity may 
coordinate the αβ/γδ lineage decision during intrathymic development (Guidos, 2006) 
(Ciofani et al., 2006) (Garbe and von Boehmer, 2007). 
 
2.5. Molecular signatures of T cell specification and αβ versus γδ T cell lineages. 
 
Hematopoiesis is characterized by a progressive loss of developmental potentials that 
correlates with the activation of lineage-specific transcriptional programs. T cell development 
involves the Notch1-mediated inhibition of non-T cell lineages, which is the result of 
transcriptional repression of B and myeloid specific genes as C/EBPα, EBF1, PAX5 and PU.1. 
Conversely, Notch1 activation induces the expression of T cell lineage specific transcriptional 
program, including expression of IL7R, GATA-3, TCF-1, LEF-1, E2A or BCL11B, which in 
turn will later activate expression of genes involved in TCR assembly and signaling, as RAG, 
pTα or CD25 (Rothenberg, 2014) (Yui and Rothenberg, 2014). Once the T cell lineage is 
specified, progenitors must choose between two alternative fates: αβ or γδ, but a consensus 
about αβ/γδ lineage-specific transcriptional programs has not been reached as yet. It is 
known, though, that high Notch activity increases the expression of DTX1, NRARP and 
RUNX3 genes, which are down-regulated during αβ-lineage differentiation (Taghon and 
Rothenberg, 2008). Additionally, strong signaling transduced by the γδTCR leads to greater 
activation of the MAPK pathway, upregulation of Id3 and Egr family transcription factors 
(Robey, 2005) (Taghon et al., 2006), and thus the initiation of the γδ rather than the αβ T cell 
program; a finding that concurs with the fact that Id3 plays a prominent role in γδ fate 
determination but is dispensable for adoption of the αβ fate (Lauritsen et al., 2006). 
 
Recently, new gene signatures of the γδ T cell lineage have been identified in mice, 
including Etv5 and the TCF-1 related transcription factor Sry-like HMG-Box 13 (Sox13) 
(Melichar et al., 2007) (Jojic et al., 2013), which are both expressed in thymic precursors, and 
may thus be among the earliest determinants of the γδ lineage. But whether these factors are 
activated downstream of the γδTCR or by an inductive signal prior to TCR expression 
remains unclear. 
 
  32
Introduction 
 
2. The Notch signaling pathway. 
 
We are about to celebrate the centenary of the discovery of Notch, an evolutionary 
conserved gene identified in 1917 by a mutant fly with “notches” in its wings (Morgan, 
1917). Since then, Notch has been characterized as one of the key players during embryonic 
and adult development. Notch regulates cell fate and tissue patterning in many organisms, by 
controlling a huge diversity of key cellular processes as cell fate determination, proliferation, 
differentiation or cell death in many different tissues, including the hematopoietic system 
(Tanigaki and Honjo, 2007). Additionally, Notch activation plays a role in disease, as several 
cancer-related genes, including MYC, CCND1, BCL2 or CDKN1A (Weng et al., 2006) are 
Notch direct targets; and Notch is itself mutated in different cancers, including more than 
50% of T-cell acute lymphoblastic leukemias (T-ALL) (Weng et al., 2004). 
 
3.1. Notch receptors, ligands and intracellular signaling. 
 
Notch receptors comprise a highly conserved family of transmembrane heterodimeric 
receptors. In mammals, Notch family members include four receptors (Notch1, Notch2, 
Notch3 and Notch4) that may interact with up to five ligands, two from the Jagged family 
(Jag1 and Jag2) and three of the Delta family (Dll1, Dll3 and Dll4) (Fig. 11). Ligand binding 
induces the exposure of an extracellular site at the juxtamembrane heterodimerization domain 
(HD) susceptible of proteolitic cleavage by the ADAM-family metalloproteases, which 
promotes in turn, a second cleavage at the intracellular region by the γ-secretase complex, and 
releases the intracellular active form of the Notch receptor (ICN) required for T cell 
development (Doerfler et al., 2001). Next, ICN rapidly translocates into the nucleus were it 
interacts with the DNA-binding protein CSL (RBPjκ in mice) and its co-activator Mastermind 
(Mam) to activate the transcription of Notch target genes, including the conserved 
hairy/enhancer of split (HES1, HES5 and HES7) family genes, the Hey subfamily (HEY1, 
HEY2 and HEYL), NRARP or DTX1 (Iso et al., 2003) (Fig. 11). In T cells, CD25, the IL7RA, 
PTCRA and the GATA3 transcription factor gene are direct targets of Notch1 (Gonzalez-
Garcia et al., 2009) (Reizis and Leder, 2002) (Deftos et al., 2000) (Fang et al., 2007). 
Interestingly, Notch family genes as NOTCH1 and NOTCH3 are themselves Notch targets, 
thus establishing a positive feedback activation loop (Ikawa et al., 2006) (Del Monte et al., 
2007) (Van de Walle et al., 2009), which is a key feature of the pathway, as it amplifies small 
differences in Notch ligand and Notch receptors expression within equivalent cells. In the 
thymus, for example, transgenic mice expressing a constitutively active form of Notch1 
upregulate the endogenous NOTCH1 gene (Robey et al., 1996).  
  33
Introduction 
 
 
 
 
 
 
 
 
 
 Notch signaling is also involved in the maintenance of the stem cell pool in different 
adult tissues, as the hematopoietic system (see 3.2) and the gut (Pellegrinet et al., 2011), while 
in other contexts, such as in skin keratinocytes, Notch signals seem to promote differentiation 
(Lefort and Dotto, 2004). These differential Notch activation outcomes may depend on the 
spatial and temporal-restricted expression of: (1) the ligands and/or receptors, or (2) Notch 
receptor modulators (Bray, 2006). Indeed, many molecular mechanisms differentially regulate 
the pathway in a context-dependent manner, including post-translational modification of 
Notch receptors by Fringe glycosil transferases that modify their capability to respond to 
Delta ligands (Koch et al., 2003), and by Neuralized (Neur) and Mindbomb (Mib) ubiquitin 
ligases, that are required for ligand activation (Glittenberg et al., 2006) (Chitnis, 2006). 
Additionally, intracellular ligand trafficking that occurs upon endocytosis of ligand-engaged 
Notch receptors is an essential event for successful activation of Notch in the responding cell 
(Seugnet et al., 1997) (Nichols et al., 2007) (Kopan and Ilagan, 2009). More importantly, 
distinct Notch ligands and receptors have non-redundant functions and activate the Notch 
pathway differently (Shimizu et al., 2002) (de La Coste and Freitas, 2006). Several reports 
Figure 10. Notch ligands and receptors: Molecular structure and Notch ligand – Notch 
receptor putative interactions. A, The structure of Notch receptors comprises an 
extracellular region with 29 to 36 EGF-like repeats (EGF) and three copies of a 
LIN12/Notch-motif (LIN), and an intracellular region containing Ankyrin repeats (ANK) and a 
PEST domain (P). The molecular architecture of Notch ligands includes an N-terminal MNL 
domain, a cysteine-rich DSL module and 6 to 16 EGF-like repeats. Jagged ligands also 
contains a cisteine-rich region (CR) preceding the transmembrane domain. B, Notch ligands 
and receptors expressed in the human thymus and their putative interactions. The solid-
phase binding assays used to tests Notch ligands – Notch Receptor interactions may not 
indicate final affinity of each ligand to each receptor as binding affinities may be modified by 
Fringe proteins. (1) (Shawber et al., 2003); (2) (Shimizu et al., 2000a); (3) (Shimizu et al., 
2000b); (4) (Shimizu et al., 1999); (5) (Andrawes et al., 2013); (6) (Van de Walle et al., 
2013); (7) (Mohtashami et al., 2010); (8) (Yan et al., 2001); (9) (Indraccolo et al., 2009); (10) 
(Pedrosa et al., 2015) (11) (Shutter et al., 2000), (12) (Besseyrias et al., 2007). 
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show that Notch1 receptor interacts differently with Dll1, Dll4 and Jag1 ligands in vitro, and 
comparative binding studies show preferential interaction of Notch1 with Dll4, whereas 
binding of Notch1 to Dll1 (Besseyrias et al., 2007) (Andrawes et al., 2013) (Cordle et al., 
2008b) or Jag1, is weaker (Cordle et al., 2008a). Notch ligands and receptors also show non-
overlapping roles in vivo. For example, mature T cells developed in a Dll1- or Dll4-enriched 
environment show different profiles of cytokine production (de La Coste et al., 2005). Also, 
the Notch1-Dll4 interaction induces T cell lineage commitment in ETPs, while Notch2-Dll1 is 
capital for marginal zone B-cell development (Hozumi et al., 2004) (Saito et al., 2003). In the 
vascular system, the Notch1-Dll4 interaction induces angiogenesis (Hellstrom et al., 2007), 
while the Notch1-Jag1 axis counteracts this effect (Benedito et al., 2009).  All these data 
demonstrate that besides Notch is a well-known signaling pathway, the outcome of Notch 
activation is very diverse and strictly dependent on multiple context-dependent factors (Pear 
and Radtke, 2003). Therefore, it is tempting to speculate that such context-dependent factors 
may well reflect the regulation of signals provided by distinct ligand-receptor complexes, due 
to their differential spatial and temporal regulation during a particular developmental process. 
Whether this regulatory mechanism actually controls the generation of T cells in the human 
thymus represents an important aim investigated in this study.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. The Notch signalling pathway. (1) Notch ligand – Notch receptor engagement: 
The ligand is endocytosed by the signalling cell generating a pulling force that expose de 
ADAM10/17 cleavage site of the receptor (2). ADAM10/17 cleavage induces second cleavage 
by the γ-secretase complex (3) that releases the intracellular active portion of the Notch 
receptor (ICN), which translocate to de nucleus and activate transcription (4). Adapted from 
(Kopan and Ilagan, 2009). 
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3.2. Role of Notch signaling in hematopoiesis. 
 
Notch1 activation is essential for HSC generation during embryonic development 
(Kumano et al., 2003) and seems to be involved in lineage specification at particular 
developmental branch points such as T versus B (Izon et al., 2002) (Koch et al., 2001) (Pui et 
al., 1999) (Radtke et al., 1999), αβ versus γδ (Washburn et al., 1997) (Van de Walle et al., 
2013) and CD4 versus CD8 (Robey et al., 1996) cell fate decisions. But T cell fate 
specification is the most prominent function of Notch in hematopoiesis, as loss-of-function of 
Notch1 in mice results in a complete block in T cell development at the DN stage 
accompanied by an ectopic emergence of B cells in the thymus (Radtke et al., 1999). 
Interestingly, mice lacking RBPjκ (Han et al., 2002) or bearing a Dll4 conditional deletion in 
TECs (Koch et al., 2008) (Hozumi et al., 2008) showed an identical phenotype, a finding that 
places Dll4 as the critical Notch ligand for in vivo T cell development. Conversely, Notch1 
gain-of-function induced by ICN1 overexpression in BM imposes ectopic T cell development 
at the expense of B-cell development (Pui et al., 1999), and the same effect was observed 
after Dll4 overexpression in the thymus (Dorsch et al., 2002) (Fig. 12). Additionally, 
numerous in vitro studies have demonstrated that ligand-dependent activation of Notch on 
HPCs induce T cell commitment (see 2.2.) The mechanism of action of Notch signaling 
underlying differential outcomes at distinct developmental branch points seems to be 
quantitative rather than qualitative, as discussed above for the αβ/γδ lineage decision (see 
section 2.4). In fact, increasing thresholds of Notch signaling in CB progenitors sequentially 
suppress B, myeloid/DC an NK lineage fates in human and mice (De Smedt et al., 2005) 
(Garcia-Peydro et al., 2006) (Pui et al., 1999). In the thymus, Notch1 is preferentially 
expressed in vivo at the thymic cortex and Notch1 downregulation is required for further 
maturation of cortical thymocytes, this indicating that Notch activation is tightly regulated 
during thymopoiesis (Hasserjian et al., 1996) (Huang et al., 2003) (Radtke et al., 1999). These 
differential Notch activation levels can be provided by different Notch ligands. For example, 
in vitro T cell specification of human CD34+ CB progenitors (Jaleco et al., 2001) (Hozumi et 
al., 2004) or murine BM-derived HPCs (Lehar et al., 2005) is achieved through Dll1 or Dll4, 
but not by Jag1. Conversely, all Notch ligands support T cell development from ETPs 
(Besseyrias et al., 2007), suggesting that not only differential Notch-ligand induced signaling, 
but the progenitor developmental stage results in different outcome. This is because Jagged 
ligands seem to induce lower Notch1 activation than Delta ligands (Van de Walle et al., 
2011), being Dll4 a more effective inducer of T cell differentiation than Dll1 at low 
expression levels similar to those observed in vivo in cTECs (Lefort et al., 2006) 
(Mohtashami et al., 2010), as Dll1 at low densities enhance the generation of B-lymphoid 
precursors (Dallas et al., 2005).  Moreover, binding studies show preferential interaction of 
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Notch1 with Dll4 rather than with Dll1, which binds Notch1 weakly (Besseyrias et al., 2007). 
Thus a quantitative regulation of Delta expression levels within the TME or a differential 
expression of distinct Notch ligands at particular intrathymic niches could be responsible for 
the induction of a different Notch activation strength during thymopoiesis (Fiorini et al., 
2008) (Billiard et al., 2011). 
 
Regarding the intrathymic distribution of Notch ligands, several reports in mice have 
shown that Dll1, Dll4, Jag1 and Jag2 are differently expressed at singular thymic regions. For 
example Dll1 is abundant in the vasculature and at the CMJ (Schmitt et al., 2004) (Griffith et 
al., 2009), while Dll4 is abundantly present in cTECs specifically at the SCC (Hozumi et al., 
2008) (Koch et al., 2008) (Mohtashami et al., 2010). Conversely, Jag1 is exclusively 
expressed at the medulla, and Jag2 mRNA has been detected only at the inner thymic cortex 
(Lehar et al., 2005), (Heinzel et al., 2007) (Mohtashami et al., 2010). But nothing is known 
about Notch ligand distribution in the human thymus.  Among all Notch ligands present in the 
thymus, Dll4 is the essential and non-redundant ligand for T cell commitment at least in mice 
(Koch et al., 2008) (Hozumi et al., 2008). Conditional deletion of Dll4 in vivo in the murine 
thymus results in a complete abrogation of T cell development and the ectopic appearance of 
B cells (Koch et al., 2008); a phenotype similar to that obtained upon Notch1 abrogation 
(Radtke et al., 1999). On the contrary, Dll1 abrogation in TECs does not impair T cell 
development (Hozumi et al., 2004). Interestingly, Dll4 supports T cell lineage development 
exclusively via the Notch1 member of Notch receptors. Although Notch2-Dll1 interactions 
can also induce T cell lineage commitment, they do not support T cell maturation beyond the 
DN3 stage (Besseyrias et al., 2007). Thus, specific Notch ligands – Notch receptors 
interactions are required for successful T cell commitment and development (Fig. 10). 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 12. Notch1 and T cell fate 
specification. Loss of Notch 
function through Notch1 or RBPjκ 
abrogation in HPCs, or Dll4 in 
TECs, blocks T cell development. 
Conversely, gain of function of 
Notch signalling via over-
expression of ICN1 or Dll4, favours 
the generation of the lymphoid 
progenitor, while blocks myeloid 
progenitor development. Notch 
mediated-inhibition of the myeloid 
potential is ligand specific, Dll4 is 
the essential Notch ligand for T 
cell specification, as Dll1 in low 
levels is not able to sustain T cell 
development in vitro. 
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3. 3. Role of Notch signaling in γδ T cell development and function.  
 
As discussed above, Notch signaling may play a critical role in αβ versus γδ T cell 
fate determination once T cell fate has been specified, but whether Notch signaling also 
regulates further differentiation and function of γδ T cells after γδ T cell commitment has 
been induced is essentially unknown. As learned from αβ T cell development, Notch 
signaling must be delivered in a step-wise fashion during the intrathymic journey of γδ T 
cells, but little is known about the intrathymic niches that host γδ T cells in vivo. What is 
known from in vitro studies, is that the TCRγδ DP differentiation pathway is strongly 
dependent on Notch signaling (Van Coppernolle et al., 2012) and highly proliferative, while 
the TCRγδ DN pathway gives rise to functionally mature DN and CD8 SP γδ cells in the 
absence of Notch signaling. Thus, a capital role for Notch signaling in γδ T differentiation 
and functional maturation is beginning to emerge. In this regard, expression analysis 
performed on ex vivo-expanded human γδ T cells showed a remarkable Notch1 and Notch2 
expression. Additionally, stimulation of γδ T cells with phosphoantigens triggers Notch 
activation (Gogoi et al., 2014), while inhibition of Notch signaling with GSI, leads to a 
reduction in TNFα, INFγ and IL17 production. Accordingly, specific knockdown of Notch1 
and Notch2 inhibits γδ T cell antitumor cytotoxic potential, indicating that Notch signaling 
may regulate effector functions of γδ T cells (Gogoi et al., 2014). 
 
In contrast to what occurs with αβ T cells, which acquire their functional competence 
at the periphery, functional maturation of  γδ T cells occurs in the thymus, at least in mice 
(Narayan et al., 2012). Two main functional subsets of γδ T cells have been characterized so 
far, the IFNγ- and the IL17-secreting γδ T cells. In mice ex vivo isolated γδ T cells from the 
thymus produce IL-17 in response to PMA and ionomycin (Shibata et al., 2008), thus 
functional pre-programming occurs in the thymus. The developmental cues provided by the 
TME for specific functional differentiation of IL-17 or INFg γδ T cell producers are largely 
unknown, although intrathymic development of the naturally occurring IL-17–producing γδ T 
cells was shown to be dependent on the RORγt transcription factor (Ribot et al., 2009), and it 
is known that IL7 selectively activates the production of IL-17 by γδ T cells via STAT5 
(Michel et al., 2012). Interestingly, the canonical Notch target Hes1 is specifically expressed 
in IL-17–producing γδ T cells and seems to be involved in their development, as RBPjκ 
directly interacts with the IL17 promoter (Mukherjee et al., 2009). Additionally, Dll4–
expressing stromal cells support the development of IL-17–producing γδ T cells in vitro. All 
these evidences support a role for Notch signaling in the functional differentiation of γδ T 
cells (Shibata et al., 2011). 
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3.4. Role of Notch signaling in TEC development and homeostasis. 
 
As discussed above, an essential part of TEC development depends on crosstalk 
signals delivered from developing thymocytes. Characterization and understanding of those 
signals is important to address thymic regeneration and thus improvement of the immune 
response in the elderly and in patients that undergo inmmunoablative treatments.  However, 
little is known about the nature of those signals, although the Notch pathway could be 
involved, as it has been shown that TECs express Notch receptors (Felli et al., 1999) (Radtke 
et al., 2004). Interestingly, Notch signaling is involved in epithelial cell development in other 
organs like the skin and the gut (Nowell and Radtke, 2013). Additionally, recent in vitro 
studies in mice suggest that Notch signaling from thymocytes to TECs could induce TEC 
development at an early phase of thymic organogenesis (Masuda et al., 2009). Therefore, 
thymic crosstalk could include reciprocal Notch signaling between TECs and thymocytes, but 
evidence that this is actually the case is still scarce.  
 
Likewise, little is known about the possible involvement, of Notch signaling in the 
natural process of age-related thymic atrophy, known as thymic involution (Haynes et al., 
2000). This process results in a progressive decline in naive T cell generation, leading to a 
loss of peripheral T cell diversity. The involuted thymus suffers several molecular and 
histological changes (Fig. 13), including a dramatic decline of FoxN1 expression (Ortman et 
al., 2002). In humans, total thymocyte numbers decline after the first year of life (Bertho et 
al., 1997), although the more accused loss of thymocyte counts coincides with puberty and the 
release of sex steroids (Hince et al., 2008). This is accompanied by a decline in total thymus 
weigh, an increase in adipose tissue and a disorganization of the cortex and medulla. Besides, 
it is known that the size of Hassal’s bodies and cysts increases with age (Steinmann et al., 
1985), that there is higher frequency of “epithelial-free” areas (Aw et al., 2008), and that the 
PVS enlarges (Flores et al., 1999) (Haynes et al., 2000); but little is known about the 
molecular mechanisms underlying this processes. In situ quantification of epithelial markers 
revealed an age-dependent decline of cortical and medullary markers (such as keratin-8 and 
MHC-II) and IL-7 production (Alves et al., 2009) (Alves et al., 2010) (Aw and Palmer, 2011), 
together with an increase in Notch1 and Dll1 expression (Ortman et al., 2002) (Aw et al., 
2009). In contrast, Dll4 is downregulated in cTECs in aged mice (Fiorini et al., 2008). Further 
evidence supporting a role for Notch in thymic involution comes from in vivo studies showing 
that activation of Notch signaling in TECs via Jag1 is associated with premature thymic 
atrophy (Beverly et al., 2006). All these data suggest that thymic involution encompasses 
changes in the TME that may affect Notch signaling in TECs. However no evidences of in 
vivo Notch activation in TECs have been provided to date. 
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Figure 13. Histologic changes of the TME with thymic involution. A, Neonatal human thymus 
(17 months-old). B, Involuted human thymus (11 years-old). Age-related enlargement of Hassal’s 
corpuscles, PVS and interlobular septae decrease the functional volume of the thymic 
parenchyma. White-dotted line: CMJ; magenta-dotted line: PVS; asterisks: Hassal’s corpuscles. 
Scale bar: 100 um. 
 
  41
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Specific Aims 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  43
Specific Aims 
 
 
 
 
The general goal of this study has been to determine whether a differential 
distribution of Notch ligands and receptors in the human thymus could define discrete 
microenvironments with specific developmental functions, paying special attention to the 
critical check-point that controls the split of developing thymocytes into αβ and γδ T cells, 
and also to the physiological role of the Notch pathway in the biology of the thymic 
epithelium. To address this goal, we propose the following specific aims:     
 
 
1. To characterize the regulation of Notch signaling activation and the expression of 
Notch ligands and receptors during thymus ontogeny and involution in human and 
mouse.  
 
2. To investigate the contribution of different Notch ligands to the human 
αβ/γδ developmental branch point as well as to γδ T cell generation, expansion and 
functional maturation. 
 
3. To assess the dynamics of γδ T cell development in the human thymus. 
 
4. To study the role of Notch signaling in TEC biology using a conditional loss-of-
function murine model. 
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1. Tissue processing and immunohistochemistry. 
 
1.1. Histology proceedings. 
 
Experiments were performed in accordance with procedures approved by the Spanish 
Research Council Bioethics Committee. Human thymic biopsies were obtained from newborn to 15 
years-old children undergoing cardiac surgery, after informed consent was provided in accordance 
with the Declaration of Helsinki. Murine tissue samples were obtained from 5 to 16 week-old 
C57BL/6 mice, and from 3 to 12 months-old C57BL/6 RBPjk-KOTEC mice. Tissue samples were 
fixed over-night (O/N) at 4ºC in 4% paraformaldehyde/PBS (PFA, Sigma-Aldrich) and paraffin 
embedding was performed following a dehydration protocol using graded ethanol series, xylene 
washes and a final paraffin embedding step (Paraplast Plus, Sigma-Aldrich). Timing of each 
inclusion step was specifically optimized for human and murine thymic tissue. Formalin-fixed 
paraffin-embbed (FFPE) human fetal thymic samples were kindly provided by Dra. N. Torán 
(Anatomic Pathology Service, Vall d’ Hebron Hospital, Barcelona, Spain). In parallel, some other 
human thymic fresh tissue samples were included in O.C.T compound (Tissue-Tek, Sakura), snap-
frozen and stored at -70ºC. From both types of tissue-embed specimens, serial 8 um sections were 
obtained (Reichert-Jung Frigocut 2800N) and mounted on poly-lysine-coated slides (SuperFrost Ultra 
Plus, Thermo Scientific). Prior immunostaining, FFPE tissue slides were deparaffinised in xylene and 
ethanol-graded series. Next, tissue antigens were retrieved by boiling samples in a microwave oven 
for 10 to 15 minutes in sodium citrate (10mM, pH 6.0). Slides were allowed to cool down to room 
temperature (RT) and washed in distilled water and phosphate buffered saline (PBS). Endogenous 
peroxidase activity was quenched using 1% H2O2 in 100% methanol (40 min, RT) followed by 
washes in PBS and PBS 0.3% Triton-X-100 (Sigma-Aldrich). For blocking unspecific antibody 
binding sites, samples were incubated 1 hour in blocking solution (3% BSA, 20mM MgCl2, 0.3% 
Tween-20, 5% FBS in PBS) in humidified chamber prior incubation with suitable primary antibodies.  
 
In the case of frozen thymic tissue, air-dried tissue slides were fixed 10 minutes in cold 
acetone and washed in PBS. Then, tissue autofluorescence was quenched with 50mM NH4Cl and 
saturated Sudan Black solution (Sigma-Aldrich). Endogenous peroxidase was quenched when 
necessary as previously described and, unspecific antibody binding sites were blocked with blocking 
solution without surfactant (3% BSA, 20mM MgCl2, 5% FBS in PBS). 
 
1.2. Immunofluorescent staining of Notch ligands, Notch receptors and Hes1. 
 
 Deparaffinised, rehydrated and properly blocked FFPE tissue slides were 
permeabilized 20 minutes in PBS 0.3% Triton-X-100, and incubated in humidified chamber 
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(O/N; 4ºC) in blocking solution containing the following primary antibodies: anti-human 
Dll1, anti-human Dll4, anti-human Jag1, anti-human Jag2, anti-human Notch1, anti-human 
cleaved Notch1, anti-human Notch3, anti-human Notch4 and anti-human Hes1 (see Table 1). 
Background and unspecific staining was determined by incubating with irrelevant antibodies, 
specie-specific normal serum and/or in the absence of primary antibody. Prior addition of 
secondary antibodies, tissue endogenous biotin was quenched by incubation in Avidin/Biotin 
blocking solutions (Vector Labs). For immunodetection of Dll4, Jag1 and Jag2, tissue slides 
were then incubated 1 hour at RT with HRP-coupled anti-rabbit IgG antibody (in 5% BSA in 
PBS, DAKO) and then, the signal was amplified by the Cyanine-3 Tyramide Signal 
Amplification kit (TSA; NEL 744, Perkin Elmer). TSA-Cy3 incubation time was 3.5 minutes. 
For Dll1, Notch1, Notch3, Notch4 and cleaved Notch1 (ICN1) immunodetection, a 
biotinylated anti-rabbit IgG antibody (Vector Labs) was added (5% BSA in PBS; 1 hour) 
prior signal amplification which comprised two steps. First, slides were incubated 1 hour with 
Avidin/Biotin-HRP complex (Elite Vectastain ABComplex kit, Vector Lab.) and then HRP 
was developed by adding TSA-Cy3 for 3.5 minutes. Finally, nuclei were stained with Topro-3 
and slides mounted with Fluoromount-G (Southern Biotech.) 
 
 1.3. Immunofluorescent staining of thymic stromal cells. 
 
 For thymic stromal cell (TECs, myeloid cells, perivascular mesenchymal cells and 
endothelium) characterization, deparaffinised, rehydrated and properly blocked FFPE tissue 
slides were permeabilized 20 minutes in PBS 0.3% Triton-X-100, and incubated in 
humidified chamber (O/N; 4ºC) in blocking solution. For total TECs immunostaining we used 
a mouse anti-human pan-cytokerain (panCK) antibody mix or a rabbit anti-human cytokeratin 
19 antibody. For myeloid cells immunostaining we used a mouse anti-human CD11c and. 
Finally, for mesenchymal and endothelial cells we used a mouse anti-human CD34 mAb (see 
Table 1). For CD34 immunodetection on intrathymic progenitors and, prior addition of 
secondary antibodies, tissue endogenous biotin was quenched by incubation in Avidin/Biotin 
blocking solutions (Vector Labs). Then, tissue slides were incubated one hour in humidified 
chamber (RT) with a biotinylated IgG anti-mouse antibody (5% BSA in PBS; Vector 
Laboratories) following 1 hour incubation with Avidin / Biotin-HRP Complex (Elite 
Vectastain ABComplex kit, Vector Labs). Next, ABC-amplified CD34 specific signal was 
developed by adding Alexa-488- or Alexa-555-conjugated Streptavidin for 20 minutes. For 
the detection of CD34 in mesenchymal areas (capsule, septae and PVS) no signal 
amplification was used, and primary antibody signal was developed directly with an Alexa-
555 coupled goat anti-mouse antibody. CD11c, CK19 and panCK were developed without 
signal amplification by one hour incubation in humidified chamber (RT) with an Alexa-488-
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coupled goat anti-mouse antibody or an Alexa-488-coupled goat anti-rabbit antibody. 
Background and unspecific staining was determined by incubating with irrelevant antibodies, 
specie-specific normal serum and/or in the absence of primary antibody. Finally, nuclei were 
stained with Topro-3 and slides were mounted with Fluoromount-G (Southern Biotech.). 
 
 1.4. Immunofluorescent staining of TCRγδ cell populations. 
 
 In vivo detection of TCRγδ cells in the human thymus was addressed in frozen 
acetone-fixed thymic tissue. Briefly, H2O2-quenched and blocked tissue slides were incubated 
with the following primary antibodies: mouse anti-human TCRγδ, mouse anti-human Vδ1, 
mouse anti-human Vδ2, mouse anti-human intracellular TCRβ (kindly provided by M. 
Brenner, Brigham and Women's Hospital, Boston, MA) and mouse anti-human CD1a (see 
Table 1). Human Vδ1 and Vδ2 γδ T cells show two distinct molecular configuration of the 
TCR. In Vδ2 γδ T cells TCRδ and TCRγ chains are disulfide-linked, while Vd1 TCRd and 
TCRgd chains are not disulfide linked (Brenner et al., 1987). This molecular characteristic 
allow to detect these two γδ T cell subpopulations with different monoclonal antibodies 
(Bottino et al., 1988) (Grossi et al., 1992) that we have used to locate Vδ1 and Vδ2 gd T cells 
in vivo in the human thymus. Background and unspecific staining was determined by 
incubating with irrelevant antibodies, specie-specific normal serum and/or in the absence of 
primary antibody. For TCRδ, Vδ1, Vδ2 and TCRβ detection an Alexa-488- or Alexa-555-
coupled anti-mouse IgG1 secondary antibody was added (5% BSA in PBS; Vector 
Laboratories, 1 hour) depending on the combination with the stromal marker CK19 (see 
above) or CD1a. For CD1a immunodetection an Alexa-555-coupled anti-mouse IgG2a 
secondary antibody was used. For nuclei were stained with Topro-3 and slides mounted with 
Fluoromount-G (Southern Biotech.). 
 
 1.5. Haematoxilin/eosin and β-galactosidase (LacZ) stainings. 
 
 FFPE tissue slides of postnatal (< 17 months-old) and involuted (> 6 years-old) 
human thymic tissue were stained with haematoxilyn/eosin for tissue morphology 
observations. Briefly, deparafinized tissue slides were incubated for 3 minutes in Harry’s 
haematoxilyn (Sigma), washed and quickly differentiated (10 to 15 sec) in acid alcohol 
solution (0,5% HCl; 70% ethanol). Next, they were incubated 9 minutes in 0,5% (w/v) Eosin 
solution (Sigma) and sequentially dehydrated in graded ethanol series. Finally, tissue slides 
were briefly incubated in xylene and mounted with Entellan mounting medium (Merck, 
Millipore). 
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For β-galactosidase staining, intact thymic lobes from 3 days-old and 8 weeks-old 
C57BL/6J Rosa26-LacZflox/flox and B6D2F1/J FoxN1-Cre-Rosa26-LacZflox/flox mice were 
fixed in 0,125% glutaraldehyde/PBS solution for 30 min at RT. Next, thymic lobes were 
washed in wash buffer (0,02% Nonidet-P40; 0,11% sodium deoxycholate and MgCl2 2mM; 
in phosphate buffer 0,1M; pH 7,3) and stained O/N RT in X-gal staining solution (wash 
buffer supplemented with potassium ferricyanide 5mM, potassium ferrocyanide 5mM and 
1mg/ml of X-gal resuspended in N,N-dimethyformamide). The cleavage of X-gal (5-bromo-
4-chloro-3-indolyl-b-galactopyranoside) by b-galactosidase results in a dark blue precipitate. 
After X-gal staining, thymic lobes were washed in wash buffer, fixed in 4% PFA/PBS 
(Sigma-Aldrich) and paraffin-embed as described previously. Serial 8 um sections were 
mounted on poly-lysine-coated slides (SuperFrost Ultra Plus, Thermo Scientific) and 
deparaffinised as specified earlier. Cell nuclei were stained with Nuclear Fast Red (Vector 
Labs), sequentially dehydrated in graded ethanol series and xylene, and mounted with 
Entellan mounting medium (Merck, Millipore). 
 
1.6. Table of antibodies used in immunohistochemical analysis. 
 
Specificity Reactivity Clone Isotype Origin Conjugate 
Anti-mouse IgG1 M Polyclonal Goat  Thermo Alexa-488 
Anti-mouse IgG2a  M Polyclonal Donkey Thermo Alexa-555 
Anti-mouse IgG M Polyclonal Goat  Vector Lab. Biotin 
Anti-Rabbit IgG Rbb Polyclonal Goat DAKO HRP 
Anti-Rabbit IgG Rbb Polyclonal Goat Vector Lab. Biotin 
Anti-Rabbit IgG Rbb Polyclonal Donkey Thermo Alexa-488 
CD11c H 5D11 Mouse IgG2a Novocastra Purified 
CD1a H Na1/34 Mouse IgG1 AbcSerotec Purified 
CD34 H My10 Mouse IgG1 J.H. Shaper Purified 
Cleaved Notch1  H, M D3B8 Rabbit IgG Cell Sign. Purified 
Dll1 H, R Polyclonal Rabbit IgG Abcam Purified 
Dll4 (H-70) H, M, R Polyclonal Rabbit Sta. Cruz Purified 
Hes1 H, M D6P2U Rabbit IgG Cell Sign. Purified 
Jag1 H, M 28H8 Rabbit IgG Cell Sign. Purified 
Jag2 (2205) H C83A8 Rabbit IgG Cell Sign. Purified 
Jag2 (2210) H, M C23D2 Rabbit IgG Cell Sign Purified 
Cytokeratin 19 H Polyclonal Rabbit Sigma Purified 
Notch1 (C-20) H Polyclonal Goat Sta. Cruz Purified 
Notch3 H Polyclonal Rabbit IgG Abcam Purified 
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Notch4 H Polyclonal Rabbit IgG Abcam Purified 
Pan-cytokeratin H, M, Rbb Polyclonal  
mixture 
Mouse IgG1  
and IgG2a 
SIGMA Purified 
TCR Vδ2 Human BB3 Mouse IgG1 L. Moretta Ascytes 
TCR Vδ1Jδ1  H TSC1 (TS-1) Mouse IgG1 Thermo Sc. Purified 
TCRβ Human bF1 Mouse IgG1 M. Brenner Purified 
TCRγδ H B1.1 Mouse IgG1 eBioscience Purified 
TCRγδ Human  5A6.E9 Mouse IgG1 Invitrogen Purified 
Table 1. Antibodies used in immunohistochemistry. Legend: H: human; M: mouse; R: rat; Rbb: rabbit. 
 
2. Acquisition, analysis and statistics of confocal microscopy images. 
 
 Images were acquired using an LSM510 laser scan confocal microscope (Zeiss) 
coupled to an Axio Imager.Z1 or an Axiovert 200  (Zeiss) microscope using the following 
magnifications (Zeiss): 10× Plan-Neofluar (numeric aperture [NA] 0.3), 25× Plan-Neofluar 
(oil [NA] 0.8), 40× Plan-Neofluar (oil [NA] 1.3) and 63x Plan-Apochromat (oil [NA] 1.4). 
Images were obtained at 1024px x 1024px resolution and 8-bit colour depth for descriptive 
purposes and at 12-bit for quantifications. Images were processed using ImageJ and Adobe 
Photoshop CS4 software (brightness and contrast were adjusted equally in samples and 
controls). Co-expression, Mean Fluorescence Intensity (MFI) analyses and 
histomorphometric measurements were performed in ImageJ by definition and comparison of 
ROIs (region of interest) created by threshold of intensity of fluorescence (image 
thresholding) by applying the Otsu algorithm (Otsu, 1979). M1 and M2 Mander’s coefficients 
were obtained by applying the Intensity Correlation Analysis (ICA) plugin  
(http://www.uhnresearch.ca/facilities/wcif/imagej/colour_analysis.htm) to thresholded 
images. When comparing MFI in TECs from different anatomic regions of the same sample 
(25x magnification images), equivalent square ROIs (100µm x 100µm) were defined on each 
region on which application of intensity threshold (Otsu, 1979) allowed us to create a final 
specific ROI in TECs. Cell counting analyses were performed in Adobe Photoshop CS4 
(Extended) by using the “Count” tool. Data are presented as mean +/- SEM and statistical 
analyses were performed using Graph Pad software. Statistical significance was determined 
with the unpaired 2-tailed Student t test and one-way ANOVA, with the α level set at 0.05. 
3. Immunomagnetic isolation of human primary thymocyte subsets. 
Normal human postnatal thymocytes were isolated by mechanical disruption of 
thymus fragments, removed during corrective cardiac surgery of patients aged from 3 days up 
to 4 years, after informed consent was provided in accordance with the Declaration of 
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Helsinki. Experiments were performed in accordance with approved guidelines established by 
the Research Ethics Board of the Spanish Research Council. A thymocyte cell suspension 
was obtained after Ficoll-Hypaque (LymphoprepTM; ATOM) centrifugation of the total cell 
suspension resulting from mechanical disruption of the thymic tissue. For CD34+ intrathymic 
progenitors isolation, thymocyte cell suspension was subsequently enriched in non-T cells by 
sheep erithrocyte rosseting, as previously described (Martin-Gayo et al., 2010). Next, CD34+ 
cells were selected from the resulting cell fraction using magnetic-activated cell sorting with 
CD34+ MicroBeads (Dynal, CD34 Progenitor Cell selection System, Invitrogen). Two 
different populations of intrathymic progenitors, CD34+ cells (DN2) and CD34hi cells 
(ETPs), were obtained from the CD34-labeled fraction by sequential incubations with an anti-
CD34 competitor antibody (DETACHaBEAD, Dynal, Invitrogen) at 25ºC and 37ºC, 
respectively. Additionally, selected CD34hi and CD34+ populations were depleted from 
CD1a+ cells by the incubation with anti-CD1a MicroBeads (MACS, Miltenyi Biotec) and 
negative selection using an AutoMACS magnetic cell sorter (Miltenyi Biotec), obtaining a 
CD34+ CD1a- population (DN2 progenitors). The resulted positive fraction was depleted 
from CD4+ cells by incubation with anti-CD4 Microbeads (MACS, Miltenyi Biotec)  
obtaining a CD34 CD1a+ population (proT cells). 
 
For total human intrathymic TCRγδ cell isolation, the thymocyte cell suspension 
obtained after Ficoll-Hypaque (LymphoprepTM; ATOM) centrifugation was left O/N at 4ºC in 
RPMI supplemented with 10% of FBS, and then subjected to a second Ficoll-Hypaque 
centrifugation to remove apoptotic thymocytes. The resultant fraction was incubated with 
Hapten-labelled anti-human TCRγδ mAb and FITC-labelled anti-Hapten MicroBeads 
(Human TCRγδ+ Isolation kit, MACS, Miltenyi Biotec), and isolated by manual magnetic 
cell sorting using positive selection columns (MACS LS Column, Miltenyi Biotec). For the 
specific isolation of CD1a+ immature γδ T cells, the thymocyte cell suspension obtained from 
the second Ficoll-Hypaque centrifugation was fractionated by centrifugation on Percoll 
density gradients (GE Healthcare). Big size thymocytes recovered from the 1.068 g/ml 
density layer (F50) were then incubated with PE-labelled anti-human CD1a mAb (Coulter) 
and anti-PE MicroBead Multi-Sort Kit (MACS, Miltenyi Biotec). Then, CD1ahi cell were 
isolated by manual magnetic cell sorting using positive selection columns (MACS LS 
Collumn, Miltenyi Biotec). Next, TCRγδ cells were selected from the CD1ahi thymocyte 
population (purity 100%) by incubation with Hapten-labelled anti-human TCRγδ mAb and 
FITC-labelled anti-Hapten MicroBeads (Human TCRγδ+ Isolation kit, MACS, Miltenyi 
Biotec). Finally, CD1ahi TCRγδ-labelled cells were isolated by manual magnetic cell sorting 
using positive selection columns (MACS LS Collumn, Miltenyi Biotec) (purity > 90%). 
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4. Isolation of peripheral blood lymphocytes (PBLs). 
 
Human peripheral blood samples (buffy coat) obtained from healthy individuals were 
used to isolate PBLs, after informed consent was provided in accordance with the Declaration 
of Helsinki. Briefly, total mononuclear blood cells were obtained by Ficoll-Hypaque 
(LymphoprepTM; ATOM) density gradient centrifugation. The resulted fraction of 
mononuclear cells was incubated with erythrocyte lysis buffer (9 vol. NH4Cl 0,83%; 1 vol. 
Tris HCl 2%) to discard erythrocyte remnants. Next, mononuclear blood cell suspension was 
enriched in lymphoid cells (T and NK cells mainly; purity > 90%) by depletion of myeloid 
lineage cells using lineage specific antibodies followed by negative selection using an 
AutoMACS magnetic cell sorter (Miltenyi Biotec). 
 
5. Flow cytometry. 
 
5.1. Cell membrane staining. 
 
Single cell suspensions of lymphocytes from murine thymus and spleen, were 
prepared by standard procedures. Additionally, the expression of surface markers on human 
primary and in vitro cultured thymocytes was determined by staining (for three to six colors) 
of 2 x 104 cells per condition in ice-cold FACS buffer (PBS, 1% BSA, 3mM EDTA). The 
direct fluorochrome- or biotin-labelled mAbs used are detailed in Table 2, as well as, second-
step reagents including PE-conjugated goat anti-mouse IgGs or PE- or APC-conjugated 
streptavidine. Data were collected on 1 to 5 x 103 viable cells as determined by electronic 
gating on forward and side scatter light parameters. Isotype-matched irrelevant antibodies 
were used as negative controls to define background fluorescence. Three-colour flow 
cytometry acquisition was performed using a FACSCalibur cytometer and the CellQuest 
software (BD Biosciences), up to six-colour flow cytometer acquisition was performed in a 
FACSCanto II and FACSDiva software. FACS Flow cytometric data analysis was performed 
using FlowJo vX (LLC software).  
 
5.2. Intracelullar stainings. 
 
Intracelullar TCR-β expression on ex-vivo or in vitro developing thymocytes was 
assessed using the CytoFix-CytoPerm Permeabilization Kit (BD Biosciences) following 
manufacturer’s intructions. Briefly, 5 x 104 cells were fixed and incubated with anti-human 
βF1 mAb (provided by M. Brenner, Brigham and Women's Hospital, Boston, MA) in 
CytoPerm solution. Then, PE-labelled anti-mouse IgG1 secondary antibody was added to the 
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cells. A PE-labelled irrelevant isotype-matched antibody was used as control. Next, and after 
proper blocking in normal mouse serum, mAbs for staining of other markers were added. 
 
IL-17 and INFγ cytokine expression on ex-vivo or in vitro generated γδ T cells and 
human PBLs was assessed in activated cells (see 11.3) by fixation of previously membrane-
stained 5 x 104 cells in 2% PFA/PBS for 10 minutes at RT. After proper wash, PE-labelled 
anti-human IL-17 or anti-human IFNγ mAbs were added to the cells in permeabilizing 
solution (FACS Buffer; 0,5% Saponin/PBS pH 7,4) and incubated for 30 minutes at RT. 
Then, cells were washed in permeabilizing solution and re-suspended in FACS buffer. 
 
5.3. Table: Summary of antibodies used in flow cytometry. 
 
Specificity Reactivity Clone Isotype Origin Conjugate 
CD1a Human SFCI19Thy1A8 Mouse IgG1 B. Coulter PE 
CD1a Human Na1/34 Mouse IgG1 AbcSerotec Biotin 
CD3 Human  B-B11 Mouse IgG1 Diaclone FITC 
CD3 Human UCHT1 Mouse IgG1 BD PE, APC 
CD3 Human S4.1 Mouse IgG2a Life Technol. TC 
CD4 Human 13B8.2 Mouse IgG1 B. Coulter FITC, TC 
CD4 Human  SFCI12T4D11 Mouse IgG1 B. Coulter PE 
CD5 Human L17F12 Mouse IgG2a BD FITC 
CD7 Human CD4-6B7 Mouse IgG2a Life Technol. PE-Cy5 
CD8a Human G42-8 Mouse IgG2a BD FITC 
CD8a Human 3B5 Mouse IgG2a Life Technol. PE 
CD8a Human  RPA-T8 Mouse IgG1 BD PE-Cy7 
CD8b Human 2ST8.5H7 Mouse IgG2 B. Coulter PE 
CD27 Human M-T271 Mouse IgG1 BD FITC, PE 
CD33 Human D3HL60.251 Mouse IgG1 B. Coulter PE-Cy5 
CD34 Human 581 Mouse IgG1 B. Coulter FITC, PE-Cy5 
CD44 Human G44-26 Mouse IgG2b B. Coulter FITC 
CD56 Human MEM-188 Mouse IgG2a Caltag PE 
CD69 Human CH/4 Mouse IgG2a Life Technol. PE 
CD127 Human R34.34 Mouse IgG1 B. Coulter PE 
IFNγ Human B27 Mouse IgG1 BD PE 
IL-17A Human  eBio64DEC17 Mouse IgG1 eBioscience FITC 
Mouse IgG1 Mouse Polyclonal Goat IgG1 Southern Bio FITC, PE-Cy5 
Mouse IgG1 
Isotype Control 
- MOPC-21 Mouse IgG1 BD FITC, PE, PE-
Cy5, APC 
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Mouse IgG2a 
Isotype Control 
- G155-178 Mouse IgG2a BD PE 
Notch1 Human MHN-519 Mouse IgG1 Biolegend PE 
Notch3 Human MHN3-21 Mouse IgG1 Biolegend PE 
Biotin - - Streptavidin Biolegend APC 
TCRαβ Human IP26A Mouse IgG1 B. Coulter PE-Cy5 
TCRγδ Human IMMU510 Mouse IgG1 B. Coulter PE 
TCRγδ Human 5A6.E9 Mouse IgG1 Life Technol. Pe-Cy5 
TCRγδ Human  B1 Mouse IgG1 BD APC 
TCR Vδ1 Human TS8.2 Mouse IgG1 Thermo Sc. FITC 
TCR Vδ2 Human  B6 Mouse IgG1 Biolegend PerCP 
TCR Vδ1  Human TSC1 (TS-1) Mouse IgG1 Thermo Sc. Purified 
TCR Vδ2 Human BB3 Mouse IgG1 L. Moretta Ascytes 
TCRβ Human bF1 Mouse IgG1 M. Brenner Purified 
Table 2. Antibodies used in flow cytometry.  
 
6. RNA Isolation. 
 
Total RNA was obtained, by using TRIzol reagent (Invitrogen Life Technologies) 
according to manufacturer’s instructions, from the following sets of human samples: CD34+ 
CD1a- lymphoid progenitors (LP), total TCRγδ+ cells, CD34+ CD1a+ pro-T cells generated 
in vitro under different culture conditions (GFP, Dll4, Jag1 and Jag2) and HeLa cell line. 
RNA concentration and purity was determined by 260/280 (< 1.8) and 260/230 (< 1.8) 
absorbance ratios (Nanodrop ND-100, Thermo Scientifc). 
 
7. Polimerase chain reaction (PCR). 
 
7.1. Reverse transcriptase PCR (RT-PCR). 
 
RT-PCR assay was performed for the amplification of the human Jagged2 c-terminal 
region. To prepare total RNA for reverse transcription of Jag2 DNA, HeLa cells (ATCC) 
were lysed in TRIzol Reagent (Invitrogen) and extracted according manufacturer’s 
instructions. Next, cDNA was reverse transcribed using oligo (dT)12-18 primers (Invitrogen) 
and Expand Reverse Transcriptase (Roche). WT human JAG2 c-term (1.8 Kb fragment 
containing the TAG stop codon) was PCR amplified from total HeLa cDNA by Jag2 c-term 
specific primers, containing hanging NotI restriction sites. The upstream primer was the 
following: agccGCGGCCGCtgctacga. The downstream primer was the following: 
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atatGCGGCCGCctactccttgccggcgtagcgg (NotI restriction sites are given in capital letter). 
PCR reaction was performed using X Pfu polymerase (Roche). Samples were denatured at 
95ºC for 2 minutes and amplified at 95ºC for 30 seconds, 65ºC for 30 seconds and 72ºC for 2 
minutes followed by a final extension at 72ºC for 10 minutes. cDNA integrity was assessed 
by parallel amplification of β-actin (primers). Amplified PCR products were subjected to 1 % 
agarose (Promega) electrophoresis and visualized with ethidium bromide. 
 
7.2. Cuantitative PCR (qPCR). 
 
Real-time PCR quantification of complementary DNA synthesized from TRIzol-
extracted (Invitrogen) total RNA using oligo (dT)12-18 primers (Invitrogen) was performed 
using TaqMan Gene Expression Assays (Applied Biosystems), according to the 
manufacturer’s instructions, in a ABI PRISM 7900 HT Sequence Detection system (Applied 
Biosystems). The TaqMan probes used are detailed in the following table. 
 
Target mRNA TaqMan reference  Target mRNA TaqMan Reference 
TOX2 Hs00262775_m1 
 
LEF1 Hs01547250_m1 
ITGAE Hs01025372_m1 
 
THEMIS Hs01041269_m1 
GATA3 Hs00231122_m1 
 
FOXO1 Hs01054576_m1 
SOX13 Hs00232193_m1 
 
BLK Hs01017482_m1 
ETV5 Hs00927557_m1 
 
HES1 Hs00172878_m1 
RUNX3 Hs00231709_m1 
 
GAPDH Hs0258991_g1 
Table 3: TaqMan probes used in qPCR assays. 
 
8. DNA cloning into retroviral and expression vectors. 
 
The pLZRS-polylinker-IRES-enhancedGFP retroviral constructs encoding either the 
full-length human Dll1 or Jag1, and the GFP empty vector were kindly provided by Dr L. 
Parreira (Instituto de Histologia e Embriologia, Lisboa, Portugal). Human Dll4 full-length 
cDNA in the pcDNA3.1/myc-His expression vector, was a generous gift by Dr G. Tosato 
(National Institutes of Health, Bethesda, MD). Dll4 cDNA was excised from the pcDNA3.1 
expression vector and cloned into the BamHI and EcoRI restriction sites of the pLZRS-linker-
IRES-eGFP retroviral construct. Restriction and sequence analysis were performed to confirm 
proper ligation of the human Dll4 open reading frame into the pLZRS-IRES-eGFP vector. A 
myc-tagged human JAG2 cDNA cloned in the pcDNA3 expression vector was kindly 
provided by Dr P. Menendez (Andalusian Stem Cell Bank, Spain). This JAG2 construct was 
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lacking the last 20 aminoacids (C-term) of the JAG2 protein, carrying instead a tandem of 3 
myc-tag copies. As endocytosis of C-terminal region of Notch ligands is necessary for proper 
Notch signalling, WT human Jag2 C-term cDNA (1,8 Kb fragment containing the TAG stop 
codon) was PCR amplified from total RNA isolated from HeLa cells as described above (see 
section 7.1). Finally, for Jag2 full-length composite, Jag2-myc-tagged cDNA was excised 
from the pcDNA3/myc-His using HindIII and XbaI restriction sites and cloned into a 
pBluescript II SK- intermediate vector where the fragment of 1,8 Kb containing the C-
terminal myc-tag tandem was removed and discarded by enzimatic restriction with NotI 
enzyme. Next, the remaining N-terminal portion of JAG2 (2,1 Kb fragment containing the 
ATG initiation codon) was also excised using the EcoRI site available at the pBluescript II 
SK- cloning cassette. Finally, the N-terminal 2,1kb JAG2 fragment (EcoR-NotI) and the WT 
PCR-amplified JAG2 c-term 1,8Kb fragment (NotI-NotI) were sequentially ligated into the 
final pLZRS-IRES-GFP retroviral vector. Restriction and sequence analysis were performed 
to confirm proper amplification and ligation in correct orientation of both JAG2 fragments in 
the LZRS-IRES-eGFP vector. 
 
9. Generation of retroviral particles and retroviral transduction of the OP9 stromal cell 
line. 
 
Dll1, Dll4, Jag1, Jag2 and GFP retroviral constructs were used for lipofection 
(Fugene6, Roche) of the packaging 293T Phoenix-Amphotropic cell line (kindly provided by 
G. Nolan, Stanford University, Stanford, CA). 48 hours after transfection, transfected 293T 
Phoenix-Ampho cells were selected by addition of 2,5 µg/ml of puromycin (Sigma). Two 
weeks after transfection, puromycin-selected cells were plated confluent on p100 plates 
(Falcon) of DMEM medium supplemented with 10% fetal calf serum and 1% HEPES (Gibco, 
Invitrogen) without puromycin, from which we obtained high titres of empty (control GFP 
only) or Dll1, Dll4, Jag1 and Jag2 recombinant retrovirus. The following day retroviral 
supernatants were harvested and used for transduction of the OP9 stromal cell line (ATCC). 
OP9 cells were seeded semi-confluent onto p24 well plates and transduction was performed 
by centrifugation at 1800 rpm in the presence or 8 µg/ml of polybrene. 48h post-transduction 
OP9 cells were analyzed for GFP expression by flow cytometry and highly transduced cells 
(between 103 – 104 log) were sorted until 100% of the cells expressed homogeneous levels of 
GFP. 
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10. Western blotting. 
Ectopical overexpression of Notch ligand on the OP9-engineered cell lines was 
confirmed by Western blot. OP9 cells were lysed in RIPA buffer (50mM Tris pH 8.0, 150mM 
NaCl, 0.5% Sodium deoxycholate, 1% NP-40, 0.1% SDS) plus a protease inhibitor cocktail 
containing sodium fluoride, sodium orthovanadate, aprotinin, pepstatin A and PMSF (all from 
Sigma). Protein quantification was performed using BCA assay (MicroBCATM, Pierce) and 
equal amounts of total protein from OP9-GFP, OP9-Dll1, OP9-Dll4, OP9-Jag1 and OP9-Jag2 
were elecrophoretically separated and transferred to PVD blotting membranes (Millipore). 
Membranes were blocked 1 hour in 5% non-fat milk TBS-T buffer (TBS plus 0.05% Tween-
20, Sigma-Aldrich) prior incubation with the following primary antibodies:  rabbit anti-
human Dll1 (Abcam), rabbit anti-human Dll4 (Abcam), rabbit anti-human Jag1 (Cell 
Signaling) and rabbit anti-human Jag2 (Cell Signaling). Mouse anti−α−tubulin mAb (Sigma) 
was used as loading control. Signal was developed with the appropriate secondary Abs 
conjugated to HRP (Jackson Laboratories) in conjunction with a luminescent substrate (ECL, 
Roche). 
 
11. Cell culture. 
 
11.1. Co-culture of human intrathymic progenitors and intrathymic TCRγδ 
cells. 
 
In vitro differentiation of αβ and γδ T cells from DN2-like lymphoid human CD34+ 
intrathymic progenitors was performed as previously described using the OP9 system (see 
Introduction 2.2). Briefly, engineered Notch ligandhi-expressing OP9 cells were seeded semi-
confluent on p24 well plates (Falcon) and co-cultured during 31 days with DN2-like CD34+ 
CD1a- intrathymic progenitor cells in minimum essential medium (α-MEM, Invitrogen) 
supplemented with 20% fetal calf serum (Invitrogen), 200IU/ml of human recombinant 
Interleukin-7 (hrIL-7, PreproTech) and 100IU/ml of Flt3L (NIBSC) at 37°C, 5% CO2. Co-
cultures were initiated with around 1 x 105 cells per well and were harvested by forceful 
pipetting every 3 or 4 days for phenotype analysis. Seeding to a fresh OP9-seeded well was in 
all cases preceded by filtration of the total cell suspension through a 45µm filter, in order to 
separate developing thymocytes from stromal OP9 cells. In the case of priming short co-
cultures for qPCR analysis of thymocyte populations, lymphoid progenitors were co-cultured 
for 6 days in the same conditions. Then, resulting proT cells were separated from the stroma 
by filtering as early mentioned and stroma remnants were discarded by plate adhesion during 
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20 minutes at 37ºC, so no RNA from OP9 stromal cells was in any case contaminating qPCR 
analyses. 
 
Ex-vivo isolated CD1a+ γδ T cells were cultured at 5 x 105 cells/ml at 37°C, 5% CO2 
in p24-well plates seeded with a semi-confluent monolayer of either Dll4-, Jag1-, Jag2- or 
GFP empty vector- expressing OP9 cells in α-MEM media (Invitrogen) supplemented with 
20% FBS (Invitrogen), hrFlt3L (PreproTech) and 200IU/ml of hrIL-7 (NIBSC). Co-cultures 
were initiated with around 5 x 105 cells per well and harvested by forceful pipetting every 3 or 
4 days for phenotypic analysis.  
 
11.2. In vitro activation of T cells.  
 
Ex vivo isolated peripheral blood lymphocytes or TCRγδ cells and in vitro generated 
αβ and γδ T cells were activated in vitro by culturing them 36 hours onto p46-well plates 
coated with 10µg/ml of anti-CD3-coated (OKT3, purified) and, in the presence of hrIL-2 
(Peprotech). As in vitro activation induces CD3 (and thus TCR) downregulation, cells were 
passed to a new plate without anti-CD3 and cultured for further 5 to 6 days to recover TCR 
expression. Then cells were treated with Brefeldin A (Sigma) and stimulated with phorbol 12-
myristate 13-acetate (PMA, Sigma) and ionophore prior FACS analysis. 
 
12. Mice. 
 
Mice were kept under specific pathogen-free conditions and used according to 
institutional regulations. C57BL/6J WT mice were obtained in-house from the departmental 
breeding facility, whereas B6D2F1/J FoxN1-Cre mice were obtained from Dr. George 
Hollander (University of Basel) (Zuklys et al., 2009). C57BL/6J RBPjkflox/flox mice (Oka et 
al., 1995) and C56BL/6J Rosa26-LacZflox/flox were obtained from Dr. Jose Luis de la Pompa 
(CNIC, Madrid), respectively. Mice genotyping was performed by PCR analysis of genomic 
DNA obtained by proteinase K (Sigma) digestion of 3 weeks-old mouse ear discs tissue. 
Primers used to detect Cre recombinase transgene were P1, 5’-TCT GAT GAA GTC AGG 
AAG AAC C-3’, and P2, 5’-GAG ATG TCC TTC ACT CTG ATT C-3’, which generates a 
fragment of about 500bp long. PCR were performed for 34 cycles of 94ºC (30 sec), 58ºC (40 
sec), and 72ºC (1 min). For the detection of the RBPjkflox/flox alleles the following primers 
were used: P3, 5’-ACC AGA ATC TGT TTG TTA TTT GCA TTA CTG-3’, and P4, 5’-ATG 
TAC ATT TTG TAC TCA CAG AGA TGG ATG-3’, which generates a product of 430bp 
long for the RBPjkflox/flox allele and 274bp long for the WT allele. For specific detection of 
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RBPjκ deletion, the primer P5, 5’-TAA TGC ACA CAA GCA TTG TCT GAG TTC-3’ was 
used in combination with primer P3 which yields no product in a non-deleted allele or a 
640bp long product when the RBPjk gene has been successfully deleted. In this case, PCR 
was performed for 40 cycles of 94ºC (30 sec), 60ºC (1 min) and 72ºC (1 min). PCR products 
were subjected to agarose electrophoresis and visualized with ethidium bromide. 
 
13. Statistical analysis. 
 
Data are presented as mean +/- SEM and statistical analyses were performed using 
Graph Pad software. Statistical significance was determined with the unpaired 2-tailed 
Student t test and one-way ANOVA, with the α level set at 0.05. 
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I. IN VIVO CHARACTERIZATION OF INTRATHYMIC NICHES DEFINED BY 
DIFFERENTIAL EXPRESSION OF NOTCH LIGANDS AND NOTCH RECEPTORS. 
 
1.1. Dll1, Dll4, Jag1 and Jag2 Notch ligands are differentially expressed in the thymus, 
thus defining specific Notch signaling niches. 
 
 As described in detail in the Introduction, Notch signaling is a key player in T cell 
development. However, little is known about which Notch ligands or receptors are expressed 
in vivo in the thymus, and how they are distributed and regulated in the different thymic 
anatomic regions. This information is particularly scarce in the human thymus.  
 
As T cell development is a step-wise process that occurs at discrete regions of the 
thymus, differential patterns of Notch ligand expression in those regions may be essential for 
shaping T cell developmental dynamics. Aware of this concern, our study on the 
characterization of intrathymic Notch ligand and receptor expression will focus on specific 
thymic anatomic regions, in order to obtain a better picture of each specific niche. Therefore, 
we will pursue the analysis of the spatio-temporal regulation of Notch ligands and Notch 
receptors expression in the human thymus, paying also attention to the mouse thymus for 
comparative purposes. 
 
1.1.1. Notch ligands expression at the cortex and subcapsular region. 
 
It has been reported that Delta family ligands are expressed in vivo in the cortex of the 
murine thymus (Schmitt et al., 2004) (Koch et al., 2008) (Hozumi et al., 2008). Our results 
confirmed Dll1 and Dll4 expression on murine cTECs; but, additionally, we found that rare 
non-epithelial cells in the cortex express both Delta ligands (Fig. 14B, C). When expression of 
Dll1 and Dll4 was analysed in human postnatal thymus samples (< 17 months-old), we found 
that Dll1 expression is quite conserved between mice and humans, as it is confined mostly to 
subcapsular cTECs (Fig. 15A) and expressed in low levels by IC cTECs and some thymocytes 
(Fig. 15B; 19A). But, in contrast to mouse, human cTECs do not express Dll4. Rather, only 
scarce subcapsular cTECs, together with few scattered hematopoietic cells and capillary 
endothelial cells express detectable levels of Dll4 in the human thymus cortex (Fig. 15E; 19A). 
This finding demonstrates that Dll4 expression is significantly different in the human and 
murine postnatal thymus.  
 
 Regarding the Jagged ligand family, it is known that Jag1 is completely absent from 
the cortex in the murine thymus (Lehar et al., 2005) and we found that this feature is conserved 
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in humans. Indeed, no single cell was found in our study to express Jag1 neither in the murine 
(Fig. 16A, B), nor the human thymus cortex (Fig. 17A, B; Fig 19A). But intrathymic Jag2 
expression has been poorly addressed, as only analyses of Jag2 mRNA distribution in mouse 
thymus (Heinzel et al., 2007) (Mohtashami et al., 2010) and functional analyses of Jag2 KO 
mice (Jiang et al., 1998) have provided just a hint about the spatial regulation of this ligand in 
the intrathymic T cell niche. In this regard, we have found that Jag2 expression is prominent in 
the cortex, where it is exclusively expressed by cTECs both in mice (Fig. 16E) and humans 
(Fig. 17E; 19A). Despite both species share expression of Jag2 throughout the cortex, we found 
a specie-specific regulation at particular cortical niches: in mice, Jag2 expression is confined 
to cTECs at the SCC (Fig. 16A, E), while, in humans, Jag2 is broadly expressed at the cortex 
but specifically enriched in cTECs at the CMJ (Fig. 17D; see 1.1.2. below). This differential 
enrichment at either the SCC or the CMJ is another significant difference between the murine 
and human cortical niche.  
 
1.1.2. Notch ligands expression at the CMJ. 
 
 The CMJ is a complex transitional region between the thymic cortex and the medulla, 
and we consider it as the narrow part of the inner cortex that it is in close proximity to the 
medulla. Epithelial cells at the CMJ are cTECs and, accordingly, Dll1 is fairly expressed at this 
location in both human and murine thyme (Fig. 14A, 15A). In contrast to Dll1, Dll4 is absent 
from cTECs at the CMJ, as it is from the rest of the cortex in the human thymus (Fig. 15A), but 
not in the murine thymus, where Dll4 is highly abundant at the CMJ (Fig. 14A). 
 
Definitely, the most prominent ligand expressed at the CMJ in the human thymus is 
Jag2 (Fig. 17D). As mentioned previously, Jag2 expression is maximal at, and exclusive of, 
cTECs at the CMJ. In order to formally quantify this observation and, with the aid of the pan-
cytokeratin epithelial marker (panCK), cTECs were selected in regions of interest (ROIs) by 
fluorescence intensity thresholding (Otsu, 1979). Several ROIs from cortex (COR; N = 45) and 
CMJ (N = 45) were defined from N ≥ 10 independent images of Jag2-stained tissue (25x) per 
thymic sample (N = 3) (Fig. 18B). Then, cortical and corticomedulary ROIs were used to 
measure Jag2 mean fluorescent intensity (MFI) specifically on TECs (Fig 18C, D). Total Jag2 
MFI values of cTECs from cortical regions (COR) and from the CMJ were statistically 
compared, obtaining a highly significant difference between both intrathymic niches (Fig. 18E). 
Collectively, these findings indicate that Notch ligand expression in cTECs, and particularly 
Jag2 expression, is differentially regulated at specific intrathymic niches.  
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Figure 14. Dll1 and Dll4 Notch ligand expression in murine postnatal thymus. Images show 
FFPE sections of murine postnatal thymic tissue (< 16 week-old) stained for Dll1, Dll4 (red) and 
panCK (green). Topro3 was used for nuclear staining (blue). A, D, General view of Dll1 and Dll4 
distribution, respectively, in the murine thymus. Thymic regions are labeled as; c: cortex; and m: 
medulla; dotted line: CMJ. Scale bar: 100µm. B, E, Dll1 and Dll4 expression at the cortex, 
respectively. C, F, Dll1 and Dll4 expression at the medulla, respectively. Arrowheads indicate Dll1 or 
Dll4 expression in TECs (panCK+). Arrows indicate Dll1 or Dll4 expression in non-epithelial (panCK-
) cells. Dotted line: PVS; asterisks: Thymic cysts; e: endothelium. Scale bars: 50µm. Images shown 
are representative of results obtained in N ≥ 3 different tissue samples per ligand. 
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Figure 15. Dll1 and Dll4 Notch ligand expression in human postnatal thymus. Images show 
FFPE sections of human postnatal thymic tissue (< 17 months-old) stained for Dll1, Dll4 (red) and 
panCK (green). Topro3 was used for nuclear staining (blue). A, D, General view of Dll1 and Dll4 
distribution, respectively, in the human thymus. Thymic regions are labeled as c: cortex; and m: 
medulla; dotted line: CMJ. Scale bar: 100µm. B, E, Dll1 and Dll4 expression at the cortex, 
respectively. C, F, Dll1 and Dll4 expression at the medulla, respectively. Arrowheads indicate Dll1 or 
Dll4 expression in TECs (panCK+). Arrows indicate Dll1 or Dll4 expression in non-epithelial (panCK-
) cells. Dotted line: PVS; h: Hassal’s corpuscles; e: endothelium. Scale bars: 50µm. Images shown 
are representative of results obtained in N ≥ 3 different tissue samples per ligand. 
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1.1.3. Notch ligands expression at the thymic medulla. 
 
The thymic medulla is rich in Notch ligands. The four Notch ligands present in the 
thymus are found in this region, although they are differentially expressed by diverse cell types. 
In both human and mouse, Dll1 is highly expressed almost exclusively by mTECs, with the 
highest expression levels corresponding to mTECs near of or forming Hassal’s corpuscles (Fig. 
15C; 19B), also known as thymic cysts in mice (Fig. 14C). Additionally, some rare non-
epithelial medullary cells do express Dll1. Owing to its absence from the cortex, Dll4 could be 
considered as a medullary ligand in the human thymus (Fig. 15D). Scarce mTECs expressed 
Dll4 at the medulla (Fig. 15F; 19B) but importantly, Dll4 is highly expressed at 
extraparenchymal sites, such as the PVS, and non-epithelial cells at the medulla (Fig. 15F and 
see 1.2.2 below), a different expression pattern to that found in the murine thymus medulla, 
where Dll4 is more notably expressed by mTECs (Fig. 14F). 
 
Regarding Jagged ligands, Jag1 is a medullary-specific ligand in both mouse (Fig. 16A) 
and human thymus (Fig. 17A). Importantly, Jag1 is the only Notch ligand restricted to a specific 
anatomic region, and therefore it can be used as a formal medullary marker. In the medulla, 
Jag1 is abundantly expressed by mTECs, some non-epithelial cells, and by the vasculature (Fig. 
17C; 19B). In contrast, Jag2 has a limited representation at the medulla, where it is almost 
absent in mouse (Fig. 16D, F) and is expressed by few mTECs and scarce non-epithelial cells 
in humans (Fig. 17D, F; 19B).  
 
In summary, although Dll4 has been identified as the essential and non-redundant 
cortical Notch ligand required for T cell specification in mice (Koch et al., 2008) (Hozumi et 
al., 2008), our results show that Dll4 is absent from the human postnatal thymic cortex, where 
its expression is essentially restricted to blood vessels (Petrie, 2002). Instead, other ligands have 
a prominent expression by human cTECs, such as Jag2, followed by Dll1. Interestingly, Jag2 
expression in cTECs is regulated in different cortical niches. Our studies also indicate that Jag1 
displays the most restricted and conserved thymic expression pattern, as it is exclusively 
expressed at the medulla by mTECs in both mouse and humans. Therefore, it is important to 
note that Jag1 and Jag2, two ligands of the same family, which are expected to have 
redundant functions, do define reciprocal microenvironments in the human thymus, i.e., 
thymic medulla and cortex, respectively (Fig. 18), which suggests putative functional 
differences. 
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Figure 16. Jag1 and Jag2 Notch ligand expression in murine postnatal thymus. Images show 
FFPE sections of murine postnatal thymic tissue (< 16 weeks-old) stained for Jag1, Jag2 (red) and 
panCK (green). Topro3 was used for nuclear staining (blue). A, D, General view of Jag1 and Jag2 
distribution, respectively, in the murine thymus. Thymic regions are labeled as: c: cortex; and m: 
medulla; dotted line: CMJ. Scale bar: 100µm. B, E, Jag1 and Jag2 expression at the cortex, 
respectively. C, F, Jag1 and Jag2 expression at the medulla, respectively. Arrowheads indicate Jag1 
or Jag2 expression in TECs (panCK+). Arrows indicate Jag1 or Jag2 expression in non-epithelial 
(panCK-) cells; e: endothelium; asterisks: Thymic cysts. Scale bars: 50µm. Images shown are 
representative of results obtained in N ≥ 3 tissue samples per ligand. 
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Figure 17. Jag1 and Jag2 Notch ligand expression in human postnatal thymus. Images show 
FFPE sections of human postnatal thymic tissue (< 17 month-old) stained for Jag1, Jag2 (red) and 
panCK (green). Topro3 was used for nuclear staining (blue). A, D, General view of Jag1 and Jag2 
distribution, respectively, in the human thymus. Thymic regions are labeled as: c: cortex; and m: 
medulla; dotted line: CMJ. Scale bar: 100µm. B, E, Jag1 and Jag2 expression at the cortex, 
respectively. C, F, Jag1 and Jag2 expression at the medulla, respectively. Arrowheads indicate 
examples of Jag1 or Jag2 expression in TECs (panCK+). Arrows indicate Jag1 or Jag2 expression 
in non-epithelial (panCK-) cells. Dotted line: PVS; h: Hassal’s corpuscles; e: endothelium. Scale bars: 
50µm. Images shown are representative of results obtained in N ≥ 3 different tissue samples per 
ligand. 
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Figure 18. Jag1 and Jag2 Notch ligands define reciprocal microenvironments in the human 
thymus. Images show FFPE sections of human postnatal thymic tissue (< 17 months-old). A, B, 
Jag1 and Jag2 staining (red), respectively, plus panCK (green) staining showing co-localization 
(yellow) of Jag1 with mTECs and Jag2 with cTECs. Thymic regions are labeled as c: cortex; and 
m: medulla; dotted line: CMJ. Scale bars: 100µm. Images are representative of results obtained in 
N ≥ 3 different tissue samples per ligand. C, D, ROIs (116µm x 116µm; N = 45) obtained from 
Jag2-stained tissue images of inner cortical and subcapsular (COR) or corticomedulary regions 
(CMJ) (N ≥ = 10 per sample; N = 3 samples). PanCK staining allowed to create a selection area 
(yellow line) in cTECs by using Otsu’s thresholding algorithm. cTEC-specific ROIs where used to 
obtain Jag2 Mean Fuorescence Intensity (MFI) values (C’, D’). Scale bars: 50µm. E, Jag2 MFI 
values in cTECs at the COR and CMJ regions. All images were acquired in 12-bit with the same 
non-saturating settings. ***, p < 0,001. 
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Figure 19. RGB co-localization profiles of Notch ligands win panCK in 
cTECs and mTECs. A, Image crops (30mm) of FFPE sections of the human 
thymus cortical region stained for Notch ligands. B, Image crops (30m) of 
FFPE sections of human thymus medulla stained for Notch ligands. PanCK, 
Notch ligands and Topro3 MFI of isolated TECs was measured by tracing a 
linear ROI (yellow line) along the cells and RBG profiles (.right) were plotted for 
each Notch ligand.  Images are representative of results obtained in N ≥ 3 
different tissue samples per ligand. Scale bars: 10µm. 
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1.2. Non-epithelial thymic stromal cells also express Notch ligands in the human 
thymus. 
 
We have identified an important number of non-epithelial cells in the human thymus, 
which are morphologically distinct from thymocytes, and express Notch ligands in vivo. As the 
most important thymic non-epithelial stromal cells include macrophages, dendritic cells and 
mesenchymal cells, we addressed the expression of Notch ligands on such stromal cells 
characterized by expression of either the myeloid marker CD11c, or the endothelial and 
mesenchymal marker CD34.  
 
1.2.1. Notch ligands expression by myeloid CD11c+ cells. 
 
Intrathymic macrophages can be found in both the cortex and medulla, where they are 
in charge of clearing death thymocytes resulting from selection processes (Surh and Sprent, 
1994). Conversely, DCs are located exclusively at the medulla, where they play a capital role 
in the establishment of central tolerance (Savchenko et al., 2006). Therefore, the thymic 
medulla is enriched in myeloid cells that express the CD11c marker (Fig. 20A). In addition to 
CD11c+ conventional DCs (cDCs), the medulla contains plasmacytoid DCs (pDCs) positive 
for the CD123 marker. We attempted to characterize Notch ligands expression on these CD11c- 
CD123+ pDCs, but lack of a suitable anti-CD123 antibody frustrated our effort. We thus aimed 
at characterizing Notch ligand expression on intrathymic CD11c+ cells and found that they do 
express all four Notch ligands (Fig. 20G) although with different frequencies (Fig. 20F). We 
calculated total CD11c+ cells and CD11c+ cells expressing Notch ligands per field in N ≥ 10 
images (63x) from N = 3 different thymic tissue samples, and observed that Delta family ligands 
are expressed in a major CD11c+ cell subset (>50% Dll1; >70% Dll4; Fig. 20B, C, F), while 
Jag1 and Jag2 ligands are poorly expressed by CD11c+ cells (less than 20% and 10% 
respectively; Fig. 20D, E, F). Further RGB profiling on isolated CD11c+ cells confirmed these 
findings (Fig. 20G). 
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1.2.2. Notch ligands expression by endothelial and mesenchymal cells at the 
perivascular space. 
 
The CMJ region is often disrupted by perivascular regions from where HPCs can enter 
the thymus (Mori et al., 2007) (Fig. 4A). The intrathymic perivascular space (PVS) has been 
characterized as the third anatomical region of the thymus in addition to the cortex and medulla. 
It is a region separated by two basement membranes: one membrane is associated with a blood 
vessel, while the other is associated with the epithelial border (Kato and Schoefl, 1989). We 
have identified this region by the absence of epithelial markers (panCK) and by positive 
staining for CD34 (Abe et al., 2011) (Kim et al., 2014) (Fig. 21). The PVS structure includes 
mesenchymal tissue, endothelial cells, and myeloid cells. Endothelial cells of vascular walls 
and mesenchymal cells forming the PVS may provide early signaling cues to HPCs migrating 
into and/or seeding the thymus (Mori et al., 2007), which may play an important role in T cell 
development. It is known that Notch is a major pathway involved in endothelial cell function 
(Gridley, 2010), and the vasculature is rich in Notch signaling components. Indeed, we have 
observed that thymic vasculature expresses Dll4, Jag1 and Jag2 (Fig. 22B, C, D), but while 
Dll4 is expressed by the entire thymic vasculature including arteries, venules and capillaries, 
Jag1 and Jag2 are present during development and some endothelial cells presumably of arterial 
fate in the adult (Villa et al., 2001). Additionally, CD34+ mesenchymal cells surrounding blood 
vessels express Dll4 and some Jag1 (Fig. 22B, C). Conversely, Dll1 and Jag2 are not expressed 
by CD34+ perivascular cells (Fig. 22A, D). However, Dll1 expression can be detected in some 
CD34- cells (Fig. 22A), which may represent SP thymocytes leaving the thymus (Mori et al., 
2007). Therefore, vascular endothelium as well as different PVS cell types at the CMJ 
region provide an important source of Dll4 to progenitors entering the human postnatal 
thymus, suggesting that they may contribute to Notch activation at very early T cell 
developmental stages.  
<< Figure 20. Intrathymic CD11c+ myeloid stromal cells express Delta family Notch ligands. 
Images show FFPE sections of human postnatal thymic tissue (< 17 months-old) stained with the 
myeloid marker CD11c (green) and Notch ligands (red). Topro3 was used for nuclear staining (blue). A, 
General view of CD11c expression in the human thymus. Thymic regions are labeled as c: cortex; and 
m: medulla; dotted line: CMJ. Scale bar: 100µm. B, C, D, E show CD11c and Dll1, Dll4, Jag1 and Jag2 
Notch ligand staining, respectively, at the thymic medulla. Arrowheads indicate Notch ligands expression 
on CD11c+ cells. CD11c co-localization (yellow) is remarkable with Delta family ligands, while scarce 
with Jagged ligands. h: Hassal’s corspuscles; e: endothelium. Scale bars: 50µm. F, Bar graph 
represents the mean percentage of CD11c+ cells encountered per 63x field expressing each Notch 
ligand. G, left, Image crops (30µm) of FFPE sections of the human thymus medulla stained for CD11c, 
Notch ligands and Topro3. Right, RGB co-localization profiles of CD11c with Notch ligands and Topro3. 
MFI values of isolated CD11c+ cells were measured by tracing a linear ROI (yellow line) along the cells 
and. Scale bars: 10µm. Data are representative of results obtained in N ≥ 3 different tissue samples per 
ligand.  
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Figure 21. Immunohistological definition of the human perivascular space. 
FFPE tissue sections of human postnatal thymus (< 17 months-old) were stained 
with the epithelial marker cytokeratin 19 (CK19) (green) and the endothelio-
mesenchymal and hematopoietic progenitor cell marker CD34 (red). Topro3 was 
used for nuclear staining (blue). A, General view of CD34 expression in the human 
thymus. The perivascular space (PVS), defined as CK19- CD34+ tissue, is 
indicated by a dotted line. Thymic regions are labeled as c: cortex; and m: medulla; 
cp: thymic capsule. Scale bar: 100µm. B, PVS detail. e: endothelium. Images are 
representative of results obtained in N ≥ 3 different tissue samples. Scale bar: 
50µm. 
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Figure 22. Notch ligands are expressed by thymic perivascular cells and thymic endothelium. 
FFPE sections of human postnatal thymic tissue (< 17 months-old) twere stained for Dll1, Dll4, Jag1 
and Jag2 (red) and CD34 (green). Topro3 was used for nuclei counterstaining (blue). A, B, Dll1 and 
Dll4 expression, respectively, on human thymic endothelium and perivascular cells. Dll1 is only 
detected in CD34- perivascular cells (arrows), while Dll4 is expressed in mesenchymal CD34+ 
(arrowheads) cells and endothelium (e). C, D, Jag1 and Jag2 expression, respectively, on human 
thymic endothelium and perivascular cells. Jag1 and Jag2 are expressed by endothelium (e), but only 
Jag1 is expressed by perivascular CD34+ cells (arrowheads). PVS limits are indicated by a dotted 
line. Images are representative of results obtained in N ≥ 2 different tissue samples per ligand. Scale 
bars in all images represent 50µm. 
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Finally, to provide an accurate picture of Notch ligand expression by human thymic 
stroma, we have performed quantitative studies of Notch ligand expression on cortical and 
medullary TECs (panCK+) and myeloid cells (CD11c+) by using the co-localization coefficient 
of Mander’s. The ICA (Intensity Colocalization Analysis) plugin (Li et al., 2004) (see Materials 
and Methods) was applied to a N ≥ 10 cortical and N ≥ 10 medullary images (63x) for each 
stromal marker and Notch ligand, obtained from N = 3 different postnatal tissue samples. M1 
and M2 Mander’s coefficients were obtained. M1 coefficients represented in Fig. 23 formally 
confirmed the findings shown by the co-expression analyses described above. Altogether, 
these results demonstrate that Notch ligands are differentially distributed in vivo in 
different histological and functional regions of the human postnatal thymus. 
 
 
 
 
 
 
 
 
 
 
 
 
1.3. Temporal regulation of Notch ligand expression during human thymus ontogeny. 
 
1.3.1.  Dll4 is early expressed by cTECs during human thymus ontogeny. 
 
The finding that cTECs of the postnatal human thymus, in contrast to their murine 
counterparts, lack Dll4 expression prompted us to investigate the possibility that intrathymic 
niches, and particularly Notch ligand expression, may vary along time, as has been shown to 
occur during thymus involution (Haynes et al., 2000) (Aw et al., 2009). In fact, expression of 
Dll4 by cTECs is temporally regulated in mice, as Dll4 expression is high in the fetal and 
neonatal thymus, but decreases dramatically in the adult thymus (Fiorini et al., 2008). In order 
to assess temporal regulation of Notch ligand expression during human thymus ontogeny, we 
analyzed samples of human fetal thymuses ranging from 11 to 19 weeks of gestation. We found 
no substantial differences in Dll1 (Fig. 24A) or Jag1 (Fig. 25A) expression patterns between 
fetal and postnatal tissue samples. Dll1 was present in epithelial and hematopoietic cells from 
Figure 23. Mander’s coefficient of 
Notch ligands expression in human 
thymic stromal cells. Bar graph 
diagram represents the M1 co-
localization coefficient of Mander 
obtained by applying the Intensity 
Colocalization Analysis (ICA) plugin to N 
≥ 10 images from human thymic cortex 
and medulla stained with Notch ligands 
and either panCK or CD11c. Results 
obtained in N ≥ 3 different tissue samples 
per ligand are shown. 
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the cortex and medulla, although its expression in fetal cTECs was more significant than in 
postnatal cTECs (Fig. 24B), and less significant in fetal mTECs than in postnatal mTECs (Fig. 
24C), supporting previous observations of Dll1 expression up-regulation with age (Aw et al., 
2009). Moreover, cortical Jag2 expression was restricted to cTECs, as in the postnatal thymus 
(Fig. 25E). Conversely, fetal medulla showed a remarkable higher number of Jag2+ non-
epithelial cells than in the postnatal thymus (Fig. 25F). The nature of this Jag2+ fetal medullary 
cells is unknown, but it may correspond to either mature T cells or pDCs, as in the postnatal 
thymus no Jag2-expressing CD11c+ cells were found (Fig. 20E, F). Finally, analysis of Dll4 
expression in the medulla of fetal thymus samples revealed a Dll4 expression pattern similar to 
that observed in the postnatal medulla (Fig. 24F). But interestingly, the fetal cortical expression 
pattern of Dll4 was different to that observed in the postnatal thymus as in the former Dll4 was 
notably expressed in cTECs (Fig. 24D, E). To quantitatively confirm a highest Dll4 expression 
in fetal cTECs versus postnatal cTECs in the human thymus, Dll4 MFI was measured 
specifically on cTECs by creating ROIs (N ≥ 30) on panCK+ cells in N ≥ 10 images (63x) per 
thymic sample (N = 3) (Fig. 26A). Direct comparison of total fetal and postnatal cTEC Dll4 
MFI values, showed that Dll4 expression is significantly higher in fetal than in postnatal cTECs 
(Fig. 26C). But, in order to make accurate comparisons between tissue samples from different 
experiments, we used thymus endothelium, a well-known and stable Dll4-expressing tissue, as 
an internal control (Fig. 26B). Indeed, comparison of Dll4 MFI values expressed in fetal and 
postnatal thymic endothelium confirmed that Dll4 expression by thymic endothelial cells 
remains essentially constant during thymus ontogeny (Fig. 26C; p = 0,458). Therefore, 
epithelial Dll4 MFI values were normalized to endothelial Dll4 MFI values obtained from the 
very same sample (Fig. 26D). Accordingly, Epithelial/Endothelial Dll4 MFI Ratios (TEC/EC) 
showed more than 2-fold decreased Dll4 expression levels in postnatal cTECs when compared 
with fetal cTECs (Fig. 26D), thus confirming a highly significant downregulation of Dll4 in 
cTECs during human thymic ontogeny. Equivalent comparison of postnatal human and 
postnatal murine TEC/EC Ratios allowed us to confirm that Dll4 remains expressed by cTECs 
in the mouse postnatal thymus (Fig. 26D). In conclusion, Dll4 expression in fetal but not in 
postnatal human cTECs suggests that Dll4 undergoes an early downregulation during 
human thymus ontogeny. As Dll4 downregulation has been also reported in mice at later 
postnatal ages (Fiorini et al., 2008), it seems that kinetics of Dll4 downregulation in cTECs 
varies between mouse and human. 
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Figure 24. Dll1 and Dll4 Notch ligand expression in human fetal thymus. Images show FFPE 
sections of human fetal thymic tissue (11 - 19 weeks) stained for Dll1, Dll4 (red) and panCK (green). 
Topro3 was used for nuclear staining (blue). A, D, General view of Dll1 and Dll4 distribution, 
respectively, in the human thymus. Thymic regions are labeled as c: cortex; and m: medulla; dotted 
line: CMJ. Scale bar: 100µm. B, E, Dll1 and Dll4 expression at the cortex, respectively. C, F, Dll1 and 
Dll4 at the medulla, respectively. Arrowheads indicate Dll1 or Dll4 expression by TECs (panCK+). 
Arrows indicate Dll1 or Dll4 expression by non-epithelial (panCK-) cells. e: endothelium. Scale bars: 
50µm. Images shown are representative of results obtained in N = 2 different tissue samples per 
ligand. 
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Figure 25. Jag1 and Jag2 Notch ligand expression in human fetal thymus. Images show FFPE 
sections of human fetal thymic tissue (11 - 19 weeks) stained for Jag1, Jag2 (red) and panCK (green). 
Topro3 was used for nuclear staining (blue). A, D, General view of Jag1 and Jag2 distribution, 
respectively, in the human thymus. Thymic regions are labeled as c: cortex; and m: medulla; dotted 
line: CMJ. Scale bar: 100µm. B, E, Jag1 and Jag24 expression at the cortex, respectively. C, F, Dll1 
and Dll4 at the medulla, respectively. Arrowheads indicate Jag1 or Jag2 expression by TECs 
(panCK+). Arrows indicate Jag1 or Jag2 expression by non-epithelial (panCK-) cells. e: endothelium. 
Scale bars: 50µm. Images shown are representative of results obtained in N = 2 different tissue 
samples per ligand. 
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Figure 26. Quantification of Dll4 expression in fetal and postnatal 
cTECs. Images show FFPE sections of fetal human (11 - 19 weeks), 
postnatal human (< 17 month-old) and postnatal murine (< 16 weeks-old) 
thymic tissue stained for Dll4 (red) and panCK (green). Topro3 was used for 
nuclear staining (blue). A, B, Dll4 quantification strategy based on ROIs 
(yellow lines) defined on TECs and endothelial cells (ECs). Scale bars: 50µm. 
C, Bar graphs showing Dll4 MFI in different cells. EC showns similar 
expression levels of Dll4 in mice and human tissue, and along age. EC Dll4 
MFI values were obtained from N ≥ 10 images per sample (N = 3 samples) 
and used to normalize cTEC Dll4 MFI values. All images were acquired in 12-
bit color depth with the same non-saturating settings. D, Bar graph showing 
TEC/EC Dll4 MFI ratios in fetal human (FH), postnatal human (PH) and 
postnatal murine (Jiang et al.) thymus. Images shown are representative of 
results obtained in N ≥ 3 different tissue samples. **, p < 0,01; ***, p <0,001. 
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1.3.2. Jag1 expression at the SCC is upregulated with thymic involution. 
 
 We next wanted to address whether ageing and involution of the human thymus might 
involve changes in Notch ligand distribution. To this end, we analyzed Notch ligand expression 
in samples of human adult thymuses ranging from 11 to 15 years-old. Analysis of Delta ligands 
did not show any variation in their expression patterns when compared with neonatal thymus 
samples (data not shown), except an increased Dll1 expression in Hassall’s corpuscles already 
observed when compared fetal versus postnatal thymi. However, we observed that Jagged 
ligands up-regulate their expression in cTECs located at the SCC region with age. As depicted 
in Fig. 27A, E, Jag1 is completely absent from the neonatal cortex, while it is nicely expressed 
by subcapsular cTECs of the involuted thymus (Fig. 27B, F). Likewise, a slight up-regulation 
is observed for Jag2 at the SCC (Fig. 27D, H). As thymic vasculature expresses Jag1 (Lehar et 
al., 2005) and Jag2 (personal observation), we quantified subcapsular epithelial and endothelial 
MFI in neonatal and involuted thymi in N ≥ 10 images (63x) per thymic sample (N = 3), using 
the same method described for Dll4. Jag1 TEC/EC MFI Ratios were compared between 
neonatal and involuted thymi (Fig. 27I, left graph), revealing a highly significant increase in 
Jag1 expression in subcapsular cTECs with thymic involution. Regarding Jag2, as it was 
already expressed by subcapsular cTECs in the postnatal thymus (Fig. 27G), there was not 
significant upregulation with age (Fig. 27H, I, right graph; p = 0,6217). 
 
Although we found no significant upregulation of Jag2 at the SCC with age, we observed 
that the Jag2 enrichment found at the CMJ of the human postnatal thymus does not occur in the 
involuted thymus (Fig. 27D). Jag2 MFI values from involuted cTECs at the cortex (COR) or 
CMJ were obtained in the very same way as described in 1.1.2., and were statistically compared. 
MFI values obtained from both anatomic regions were not significantly distinct (Fig. 27J; p = 
0,2254), indicating that Jag2 expression levels at the cortex and CMJ are similar in the involuted 
human thymus. In order to make an accurate comparison between tissue samples from different 
experiments, we next obtained Jag2 MFI CJM/COR Ratios (N = 15 images; 63x) from postnatal 
(N = 3) and involuted thymuses (N = 2). As depicted in Fig. 27K, Jag2 CMJ/COR MFI ratio is 
significantly lower in the involuted thymus, thus confirming that Jag2 enrichment at the CMJ 
niche is lost with thymic involution. In summary, the early downregulation of Dll4 at the 
cortex, the upregulation of Jag1 at the SCC, and the lack of Jag2 enrichment at the CMJ 
observed in involuted thymus samples confirm that Notch ligand expression is regulated 
in cTECs in a temporal-manner. 
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1.4. Notch1, Notch3 and Notch4 receptors are differentially expressed in the human 
thymus. 
 
We have demonstrated that the main stromal components of the thymus express Notch 
ligands in discrete microenvironments subjected to spatial and temporal regulation. The other 
side of the coin corresponds to Notch receptors. Nothing is known about Notch receptor 
expression by stromal cells, but it has been demonstrated that thymocytes actively regulate 
Notch receptor expression along development (Hasserjian et al., 1996) (Fiorini et al., 2009). As 
detailed in the introduction, Notch1 is the essential and non-redundant receptor needed for T-
cell specification. Notch1 expression has been described to be concentrated within the outer 
cortical area of the postnatal murine thymus (Fiorini et al., 2009), but little is known about the 
intrathymic distribution of other Notch receptors. We know that Notch1, Notch2 and Notch3 
transcripts are detected in thymocytes and TECs in mice. Besides, thymocytes interacting with 
TECs expressing Notch ligands up-regulate Notch3 after T cell commitment, suggesting that 
Notch3 may be involved in thymocyte development after Notch1-induced T cell specification 
(Felli et al., 1999) (Shi et al., 2011). 
 
 
 
 
 
 
<< Figure 27. Jag1 and Jag2 expression in involuted human thymus. Images show FFPE 
sections of human postnatal (< 17 months-old) and human involuted (> 8 years-old) thymus samples 
were stained for Jag1 and Jag2 (red) and panCK (green). Topro3 was used for nuclear staining (blue). 
A, B, C, D, General view of Jag1 and Jag2 expression in postnatal and involuted human thymus. 
Thymic regions are labeled as scc: subcapsular cortex; c: cortex; and m: medulla. Dotted line: CMJ; 
Yellow dotted line: thymic capsule. Scale bars: 100µm. E, F, Detailed images of Jag1 expression at 
the SCC of postnatal and involuted thymus, respectively. G, H, Detailed images of Jag2 expression 
at the SCC of postnatal and involuted thymus, respectively. Arrowheads indicate subcapsular cTECs 
expressing Jag1 or Jag2 ligands. Scale bars: 50µm. Images shown are representative of results 
obtained in N ≥ 2 different tissue samples per ligand. I, Quantification of Jag1 and Jag2 expression 
on subcapsular cTECs of postnatal (PNT) and involuted (IVL) human thymus. Similarly to that 
described for Dll4. EC Jag1 and Jag2 MFI values were obtained by image thresholding from N ≥ 15 
images per sample, and used to normalize MFI Jag1 and Jag2 values of subcapsular cTECs from 
postnatal (N = 3) and involuted thymus (N = 2). TEC/EC MFI ratios means are shown. All images were 
acquired in 12-bit color depth with the same non-saturating settings. J, COR and CMJ Jag2 MFI mean 
values in postnatal and involuted thymus samples. Values were defined based on cortical (COR) or 
corticomedulary (CMJ) ROIs (116µm x 116µm; N = 45) obtained from images (25x; N ≥ 10 per thymic 
sample) of Jag2-stained thymus samples (N = 2). K, CMJ/COR Jag2 MFI Jag2 values of postnatal 
and involuted thymus. Results shown are representative of N ≥ 15 images per sample (N = 3 postnatal; 
N = 2 involuted samples). 
 
  85
Results 
 
 
 
 
 
 
 
 
  86
Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 We have therefore addressed intrathymic Notch receptor expression in the human 
thymus and have found, as expected, that Notch1 is broadly expressed (Fig. 28A). PanCK 
staining revealed that Notch1-expressing cells include cTECs and mTECs (Fig. 28B, C). 
Additionally, a cortical population of thymocytes, which may correspond to DN cells (Felli et 
al., 1999)  (Van de Walle et al., 2009) (Gonzalez-Garcia et al., 2012) showed Notch1 membrane 
staining. Notch3 was found expressed by cortical thymocytes in higher proportions than Notch1 
(Fig 28D, E). At the medulla, only mTECs expressed Notch3, confirming that a putative role 
for Notch3 in thymopoiesis is restricted to early developmental stages. Regarding Notch4, its 
expression was essentially restricted to the medulla, while only rare and scattered thymocytes 
expressed Notch4 at the cortex (Fig. 28G, H). Importantly, the frequency of those Notch4+ 
thymocytes increases at the CMJ (not quantified). Importantly, medullary Notch4 expression 
was mainly restricted to thymocytes (Fig. 28I), while Notch4 expression in TECs is quite rare. 
In summary, as demonstrated for Notch ligands, Notch receptors are differentially 
distributed in specific thymic niches and cell types.  
<<^^Figure 28. Notch1, Notch3 and Notch4 expression in human postnatal thymus. Images 
show FFPE sections of human postnatal thymic tissue (< 17 months-old) stained for Notch1, Notch3, 
Notch4 (red) and panCK (green). Topro3 was used for nuclear staining (blue). A, D, G, General view 
of Notch1, Notch3 and Notch4 distribution in the human thymus. Thymic regions are labeled as c: 
cortex; and m: medulla. Dotted line: CMJ. Scale bars: 100µm. B, E, H, Notch1, Notch3 and Notch4 
expression, respectively, at the cortex. C, F, Notch1, Notch3 and Notch4 expression, respectively, at 
the medulla. Arrowheads indicate Notch receptors expression by TECs (panCK+) and arrows indicate 
expression by non-epithelial (panCK-) cells. h: Hassal’s corspuscles. Scale bars in all images 
represent 50µm. Images are representative of results obtained in N ≥ 3 tissue samples per Notch 
receptor. 
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1.5. Notch1 signaling is active in cortical thymocytes and CD34+ intrathymic progenitors 
of both human and murine thymus. 
 
Although giving valuable hints about putative Notch signaling at particular thymic 
niches, neither Notch ligand nor Notch receptor expression ensures that Notch activation is 
formally occurring in vivo in those thymic locations. Aware of this limitation, we used a 
monoclonal antibody that specifically recognizes the intracellular domain of Notch1 (ICN1) to 
assess the activation in vivo of the Notch1 pathway in the thymus. ICN1 staining revealed a 
broad and quite homogeneous pattern of active Noth1 expression across the thymic cortex, 
while the medulla exhibited lower frequency of ICN1+ cells (Fig. 29A). Because of the 
importance of Notch1 function in cortical events, we analysed in detail the three cortical 
microenvironments: SCC, IC and CMJ in different human postnatal thymus samples (N = 3), 
from which N ≥ 15 images (25x) were acquired per sample. In every region, the exclusion from 
panCK staining showed that cortical ICN1+ cells are exclusively thymocytes, except at the 
SCC where some ICN1+ subcapsular cTECs where located under the thymic capsule (Fig. 29B, 
C, D). When quantifiying ICN1+ cells on each thymic region, we found a highly significant 
enrichment of ICN1+ cells at the CMJ and at the SCC (Fig. 29E). Similar results were obtained 
when analysing ICN1 expression in murine thymus (data not shown). Notably, Notch signalling 
is required for T cell commitment and β-selection, events that occur at the CMJ and the SCC, 
respectively (Petrie and Zuniga-Pflucker, 2007). It is also worth mentioning that the percentage 
of ICN1+ cells at the cortex was rather low, ranging from 5 to 15%, depending on the cortical 
thymic region (data not shown), which suggests that Notch1 is active in vivo in a narrow 
population of cortical thymocytes undergoing the above-mentioned processes. In order to 
characterize these ICN1-expressing cortical cells, we used the hematopoietic progenitor cell 
marker CD34 (Fig. 30), as Notch1 must be active in thymus seeding CD34+ progenitors. While 
it has been described that c-kit+ thymic hematopoietic progenitors in mice enter the thymus 
through the CMJ where they briefly stay until T cell commitment is induced (Lind et al., 2001) 
(Witt and Robbins, 2005), no data have been reported to date on the in vivo location of human 
CD34+ ETPs. Our CD34 immunohistochemical stainings on human thymus confirmed that an 
important proportion of CD34+ progenitors are located at the CMJ, but also at the IC and the 
SCC (Fig. 30B, C, D), suggesting that CD34+ progenitors rapidly move up to the outer cortex. 
Importantly, every CD34+ cell located at the thymic cortex in whatever cortical region, SCC, 
IC or CMJ, expressed active Notch1 (ICN1) (Fig. 31A, B, C), this confirming the capital role 
that Notch1 plays in early human T cell development. In summary, our data show that 
Notch1 receptor is active in vivo in human CD34+ progenitors, as well as in a narrow 
population of CD34- cortical cells, confirming the in vivo implication of Notch1 signalling 
in early human T cell development. 
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Figure 29. Notch1 is active in cortical thymocytes that accumulate at the SCC and CMJ. 
Images show FFPE sections of human postnatal thymic tissue (< 17 months-old) stained for the 
intracellular active form of Notch1 (ICN1) (red) and panCK (green). Topro3 was used for nuclear 
staining (blue). A, General view of active Notch1 distribution in the human thymus. Thymic regions 
are labeled as c: cortex; and m: medulla. Dotted line: CMJ. Scale bar: 100µm. B, C, D, Detailed 
expression of ICN1 in the three main regions of the thymic cortex: SCC, IC and CMJ, respectively. 
Total number of ICN1+ cells in each region (E) was quantified by defining niche-specific ROIs (B, 
C, D, yellow squares; N ≥ 45) obtained from 25x images. h: Hassal’s corspuscles. Scale bars: 50µm. 
Images shown are representative of results obtained from N ≥ 3 different tissue samples.  
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Figure 30. In vivo distribution of CD34+ progenitor cells in the human postnatal thymus. 
Images show FFPE sections of human postnatal thymic tissue (< 17 months-old) stained for CD34 
(red) and panCK (green). Topro3 was used for nuclear staining (blue). A, General view of CD34 
distribution in the human thymus. CD34 expression in hematopoietic progenitors (arrowheads) and 
mesenchymal tissue and endothelium (asterisks) is shown. Thymic regions are labeled as c: cortex; 
and m: medulla. Dotted line: CMJ. Scale bar: 100µm. B, C, D, Detailed expression of CD34 in the 
three main regions of the thymic cortex: SCC, IC and CMJ, respectively. Arrowheads indicate CD34+ 
progenitor cells; asterisks show CD34 staining in endothelium and/or mesenchymal cells. Scale 
bars: 50µm. Images shown are representative of results obtained in N ≥ 3 different tissue samples. 
**, p < 0,01; ***, p < 0,001. 
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Figure 31. CD34+ progenitors resident in 
the human thymus show activation of the 
Notch1 pathway. Images show FFPE 
sections of human postnatal thymic tissue (< 
17 months-old) stained for ICN1 (red) and 
CD34 (green). Topro3 was used for nuclear 
staining (blue). Arrowheads show CD34+ 
ICN1+ progenitor cells. B, D, F, Insets (30µm) 
from A, C and E, respectively showing ICN1 
expression in individual CD34+ progenitors. 
Scale bars: 50µm. Images shown are 
representative of results obtained in N ≥ 3 
different tissue samples. 
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II. DIFFERENTIAL ROLE OF NOTCH LIGANDS IN αβ VERSUS γδ T CELL 
DEVELOPMENT. 
 
 The characterization of Notch ligand and receptor distribution in vivo in mouse and 
human thymus has revealed their organization in different thymic niches in which their 
expression is tightly regulated during ontogeny and involution; this suggesting differential roles 
for individual Notch ligands in T cell development. In order to shed light on the particular role 
of individual ligands in T cell development, we performed functional in vitro assays using the 
Notch ligand-transduced OP9 co-culture system (Schmitt and Zuniga-Pflucker, 2002) (De 
Smedt et al., 2004). The progenitors used in this assay were intrathymic lymphoid-committed 
progenitors (LP), equivalent to mouse DN2 thymocytes, and characterized as CD34+ CD44lo 
CD1a- CD4- CD8- cells (Fig. 32A, B). These progenitors have essentially lost their potential 
to generate myeloid cells, but retain some NK cell potential, which cannot be revealed in the 
OP9 assay in the absence of exogenous IL-2 or IL-15 (Marquez et al., 1995) (de Yebenes et al., 
2002). Therefore, the system is optimal to assess the αβ versus γδ potential and developmental 
behaviour of common intrathymic progenitors (Ciofani et al., 2006) in response to different 
Notch ligands. 
 
To this end, we generated five OP9 cell lines (OP9-Dll1, OP9-Dll4, OP9-Jag1, OP9-
Jag2 and OP9-GFP) expressing high and homogeneous levels of each ligand, or GFP alone as 
control. Ligands expression levels were quantitated by MFI of the GFP tracer (Fig. 32C), as 
discussed above, only equivalent levels of expression may reveal intrinsic Notch signaling 
features of each particular ligand, as different Notch signalling intensities delivered in vitro 
generate different T-cell developmental outcomes (Van de Walle et al., 2009) (Ciofani et al., 
2006). Formal proof of ectopic Notch ligand expression by OP9 cells was provided by Western 
blot (Fig. 32D). As expected from a bicistronic vector, GFP expression levels correlated with 
protein expression of each Notch ligand. Additionally, all ligands were expressed at the plasma 
membrane of OP9 cells, as assessed by immunocytochemistry (data not shown).  As we have 
previously shown that Notch1 controls early T cell development by directly regulating IL7R 
expression (Gonzalez-Garcia et al., 2009), we took advantage of this property to directly 
evaluate the functional capability of the human Notch ligands ectopically expressed on OP9 
cells. As shown in Fig. 32E, we found that all four Notch ligand-expressing OP9 cell lines were 
able to maintain IL7R expression on human intrathymic progenitors developing in vitro, 
although Jag1 was less efficient than the others especially at late time-points (day 25-28), 
suggesting the induction of lower Notch activation levels. In the absence of Notch ligand (OP9-
GFP) however, DN2 progenitors underwent a rapid downregulation of IL7R. Altogether these 
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data indicate that Notch ligand-expressing OP9 stromal cells are able to induce functional 
Notch signaling in CD34+ CD44lo CD1a- human intrathymic DN2-like progenitors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32. Generation and functional characterization of OP9 stromal 
cells expressing different human Notch ligands. A, Flow cytometry 
analysis of CD34 and CD44 expression in human thymus cell suspensions 
depleted of mature thymocytes by sheep red blood cell rosetting (left) and 
further enritched in CD34+ progenitors (.right) by immunomagnetic cell 
sorting using anti-CD34-labeled beads. Electronic gates of DN1-like 
(CD34hi CD44hi) and DN2-like (CD34+ CD44+) thymocyte progenitors are 
shown (left). B, Phenotype of DN2-like progenitors isolated from CD34+ 
thymocytes after depletion of CD1a. C, Characterization by flow cytometry 
of parental OP9 stromal cells and OP9 cells retrovirally-transduced with 
GFP as control (OP9-GFP) o with distinct human Notch ligands (OP9-Dll1, 
OP9-Dll4, OP9-Jag1 or OP9-Jag2). Histograms show levels of Notch 
ligand expression quantified by MFI of the GFP cell tracer. D, Western blot 
analysis of control OP9-GFP (lane 1) and OP9 expressing human Dll1, 
Dll4, Jag1 or Jag2 Notch ligands (lane 2), with the indicated antibodies. 
αTubulin expression was used as protein loading control. E, Kinetics of 
IL7R expression in DN2-like human thymocytes co-cultured onto the 
indicated OP9 stromal cells. F, Absolute numbers of IL7R+ cells recovered 
by day 25 from co-cultures in (E). *; p < 0,05. Data are represented as 
mean +/- SEM of total cell numbers in 5 - 6 independent experiments. 
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2.1. Distinct Notch ligands induce T-cell commitment and developmental progression of 
human DN2-like progenitors to the DP stage with similar efficiencies.  
 
As expected, T cell development of CD34+ CD44lo CD1a- progenitors was triggered in 
vitro in the OP9 assay by exposure to Notch ligands. T-cell committed CD1a+ cells were 
detected as soon as at day 4 of culture. Thereafter, the frequency of CD1a-expressing cells 
increased rapidly up to 100% during the first week of culture. On the contrary, development of 
CD1a+ cells committed to the T cell lineage was greatly impaired in OP9-GFP stroma co-
cultures, where relative numbers of CD1a+ cells could reach up to 60% by day 10 and declined 
rapidly thereafter (Fig. 33A). However, absolute numbers were significantly decreased in 
control cultures, according to an impaired generation and maintenance of CD1a+ T-committed 
cells when Notch signalling is absent (Fig. 33B). Nonetheless, differentiation from DN2-like 
progenitors towards the CD4+CD8+ DP stage could occur independently of Notch signaling as 
reported previously (Van de Walle et al., 2009). The decreased efficiency of T cell generation 
in OP9-GFP co-cultures paralleled a relative increase in the generation of non-T cell 
populations, likely corresponding to NK cells (data not shown), defined by high expression of 
CD44 (Fig. 33C) and whose absolute numbers were specifically increased in Dll1- or Dll4-
expressing OP9 cell cultures (Fig. 33D). Cell proliferation studies revealed that numbers of 
DN2-like progenitors co-cultured on OP9 cells expressing any Notch ligand, increased 
exponentially during the first three weeks of culture (Fig. 33E). No significant differences were 
observed on the expansion potential supported by the different ligands, although cell numbers 
reached up to a 500-fold expansion with Dll1, Dll4 and Jag2 ligands, but only up to a 350-fold 
expansion in OP9-Jag1 cultures, where total cell numbers reached a plateau after the initial 3-
weeks of culture, and thereafter cells declined steadily. In contrast, DN2-like progenitors 
seeded on OP9-GFP cultures were unable to proliferate and disappeared after two-weeks of 
culture, independently of the number of DN2 seeded progenitors. 
 
To further investigate the kinetics of T cell differentiation of DN2-like thymocytes 
under the influence of different Notch ligands, we performed FACS analysis of the acquisition 
of CD4 and CD8 differentiation markers every 3 to 4 days of culture (Fig. 33F). No significantly 
different T cell differentiation kinetics were found in response to different Notch ligands, as all 
supported maximal generation of DP cells between days 24 and 28, and both cell frequencies 
(%) and absolute numbers of DN, DP, CD4+ or CD8+ were essentially equivalent (Fig. 33G). 
Acquisition of CD4 and CD8 occurred faster in OP9-GFP co-cultures, where DP cells reached 
maximal frequencies between day 7 and day 10 (Fig. 33F), but maturation into TCR-expressing 
cells was very inefficient (see below).  
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Therefore, these results indicate that human CD34+CD1a- DN2-like uncommitted 
progenitors can efficiently differentiate into CD1a+ CD4+CD8+ DP thymocytes in 
response to Notch signaling in vitro, although no differential effects in T-cell commitment 
and developmental kinetics towards the DP stage were found in response to Notch ligand-
specific signaling. 
 
 
Figure 33. Notch ligand-induced in vitro proliferation and T cell commitment of DN2-like human 
intrathymic progenitors. A, C, Kinetic of generation of T cell committed (CD1a+) and non-T cell 
(CD44hi) populations from DN2-like human intrathymic progenitors co-cultured onto the indicated 
Notch ligand-expressing OP9 cells or control OP9-GFP cells. B, D, Absolute numbers of CD1a+ and 
CD44hi cells recovered by days 10 and day 17 from co-cultures in A and C, respectively. *; p < 0,05.  
E, Fold expansion of DN2-like intrathymic progenitors co-cultured onto the indicated OP9 stromal cell 
lines during 31 days. Data are represented as mean +/- SEM of absolute cell number in 5 - 6 
independent experiments. F, Generation kinetics of CD4+ CD8+ DP thymocytes from DN2-like 
progenitors co-cultured onto the indicated OP9 stromal cell lines, analysed by flow cytometry. Numbers 
in quadrants indicate the mean +/- SEM percentages of CD4-CD8- DN, CD4+CD8+ DP, CD4+ and 
CD8+ populations. Histograms shown are representative of 5 independent experiments. G, Absolute 
number generation kinetics of DN, DP, CD4+ and CD8+ thymocytes co-cultures shown in (F). Data 
show mean +/- SEM of total cell numbers or frequencies (cell %) in 5 independent experiments. 
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2.2. Stromal cells expressing distinct Notch ligands recapitulate αβ and γδ T cell 
differentiation in vitro with different efficiencies: Jag2 selectively favors γδ T cell 
generation. 
 
Previous reports support the view that Notch ligands may influence the TCRαβ versus 
TCRγδ cell fate decision by delivering differential Notch signal strength to developing 
thymocytes (Kreslavsky et al., 2010) (Ciofani and Zuniga-Pflucker, 2010) (Van de Walle et al., 
2013). In humans, strong Notch signaling promotes TCRγδ development, while attenuation of 
Notch signal is required for αβ T cell generation in vitro (Garcia-Peydro et al., 2003) (Van de 
Walle et al., 2009). Therefore, we took advantage of the OP9 co-culture assay to directly assess 
the role of each ligand on αβ and γδ T cell generation from human DN2-like uncommitted 
progenitors. Results from co-cultures followed during 31 days indicated that all Notch ligands 
are able to generate both αβ and γδ T cells in vitro, although with different efficiencies (Fig. 
34). In all cultures, onset of γδ T cell generation preceded αβ T cell onset and was observed as 
early as at day 10 of culture, although it was not until day 13 when a significant population of 
γδ cells became evident. Conversely, αβ T cell numbers appeared one to two weeks later (day 
17-24), depending on the ligand (Fig. 34A). Interestingly, all Notch ligands, but Jag1 that was 
equally efficient at supporting differentiation of both lineages, were significantly more efficient 
supporters of γδ than αβ T cell development (Fig. 34B). Indeed, differentiation kinetics showed 
that Dll1, Dll4 and Jag2 favored the emergence of higher numbers of γδ cells in both absolute 
(Fig. 34A) and relative (Fig. 34C, D) terms along culture. An intriguing result was that the 
efficiency of αβ T cell development in Jag1 cultures was similar to that observed in the presence 
of Dll1 or Dll4, while emergence of γδ cells was clearly impaired in Jag1 cultures compared to 
the others. In striking contrast, the other Jagged family ligand, Jag2, was the most efficient 
inducer/supporter of γδ T cell development, while it was essentially impairing αβ T cell 
development. Therefore Jag2-triggered signaling almost exclusively thrust differentiation of 
DN2-like human progenitors towards the γδ T cell lineage (Fig. 34B). In conclusion, these 
results show a selective role for particular Notch ligands in the development of either αβ 
or γδ human T cells. In particular, Jag1 and Jag2, although belonging to the same family 
of Notch ligands, exhibit opposite roles in αβ versus γδ T cell generation. 
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Figure 34. Notch ligand-induced αβ and γδ T cell development from DN2-like human intrathymic 
progenitors. A, Generation kinetics of αβ and γδ thymocytes from DN2-like progenitors co-cultured 
onto the indicated OP9 stromal cell lines. Numbers in histograms indicate the mean +/- SEM 
percentages of αβ or γδ T cells. B, Absolute cell numbers mean +/- SEM of γδ and αβ T cells recovered 
at day 25 from the indicated co-cultures. C, D, Absolute number generation kinetics of γδ and αβ T 
cells, respectively, in Notch-ligand OP9 co-cultures. Statistical significance is color-coded relative to 
Jag1 in C, and to Jag2 in D.  *; p < 0,05. **, p < 0,01. ***, p < 0,001. Data are represented as total cell 
number mean +/- SEM of five independent experiments. 
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2.3. Jag2 signaling impairs TCRαβ development at the β-selection checkpoint. 
 
To investigate in more detail the mechanisms underlying the impaired development of 
αβ T cells promoted by Jag2 signaling, we next analyzed the kinetics of TCR-β chain 
appearance in developing human progenitors exposed to the different Notch ligands, and 
focused on intracellular TCRβ (icTCRβ) expression as an unequivocal marker of αβ-lineage 
commitment. As expected, progenitors co-cultured in the absence of Notch signaling did not 
acquire TCRβ chain expression, likely because productive rearrangements at the TCRB locus 
were impaired (Wolfer et al., 2002). On the contrary, all four Notch ligands supported the 
acquisition and expression of a functional TCRβ chain, but with different efficiencies (Fig. 
35A). According to the impaired production of γδ T cells in the presence of Jag1, this co-culture 
showed the highest frequency of icTCRβ+ cells at early time points and all along the whole 
culture period, but production of icTCRβ+ cells supported by Jag1 was equivalent to that 
observed in Dll1 and Dll4 cultures in absolute terms (Fig. 35B), this confirming that Dll1, Dll4 
and Jag1 are equally efficient at promoting and/or supporting αβ T-cell development. In 
contrast, cells expressing icTCRβ were significantly reduced in both absolute and relative 
numbers in Jag2 co-cultures (Fig. 35A, B), in which γδ T-cell development was concurrently 
increased, suggesting that Jag2 signaling impairs the acquisition of a functional TCRβ chain by 
common αβ/γδ thymocyte progenitors, but favors the expression of a γδ TCR. Nonetheless, we 
cannot exclude the possibility that Jag2 affects the survival and expansion of lineage-restricted 
pre-committed progenitors. In conclusion, these data indicates that the Notch Jag2 
influence γδ and αβ T cell generation in vitro by precisely impairing the generation of 
TCRβ+ αβ-lineage cells.  
 
 
2.4. Distinct Notch ligands specify similar gene expression programs in human αβ/γδ 
common intrathymic progenitors prior to TCR expression. 
 
In order to understand the precise mechanism/s responsible for the differential role of 
Jag2, and possibly other Notch ligands, on αβ- versus γδ-lineage decision of developing 
thymocytes, we decided to investigate the nature of the molecular cues that could be responsible 
for this differential outcome. As pointed out above, signals provided by different Notch ligands 
could influence αβ versus γδ T cell production in either an inductive or a selective way. In the 
former situation, specific Notch ligands may act as inductive signals for αβ or γδ cell fate 
determination prior to TCR expression, while in the latter Notch signaling would just favor the 
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survival and/or proliferation of cells that have already acquired a functional lineage-restricted 
TCR (or pre-TCR).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If the first scenario is correct, αβ- and γδ-primed T cells must exhibit an specific 
transcriptional print before TCR expression, in a similar way that has been described for T 
lineage-committed cells (Thompson and Zuniga-Pflucker, 2011) (Tabrizifard et al., 2004) (Yui 
and Rothenberg, 2014). To determine whether T cell progenitors can in fact be transcriptionally 
Figure 35. Notch ligand-induced 
generation of intraceullar TCRβ+ 
human thymocytes from DN2-like 
progenitors. A. Flow cytometric 
analysis of intracellular TCRβ 
expression (icTCRβ) in human DN2-
like thymocytes co-cultured during 4 
weeks onto OP9 stromal cells 
expressing the indicated Notch 
ligands. Numbers in histograms 
indicate mean +/- SEM cell 
frequencies (%). Data are 
representative of 3 independent 
experiments. B, Absolute number 
generation kinetics of icTCRβ+ cells 
in co-culture shown in (A). Statistical 
significance is color-coded relative 
to Jag2. *; p < 0,05. **, p < 0,01. ***, 
p < 0,001. Data are represented as 
mean +/- SEM of 6 independent 
experiments. 
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primed towards a particular T cell fate in a Notch ligand-specific manner, we co-cultured yet 
uncommitted CD34+CD1a- DN2-like progenitors isolated from the human thymus onto OP9-
GFP, OP9-Dll4, OP9-Jag1 and OP9-Jag2 stromal cells. Given that differentiation outputs with 
Dll1 and Dll4 were equivalent, only Dll4 cultures were included in the study. Thymocyte 
populations emerging from the cultures were recovered by day 6, and RNA was extracted and 
assayed for αβ/γδ lineage-associated transcription factors (Fig. 36A). At this stage, developing 
thymocytes are committed to the T cell lineage, as they are CD1a+ and express low levels of 
CD4 and CD8, but they still lack both expression of particular TCR at the plasma membrane 
as well as intracellular TCRβ chain expression (Fig. 36B), so putative differential transcriptome 
profiles would be related to Notch rather than to TCR signaling.  
 
Lineage-specific transcription factors to be analyzed were selected based on the 
extensive expression data available from the ImmunoGenome project (www.immgen.org). 
Differential expression analyses between ETPs (preT_ETP_2A_Th) and γδ- (Tgd_Th) and αβ-
lineage murine populations (T_DP_Th) revealed a number of genes that are differentially 
expressed and may represent putative lineage-specific genes. We focused on 55 of the most 
differentially expressed genes, and selected seven genes with a clear differential expression 
profile for further analysis including SOX13, TOX2, ITGAE, ETV5, THEMIS, BLK and FOXO1. 
Of them, some have been confirmed in the literature as either γδ or αβ-lineage specific, such 
as ETV5, SOX3, RUNX3 and ID3, or THEMIS, respectively (Melichar et al., 2007) (Jojic et al., 
2013) (Malhotra et al., 2013) (Mingueneau et al., 2013). In addition, LEF1 and GATA3 T-cell 
lineage genes and the Notch downstream effector HES1 were included in the quantitative study 
as positive controls. Gene expression analyses were performed by qPCR on ex vivo-isolated 
DN2-like human thymocytes and their progeny obtained upon co-culture onto OP9 cells 
transduced with different Notch ligands or with GFP alone for 6 days; γδ T cells isolated from 
the human thymus were also included in the study for comparison (Fig. 36C). Expectedly, we 
found that Notch was active in vivo in DN2-like thymocytes, as they showed a constitutive 
expression of Hes1, but this expression declined upon culture in the absence of Notch signaling 
onto OP9-GFP stromal cells. Interestingly, levels of Notch activation quantitated by HES1 
expression were maintained in Dll4 and Jag2 cultures, but decreased upon co-culture with Jag1-
expressing stromal cells to similar levels to those displayed by OP9-GFP co-cultures or in vivo 
γδ thymocytes (Fig. 36C, lower panel).  
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Expression analysis of selected genes associated with αβ or γδ T-cell specification 
revealed no significant differences between progenitors cultured in the presence of Jag1 or Jag2 
ligands, which may represent selective supportive ligands for either αβ-lineage or γδ-lineage T 
cells, respectively. Even SOX13 and ETV5, which have been described as γδ-lineage specific 
transcription factors and are expressed at high levels in ex vivo-isolated γδ thymocytes (Fig. 
36C), were equally expressed in cells co-cultured onto either OP9-Jag1 or -Jag2 stromas; 
although both genes were significantly increased in OP9-Dll4 cultures. In addition, TOX2 was 
induced by Jag2 and Dll4 signaling, while ITGAE expression was low in the presence of any 
Notch ligand, but was highly expressed on primary γδ thymocytes. Therefore, no correlations 
could be established between a specific transcriptional profile and a particular Notch ligand. In 
summary, we can conclude that signals delivered by Notch ligands do not significantly 
influence the αβ/γδ-specific lineage transcriptional program of the immediate progeny 
derived from human DN2-like uncommitted progenitors before acquisition of TCR 
expression.  
 
 
2.5. Characterization of human intrathymic γδ T cell developmental stages: CD1a+ and 
CD1a- γδ T cell subsets are differentially generated upon signaling induced by distinct 
Notch ligands. 
 
The finding that Notch signaling does not significantly impact the transcriptional 
regulation of known lineage-specific transcription factors in αβ/γδ common progenitors 
developing in vitro, suggests that the differential cell output induced by distinct Notch ligands 
might be related to a selective rather than to an instructive ligand-specific function. Particularly, 
the improved generation of γδ T cells observed in Jag2 cultures would depend on specific Jag2 
signals that may promote the survival and/or expansion of γδ-committed, but not αβ-
<< Figure 36. Gene expression profile of αβ and γδ lineage-specific transcription factors in DN2-
like uncommitted intrathymic progenitors primed with different Notch ligands in vitro. A, 
Experimental system to asses Notch ligand-induced αβ and γδ-lineage transcriptional priming of DN2-
like uncommitted αβ/γδ uncommited progenitors in vitro. DN2-like intrathymic lymphoid progenitors 
isolated from human postnatal thymus as CD34+ CD1a- thymocytes, were co-cultured onto OP9-Dll4, 
OP9-Jag1 and OP9-Jag2 stroma during 6 days in the presence of rhIL7 and rhFlt3L. After this period, 
developing thymocytes still lacking αβ or γδ cell surface markers were harvested and phenotyped by 
FACS prior cell RNA extraction. B, Phenotype of DN2-like progenitors co-cultured in (A). Numbers in 
histograms indicate the frequency of positive cells for the indicated markers. Data shown are 
representative of 3 independent experiments. C, Quantitative RT-PCR analysis of αβ and γδ lineage-
specific transcription factors in cells recovered from co-cultures in (A). Data show mRNA expression 
levels of the indicated transcription factors normalized to GAPDH and relative to values obtained for 
ex-vivo isolated DN2-like progenitors. Data show mean +/- SEM of triplicates from 2 sets of 
independent samples. 
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committed, progenitors at any developmental stage downstream of γδ TCR expression. To test 
this hypothesis, we next aimed at investigating the particular stage of γδ T cell development at 
which Jag2 could exert its function, and analyzed in detail the kinetics and phenotype of the γδ 
T cell progeny emerging in vitro. Interestingly, we found that in vitro developing γδ T cells 
were phenotypically diverse considering expression of the CD1a marker (see below). 
Supporting the physiological relevance of this finding, CD1a is known to define a similar 
phenotypic heterogeneity among γδ T cells resident in vivo in the human thymus, which display 
three different levels of surface CD1a, from negative to high (Fig. 37A). According to previous 
data (Offner et al., 1997) (Van Coppernolle et al., 2012), we also found that thymic γδ T cells 
are heterogeneous in terms of CD4 and CD8 expression. DN and CD4+ represent about 40% 
and 50% of the whole γδ intrathymic compartment, respectively; while cells with the 
conventional CD8+ phenotype of peripheral blood γδ T cells, together with unconventional DP 
γδ T cells, comprise a minor population (Fig 37A). What is more important, high CD1a 
expression was found in CD4+ and DP thymus-specific subsets; but γδ cells bearing the DN or 
CD8+ phenotypes of conventional γδ cells were mostly devoid or expressed lower levels of 
CD1a (Fig. 37C, D). Given that CD1a is a conventional marker of immature DP thymocytes in 
the αβ T-cell lineage (Galy et al., 1993), these data suggested that CD1a expression could 
define an equivalent immature intrathymic developmental stage in the human γδ T cell lineage. 
Therefore, it is possible that CD1a+ γδ thymocytes are the progenitors of CD1a- γδ cells in the 
human thymus as previously proposed (Van Coppernolle et al., 2012). 
 
Next, we compared the phenotype of human γδ thymocytes resident in vivo with that 
of γδ T cells developing in vitro, and found that cells expressing CD1a were significantly more 
frequent than CD1a- γδ T cells in all culture conditions (Fig. 37E). However, clear differences 
were observed in OP9-Jag1 cultures compared with the others, as CD1a+ γδ cells were 
significantly less frequent in the former (Fig. 37E, left). Notably, CD1a+ γδ cell were less 
efficiently generated and their relative number decreased progressively along time in Jag1 
cultures; a decrease that paralleled a simultaneous increase in CD1a- γδ T cells that was Jag1-
specific (Fig. 37E, right). Therefore, Jag1 seems to be more efficient than other Notch ligands 
in supporting the development of γδ cells with a mature CD1a- phenotype at the expense of the 
CD1a+ γδ phenotype.  
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C, Levels of CD1a expression on intrathymic CD4/CD8-defined γδ thymocyte subsets. Numbers in 
histograms indicate the frequencies +/- SEM of CD1a+ γδ cells representative of 5 independent thymus 
samples. D, Bar graph representation of CD1a+, CD1alo and CD1ahi cell frequencies within the 
indicated γδ T cell subpopulation (DN, CD8+, CD4+ and DP). Bars represent mean frequencies +/- 
SEM of 5 thymus samples. E, Generation kinetics of either CD1a+ (left) or CD1a- (.right) γδ thymocytes 
derived from DN2-like progenitors in the indicated Notch ligand OP9 co-cultures. F, Flow cytometry 
analysis of γδ cells generated in OP9-Dll4 co-cultures. Numbers in histograms indicate  frequencies 
+/- SEM of 5 experiments. G, Levels of CD1a expression on CD4/CD8-defined γδ thymocyte subsets 
derived in OP9-Dll4 co-cultures. Numbers indicate frequencies +/- SEM of CD1a+ γδ T cells 
representative of 4 - 5 independent experiments. 
 
Figure 37. Human γδ 
thymocytes are pheno-
typically diverse in vivo and 
in vitro. A, Flow cytomety 
analysis of CD4, CD8 and 
CD1a expression on human 
intrathymic γδ thymocytes 
gated based on CD3 and 
TCRγδ expression (left). 
Numbers in histograms 
indicate frequencies +/- SEM 
of cells labeled for CD4 and 
CD8 (middle). Three levels of 
CD1a expression were 
distinguished in γδ thymocytes: 
(I) CD1a-, (II) CD1alo and (III) 
CD1ahi. B, Histogram overlay 
for CD8 and CD4 expression in 
CD1a- (blue) and CD1ahi (red) 
γδ thymocytes.  
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To further investigate the developmental pathway followed by γδ T cell progenitors in 
vitro, we next analyzed the expression of CD4 and CD8 markers on the CD1a+ and CD1a- 
progenies. We found that, like their in vivo counterparts, in vitro-derived CD1a+ γδ T cells 
were highly enriched (99 + 1%) within the DP and CD4+ cell subsets, which represented the 
major populations derived in culture from DN2-like progenitors (see Fig. 37F, G as an example 
of γδ T cells generated in OP9-Dll4 cultures). Accordingly, DN γδ thymocytes, which comprise 
almost half of γδ thymocytes in vivo, were misrepresented in vitro, and the same was true for 
γδ cells with the CD8+ phenotype. Notably, poor generation of DN and CD8+ γδ T cells was 
common in all OP9 cultures, although Jag1 supported the emergence of increased frequencies 
of both subsets, compared with the other Notch ligands (Fig. 38A). Phenotypic analysis of the 
major CD1a+ population generated in all culture conditions confirmed that they were DP or 
CD4+ (Fig. 38B). Interestingly, a major proportion of DN and CD8+ γδ cells generated under 
Dll1, Dll4 and Jag2 signaling, also expressed the immature CD1a cell marker, suggesting that 
they were still immature  (Fig. 38B). Only in Jag1 cultures DN and CD8+ γδ cells were mostly 
CD1a- or expressed low CD1a levels, like their in vivo counterparts (Fig. 37D). Therefore, 
OP9 co-cultures recapitulate the generation of all γδ T cell subsets resident in vivo in the 
human postnatal thymus, but with different frequencies, as generation of cells with the 
phenotype of mature γδ T cells appeared to be impaired by Notch signaling induced by 
Dll1, Dll4 or Jag2, and only Jag1 seemed permissive for their generation. 
 
In order to understand the mechanisms responsible for the differential impact of Notch 
ligands in the generation of CD1a+ and CD1a- γδ cells, we performed kinetic analysis focusing 
on absolute numbers of each γδ cell subset. We found similar numbers of γδ T cells with a 
mature CD1a-/low phenotype in all culture conditions (Fig. 38C), which paralleled the 
generation of equivalent numbers of DN and CD8+ cells (Fig. 38D, upper graphs), although a 
slightly increased production of DN γδ cells was observed in Jag1 cultures. However, immature 
CD1a+ γδ cells, including both DP and CD4+ γδ phenotypes, were significantly decreased in 
absolute terms in Jag1 cultures (Fig. 38C, 38D, lower graphs), indicating that Jag1 is less 
efficient that the other Notch ligands at supporting the differentiation and/or expansion of 
CD1a+ γδ immature, but not of mature CD1a- γδ T cells. As a result, ratios of mature versus 
immature γδ T cell production were significantly higher in Jag1 cultures compared with the 
others, differences that increased along the culture (Fig. 38E). As in mice γδ T cells do not 
follow a DP pathway, which is characteristic of αβ-lineage thymocytes, we could not exclude 
that DP and CD4+ γδ T cells might be αβ-lineage thymocytes switched to the γδ-lineage. To 
investigate this possibility, intracellular expression of the TCRβ chain was analyzed in the γδ 
T cells generated in vitro with the different Notch ligands (Fig. 38F).  
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We found no expression of TCRβ chain by any TCRγδ+ cell in any culture condition. 
Thus CD4+ and DP human γδ developmental stages are true γδ-lineage thymocytes. 
 
In contrast to the impact of Jag1 on γδ T cell development, Jag2 was consistently more 
efficient than the other ligands, especially Jag1, in supporting the generation of γδ T cells at the 
immature CD1a+ stage; effect particularly evident for CD4+ cells, although DP cells were also 
significantly increased (Fig. 38D, lower graphs). Production of both CD4+ and DP immature 
subsets expressing CD1a was also higher in Dll1 and Dll4 than in Jag1 cultures, but they 
reached a plateu phase at day 20 of culture (Fig. 38D). Conversely, such increased production 
of CD1a+ gd T cell phenotypes augmented along time in Jag2 cultures, suggesting a selective 
expansion of immature γδ T cells in response to Jag2 signals. Therefore, higher production 
of total γδ T cells observed in Dll1 and Dll4, and mostly in Jag2, compared to Jag1 cultures 
(Fig. 34C), was essentially due to the highly efficient generation of DP and CD4 immature 
γδ T cell populations in the former, while Jag1 was more permissive than the other ligands 
for the generation of mature γδ T cells. 
<<^ Figure 38. Jag2 Notch ligand favors the 
generation of CD1a+ immature CD4+ and DP 
CD1a+ γδ thymocytes in vitro. A, Flow 
cytometric analysis of CD4 and CD8 expression 
in γδ thymocytes generated from CD34+CD1a- 
human DN2-like progenitors after 4 weeks of co-
culture onto OP9 stromal cells expressing the 
indicated Notch ligands. Numbers indicate the 
mean +/- SEM frequencies of γδ thymocyte 
populations. B, Bar graph representation of 
frequencies +/- SEM of CD1a+, CD1alo and 
CD1a- γδ cells within the indicated CD4/CD8-
defined γδ thymocyte subsets generated as 
indicated in (A).  
C, D, Absolute number generation kinetics of gd thymocyte subsets defined by either CD1a+ or CD1a- 
and CD4 and/or CD8 expression, respectively, recovered from co-cultures shown in (A). Statistical 
color-code significance relative to Jag1 is shown. *; p < 0,05. **, p < 0,01. ***, p < 0,001. E, Bar graph 
representation of mature CD1alo/CD1a- and immature CD1a+ mean ratios +/- SEM of γδ thymocyte 
generation in co-cultures shown in (A).**, p < 0,01. ***, p < 0,001. Data shown is representative of 6 
independent experiments. F, Flow cytometry analysis of icTCRβ in TCRγδ+ cells recovered at day 17 
from Notch ligand OP9 co-cultures. Blue and red gates define γδ− and αβ-lineage thymocytes, 
respectively. Numbers in histograms indicate the frequencies of the indicated populations in a 
representative experiment of two. 
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2.6. Jag2 selectively supports the proliferation of immature CD1a+ γδ T cells. 
 
The above results prompted us to investigate whether the divergent γδ T cell outcome 
in Jag1 and Jag2 cultures was actually the result of an opposed potential to support the 
maturation and/or expansion of CD1a+ γδ  thymocytes. To this end, we analyzed the 
differentiation potential of ex-vivo isolated human immature γδ thymocytes expressing high 
levels of CD1a (>99% CD1a++) in OP9 co-cultures. As expected, isolated CD1a+ γδ  
thymocytes from human thymus were mostly CD4+ (about 80%), and a minor proportion 
(about 10%) were DP (Fig. 27A, right). The resulting 10% left were CD1a+ DN γδ cells, which 
may correspond with γδ T cell progenitors (Van Coppernolle et al., 2012). Analysis of cells 
recovered from cultures of OP9 cells expressing either Jag1, Jag2 or no ligand at different time 
points, revealed that Notch signaling induced by Jag2 resulted in a 5-6-fold cellular expansion, 
while cell numbers did not significantly increased in OP9-Jag1 and OP9-GFP co-cultures (Fig. 
39C). Kinetic analyses revealed the downregulation of CD1a and the generation of CD1a- 
γδ thymocytes at early time-points in all cultures, indicating that all culture conditions allowed 
the maturation of CD1a+ thymocytes into CD1a- γδ T cells. But significant differences were 
observed between Jag1 and Jag2 cultures (Fig. 39D). By day 7, only about 30-40% of γδ cells 
remained as CD1a+ in OP9-Jag1 co-cultures and OP9-GFP controls (Fig. 39D, left), and 
thereafter CD1a+ γδ cell numbers decreased steadily and essentially disappeared, while CD1a- 
γδ cells increased concurrently (Fig. 39D, right). Conversely, proportions of CD1a+ γδ cells 
increased significantly from day 7 in Jag2 cultures, which may suggest an impaired survival of 
mature CD1a- cells developing in the presence of Jag2. In contrast to this possibility, we found 
that absolute numbers of CD1a- cells arising in OP9-Jag2 cultures were similar those in OP9-
Jag1 or OP9-GFP cultures (Fig. 39E), and numbers of γδ cells that displayed the mature DN or 
CD8+ phenotype were similar as well regardless of the Notch ligand expressed in OP9 cultures 
(Fig. 39G). Moreover, absolute numbers of CD1a+ γδ cells increased steadily in OP9-Jag2 
cultures and this expansion was confirmed to involve immature γδ cells with either the CD4+ 
or the DP phenotype (Fig. 39E, F). Therefore, Jag2 seems to be highly efficient as an inducer 
of the proliferative expansion of immature γδ T cells, which however seem to undergo 
maturation at lower rates than cells developing in the absence of Notch signaling or in the 
presence of Jag1. Supporting this possibility, mature DN and CD8+ γδ cells represented the 
major cell output in OP9-GFP and OP9-Jag1 cultures by day 16 (Fig. 39F). However, about 
one third of γδ cells in OP9-Jag2 cultures still remained as CD4+, and a similar proportion 
displayed the immature DP phenotype, suggesting an impaired maturation of γδ T cells 
compared with OP9-Jag1 or control OP9 cultures (Fig. 39F) under Jag2 signaling.  
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Collectively, these results confirm previous data by Van Coppernolle and coworkers 
(Van Coppernolle et al., 2012) showing that maturation of CD1a+ γδ thymocytes into CD1a- 
γδ  T cells can efficiently occur upon culture onto OP9 cells lacking ectopic Notch ligands and 
they extend this finding to OP9-Jag1 co-cultures. But, what is most important, our data also 
indicate that signaling provided by Jag2 supports a highly proliferative pathway of γδ T cell 
development involving mostly immature CD1a+ γδ cells of DP and CD4+ phenotype, whose 
maturation into CD1a- γδ cells is relatively impaired. Therefore, we concluded that Jag2, and 
to a lesser extent Dll1 and Dll4 signaling, efficiently supports the generation and 
expansion of immature CD1a+ γδ T cells, which may require to be released from these 
Notch ligand signals to stop proliferation and undergo further differentiation into more 
mature CD1a- γδ T cells. In this scenario, differential expression of Notch ligands at 
particular niches may critically control the γδ developmental pathway in the human 
thymus. 
 
 
 
 
 
 
 
 
<<^ Figure 39. Jag2 supports the selective expansion of CD1a+ immature CD4+ and DP γδ T 
thymocytes resident in the human thymus. A, Flow cytometry analysis of CD1a+ γδ cells isolated 
by magnetic cell sorting from human thymus. Human γδ thymocytes expressing CD1a were isolated 
by sequential CD1a and TCRγδ magnetic cell sorting. CD8 and CD4 expression on the isolated 
CD1a+ γδ thymocytes is shown. Numbers in histograms represent mean +/- SEM frequencies on the 
indicated cell populations. Data shown are representative of 1 - 3 independent experiments. B, 
Experimental design for in vitro differentiation of ex-vivo isolated CD1a+ γδ+ human thymocytes co-
cultured onto Jag1- or Jag2-transduced OP9 cells. CD1a+ γδ+ human thymocytes isolated as shown 
in (A) were co-cultured for two weeks onto OP9-GFP, OP9-Jag1 or OP9-Jag2 stromal cells in the 
presence of rhIL7 and rhFlt3L. C, Fold expansion of CD1a+ γδ+ thymocytes co-cultured during 16 
days onto the indicated OP9 stromal cells. Data are represented as mean +/- SEM of total cell number 
in 3 independent experiments. D, Kinetics of generation of CD1a+ (left) and CD1a- (.right) gd 
thymocytes in the indicated Notch ligand OP9 co-cultures. Data are represented as mean +/- SEM 
frequencies of the indicated cell subsets in 3 independent experiments. E, Absolute number 
generation kinetics of CD1a+ γδ+ (left) and CD1alo/- γδ+ cells (.right) in the indicated Notch ligand OP9 
co-cultures. Data show mean +/- SEM absolute numbers in 3 independent experiments. F, Bar graph 
show mean +/- SEM frequencies of the indicated CD4/CD8-defined γδ subsets generated by day 16 
in the indicated co-cultures. G, Absolute number generation kinetics of the indicated CD4/CD8-defined 
γδ subsets generated in the OP9-Jag1, OP9-Jag2 and OP9-GFP co-cultures. Data show absolute cell 
number +/- SEM of 3 independent experiments. *; p < 0,05. 
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2.7. Vδ repertoire of γδ T cells derived in vitro from human thymocyte precursors in 
response to distinct Notch ligands. 
 
 It is known that human Vδ2 γδ T cells are mostly resident in the PB where they display 
a mature CD1a- DN or CD8+ phenotype. Conversely, Vδ1 γδ T cells represent only 1-2% of 
PB γδ lymphocytes, but are abundant in the spleen (Falini et al., 1989) and several mucosal 
tissues (Grossi et al., 1992) (O'Brien et al., 2007) (Hua et al., 2013) and represent the major γδ 
T cell population in the human thymus (Falini et al., 1989). Analysis of intrathymic Vδ cell 
subsets showed that most (80%) Vδ1+ γδ thymocytes express CD1a, while Vδ2+ cells are more 
heterogeneous for CD1a expression (Fig. 40A). Given this heterogeneous distribution of CD1a 
in γδ cells with distinct Vδ chains, we next assessed whether equivalent populations could be 
generated in vitro in the context of different Notch ligands. To this end, human intrathymic 
DN2-like progenitors developing onto OP9 cells expressing Dll1, Dll4, Jag1 or Jag2 Notch 
ligands were analyzed for the expression of Vδ1 and Vδ2, every 3 days along the whole 31 
day-culture period. Results revealed that Vδ1 cells were produced more efficiently than Vδ2 in 
all cultures, but proportions of γδ cells expressing Vδ1, Vδ2, or a different Vδ chain (Leclercq 
et al., 1993) were essentially similar in all cultures, although Vδ1+ cells were slightly less 
represented in Jag1 cultures compared to the others  (Fig. 40B). According to our results above, 
absolute numbers of γδ cells expressing any Vδ were considerably reduced in Jag1 cultures 
compared to the other cultures, confirming an impaired potential of Jag1 to support the 
development/proliferation of all γδ  T cell subsets. Conversely, Jag2 was significantly more 
efficient than the other ligands in supporting the production an expansion of γδ T cells of the 
Vδ1+ and Vδ1-Vδ2- subsets, while numbers of Vδ2+ γδ T cells were essentially identical to 
those emerging in the presence of the other ligands (Fig. 40C). In summary, these data 
provide further evidence that Jag2 is the most efficient Notch ligand at supporting the 
development and expansion of γδ T cell subsets expressing CD1a, such as Vδ1+ cells; while 
signaling induced by Jag1 appears insufficient to support the expansion of any γδ T cell 
population, and particularly of Vδ1+ cells, which are mostly CD1a+.  
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2.8. Jag1 favors the generation of functional IFNγ-secreting γδ T cells. 
 
Several reports in mice have pointed to Notch as a capital signal for the generation of 
IL-17 γδ T cells (Mukherjee et al., 2009) (Shibata et al., 2011) (Michel et al., 2012) and also 
for the proliferation and function of PB human IFNγ-secreting γδ T cells (Gogoi et al., 2014). 
Therefore, we wanted to assess the functionality of the γδ T cell subsets generated in vitro and 
Figure 40. Heterogeneity of Vδ subsets of γδ thymocytes developing in in vitro. A, Bar graph 
represent mean +/- SEM frequencies of the indicated Vδ subpopulations of total γδ T cells (left) present 
in vivo in the human thymus; right: mean +/- SEM frequencies of CD1a+, CD1alo and CD1a- within 
the Vδ1 and Vδ2 γδ T cell subsets in vivo in the human thymus. B, Kinetics flow cytometry analysis of 
Vδ1 and Vδ2 expression in DN2-like human thymocytes co-cultured onto the indicated Notch ligand 
OP9 cell lines during 31 days. Numbers in quadrants shown mean +/- SEM frequencies of the 
indicated cell subsets. C, Kinetics of absolute Vδ1+, Vδ2+ and Vδ1-Vδ2- γδ T cell numbers generated 
along 31 days of co-culture with the indicated Notch ligand expressing OP9 cells. Data show mean 
+/- SEM cell numbers +/- in 3 independent experiments.  
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the possibility that particular Notch ligands were inducing specific γδ T cell functions. To this 
end, γδ T cells generated after 28 days in the different OP9-Notch ligand cultures were assayed 
by flow cytometry for the production of either IL-17 of IFNγ upon stimulation with anti-CD3 
and IL-2 and further activation with PMA, as has been described for PB αβ and γδ T cells 
(Michel et al., 2012 and Fig. 41A). Given that γδ T cell generation in Dll1 and Dll4 cultures 
was equivalent, only Dll4 cultures were included in this study. Upon stimulation, all cultures 
were highly enriched in γδ T cells, of which more than 30% were fully functional, as assessed 
by INFγ  secretion. Notably, IFNγ-producing γδ T cells were more frequent in Jag1 cultures, 
compared to Dll4 and Jag2 cultures (Fig. 41C). In contrast, few γδ cells produced  IL-17, 
regardless of the Notch ligand culture (Fig. 41B, C) and generation of IL-17-secreting γδ T 
cells was neither observed in a IL-17 polarization assay following stimulation with plate-bound 
anti-CD3 Ab and a Th17-polarizing cytokine cocktail including IL-1β, TGFβ and IL-6 (Manel 
et al., 2008) (Keerthivasan et al., 2011) (data not shown). Given that essentially all γδ T cells 
derived in every culture condition have undergone maturation into CD8+ γδ T cells upon 
activation through the γδ TCR (Fig. 41D), our data suggest that Jag1 is more efficient than 
Dll4 or Jag2 in supporting the generation of INFγ-secreting γδ T cells. Importantly, these 
cells were efficiently expanded in the presence of IL-2 and, therefore, this in vitro co-culture 
system could overcome the limitations of current protocols of generation of functional γδ 
T cells. It is thus possible that using this system for large-scale generation of γδ T cells may 
help the development of novel and promising xeno-free approaches to ultimately generate γδ T 
cells suitable for clinical applications.  
 
 
 
>> Figure 41. Notch signaling influences the generation of functionally mature IFNγ-secreting 
γδ T cells in vitro. A. Flow cytometry analysis of intracellular staining of IL-17 and IFNγ cytokines in 
either resting (left) or PMA-activated (.right) human PBLs was used as positive control. Histograms 
show FACS analysis of human peripheral blood lymphocytes (PBLs) stimulated with anti-CD3 and IL2 
for 36h and expanded in the presence of rhIL2 for 5 additional days. Activation with PMA plus 
ionomycin was done immediately prior cytokine staining. B, Flow cytometry analysis of intracellular 
staining of IL-17 and IFNγ cytokines in CD3- and rhIL2-stimulated human γδ thymocytes generated in 
vitro from DN2-like progenitors in the indicated Notch ligand OP9 co-cultures by day 28. Activation 
with PMA plus ionomycin was done immediately prior cytokine staining. Numbers in quadrants 
represent mean +/- SEM frequencies of the corresponding population. C, Bars graph diagrams 
representing the frequency (cell %) of INFγ+ γδ T cells and IL-17+ γδ T cells generated from DN2-like 
progenitors in the indicated co-cultures. Data were normalized to IFNγ+ or IL-17+ cell frequences 
obtained for PBL controls. **, p < 0,01. *, p < 0,05. D, Flow cytometry analysis of the CD8/CD4 
phenotype displayed by γδ T cells analyzed in B, C and by day 28 in Notch ligand co-cultures either 
before (left) of after (.right) anti-CD3 plus rhIL2 stimulation. Numbers in quadrants represent mean +/- 
SEM frequencies of the indicated cell population. 
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III. STUDY OF THE IN VIVO INTRATHYMIC DIFFERENTIATION DYNAMICS OF 
HUMAN γδ T CELLS. 
 
3.1. γδ T cells preferentially accumulate at the CMJ, a Jag2-rich niche in the human 
thymus. 
 
The differential function observed for Jag2 as a Notch ligand that selectively favors the 
generation of γδ T cells in vitro, as well as the expansion of their intermediate maturation stages, 
strongly suggests that human γδ T cells may be generated and expanded in vivo in Jag2-rich 
microenvironments. However, the particular location of γδ T cells in the human thymus and 
their intrathymic dynamics have been poorly addressed. Scarce reports point to the medulla as 
the most important niche of human intrathymic γδ T cells (Groh et al., 1989) (Falini et al., 
1989). In order to confirm these data, we performed immunohistochemical analysis of postnatal 
human thymic tissue stained with an anti-TCRδ chain-specific monoclonal antibody (Groh et 
al., 1989). Anti-panCK was also used in the study to co-stain TECs. A general analysis of TCRδ 
expression showed a broad distribution of γδ T cells both in the cortex and in the medulla of 
the human thymus (Fig. 42A). A closer view to the three different functional regions of the 
thymic cortex: subcapsular cortex (SCC), inner cortex (IC) and corticomedulary junction 
(CMJ), revealed the accumulation of γδ T cells at the later. By carefully limiting this region to 
the narrow portion of cortical tissue close to the medulla (Fig. 42A; yellow dotted line), we 
could observed a precise accumulation of γδ T cells at this location, where Jag2 is highly 
expressed by cTECs (see Fig. 18). Conversely, detailed analyses of the remaining cortical areas, 
SCC and IC (both together named as “cortex”), revealed that γδ T cells are quite scarce in these 
cortical areas (Fig. 42B), while CMJ and thymic medulla showed notably higher numbers of γδ 
T cells (Fig. 42C, D). In each thymic region, panCK staining was excluded from TCRδ-positive 
cells, characterized as thymocytes, thus confirming antibody specificity. To formally quantify 
the distribution of γδ T cells in each thymic anatomic region, quantitative analyses of γδ T cell 
numbers were performed in no less that 10 cortical, 10 CMJ and 10 medullary images (Fig. 
42B, C, D) (40x) per thymic sample (N = 3). Results showed that γδ T cells were significantly 
more abundant in the thymic cortex as a whole (SCC+ IC + CMJ regions) than in the medulla 
(Fig. 42E), in contrast with data presented in previous reports showing 3 times more γδ T cells 
located at the medulla than at the cortex (Groh et al., 1989) (Falini et al., 1989). When γδ T cell 
counting was done separately in the cortex (SCC + IC) and in the CMJ, we confirmed a highly 
significant accumulation of γδ T cells at the CMJ (Fig 42F).  
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Based on these data, we can conclude that human γδ T cells are more abundant at 
the thymic cortex but specifically in the narrow region of the CMJ, where Jag2 Notch 
ligand is highly expressed. 
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3.2. Different γδ T cell developmental stages are located at specific thymic niches:  CMJ 
and medulla selectively host immature CD1a+ and mature CD1a-/lo γδ Τ cells, 
respectively. 
 
During αβ T cell development, immature CD1a+ DP thymocytes mainly reside within 
the thymic cortex, but they migrate into the thymic medulla for further maturation. Whether γδ 
T cells follow a similar intrathymic migratory pathway is unknown. Our data have located 
human intrathymic γδ T cells in the CMJ and medulla. We have also demonstrated that CMJ 
and medulla are two very distinct niches regarding Jag1 and Jag2 Notch ligand expression. 
Additionally, Jag1 and Jag2 have opposing functional roles in vitro concerning αβ versus γδ T 
cell generation; indications that altogether suggest that cortical and medullary γδ T cells could 
be different γδ T cell populations. To test this hypothesis, we took advantage of our previous 
results showing a preferential generation of CD1a+ γδ T cells in response to Jag2 signaling, 
and ought to determine the localization in the human thymus of CD1a+ and CD1alo/- γδ T cell 
populations. As expected, CD1a was strongly expressed at the thymic cortex, where most 
immature αβ-lineage thymocytes reside. Conversely, thymic medulla showed an scarce or 
absent CD1a+ signal, according to the fact that it mostly hosts myeloid and mature T cells (Fig. 
43A). Detailed images of CD1a and TCRγδ expression at the CMJ and medulla showed CD1a+ 
membrane staining in corticomedulary but not in medullary γδ T cells; only scarce medullary 
γδ T cells showed some low CD1a expression (Fig. 43B, C; arrowheads). This observation was 
confirmed by CD1a quantitative analyses (of about 50 cortical and medulary γδ T cells per 
tissue sample) in 10 images (63x) per postnatal thymic tissue sample (N = 3) (see below).  
 
 
 
<< Figure 42. TCRγδ expression analysis in human postnatal thymus reveals accumulation of  
γδ T cells at the CMJ. Images show snap-frozen sections of human postnatal thymic tissue (< 17 
months-old) stained for TCRγδ (red) and CK19 (green). Topro3 was used for nuclear staining (blue). 
A, General view of TCRγδ distribution in the human thymus. Thymic regions are labeled as; c: cortex; 
and m: medulla; dotted line: CMJ. Yellow squares highlight cortical, corticomedulary and medullary 
ROIs. Scale bar: 100µm. B, C, D, TCRγδ expression at the cortex, CMJ and medulla, respectively. 
Arrowheads indicate TCRγδ positive staining. Dotted line: CMJ; h: Hassal’s corpuscle. Scale bars: 
50µm. E, Bars graph shows the mean +/- SEM absolute number of TCRγδ+ cells per field (40x) at the 
thymic cortex (considered as cortical plus corticomedulary regions) and at the medulla. *, p < 0,05; **, 
p < 0,01. F, Bars graph shows the mean +/- SEM absolute number of TCRγδ+ on each anatomic 
region relative to the total number of γδ T cells per field. Data are representative of results obtained in 
N ≥ 10 images (40x) per thymic region and N ≥ 3 different tissue samples. 
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Figure 43. Different TCRγδ developmental stages defined by CD1a expression are found in 
different thymic niches. Images show snap-frozen sections of human postnatal thymic tissue (< 
17 months-old) stained for CD1a (red) and TCRγδ (green). Topro3 was used for nuclear staining 
(blue). A. General view of CD1a distribution in the human thymus. Thymic regions are labeled as c: 
cortex; and m: medulla; dotted line: CMJ. Scale bar: 100µm. B, C, CD1a and TCRγδ expression at 
the CMJ and medulla, respectively. Arrowheads indicate TCRγδ+ cells co-expressing high levels of 
CD1a (yellow) at the CMJ, but not at the medulla. Dotted line: CMJ. Scale bars: 50µm. D, Bar graph 
shows mean +/- SEM frequencies of CD1a+ and CD1a- γδ T cells at the whole cortex (COR = SCC 
+ IC + CMJ) and at the medulla (MED). Data was obtained by counting CD1a+ and CD1a- TCRγδ 
cells on N ≥ 10 images (40x) per thymic region and N ≥ 3 different tissue samples. E, F, Detail of 
isolated CD1a+ γδ T cells (arrowheads) present at the cortex and the medulla, respectively. Scale 
bars: 10µm. Yellow lines represents ROIs defined by TCRγδ expression that were used to measure 
CD1a MFI on cortical (N = 45) and medullary (N = 40) CD1a+ TCRγδ+ cells (G) on N ≥ 10 images 
(40x) per thymic region and N ≥ 3 different tissue samples. ***, p < 0,001. 
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Results shown in Fig. 43D, confirmed that cortical and medullary thymic 
microenvironments host different populations of γδ T cells, as CD1a+ immature and CD1a- 
mature γδ T cells are preferentially located in the CMJ and medullary thymic 
microenvironments, respectively.  However, an important population (40%) of CD1a+ γδ T 
cells was also located at the thymic medulla. To assess whether these medullary and cortical 
CD1a+ γδ T cells were equivalent cell subsets, we performed quantitative analyses aimed at 
defining CD1a expression levels (MFI) in CD1a-expressing cortical and medullary 
γδ thymocytes. No less than N = 45 γδ T cells per postnatal thymic tissue sample (N = 3) were 
analyzed as following. As shown in Fig. 43E, F, ROIs (yellow line) were defined by TCRγδ 
intensity threshold (Otsu, 1979) on individual CD1a+ γδ T cells. Results shown in Fig. 43G 
demonstrated that CD1a expression levels of medullary CD1a+ γδ T cells were significantly 
lower than their cortical counterparts, suggesting that they represent distinct populations of γδ 
T cells. Based on these results, we can propose that medullary CD1a+ γδ T cells are an 
intermediate developmental stage between cortical CD1a+ and medullary CD1a- γδ T cells. 
Altogether, our data show that two different thymic niches, the CMJ and the medulla, 
host γδ thymocytes at successive developmental stages, suggesting that CD1a+ 
γδ thymocytes migrate into the thymic medulla while downregulating CD1a expression, 
thus following a dynamic maturation pathway similar to that of αβ T cells. 
 
 
3.3. Vδ1 and Vδ2 γδ T cells are located at different thymic microenvironments.  
 
Our results above (Fig. 40A) indicate that Vδ1+ thymocytes are mostly CD1a+ cells, 
which represent more than 50% of total γδ T cells in the human thymus. Conversely, Vδ2+ 
cells are quite scarce in the human thymus and most of them display a mature CD1alo/- γδ T 
cell phenotype. Therefore, we next investigated whether the differential distribution of CD1a+ 
and CD1a- γδ thymocytes in the human thymus, can be extended to Vδ1+ and Vδ2+ intrathymic 
populations. As expected, Vδ1 cells were shown mostly located in cortical areas, although the 
medulla also hosts some Vδ1 cells (Fig. 44A). A detailed analysis of the three thymic niches 
(Cortex, CMJ and Medulla) showed few scattered Vδ1 cells at the cortex and medulla, but 
numerous Vδ1 cells at the CMJ (Fig. 44B, C, D). Quantitative analyses of no less than 10 
images (63x) per postnatal thymic tissue sample (N = 3), confirmed that Vδ1 cells are mostly 
located at cortical regions  (cortex + CMJ regions), and accumulate at the CMJ (Fig. 44E). 
Equivalent analyses of Vδ2+ cell distribution showed that the human thymus host very few 
Vδ2 cells (Fig. 45A), and they are mostly confined to the medullary microenvironment (Fig. 
45D, E). Altogether this data demonstrate that Vδ1 and Vδ2 γδ T cells, which are mostly 
CD1a+ and CD1alo/-, respectively are hosted in two different thymic niches, either the 
cortex or the medulla. 
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Figure 44. Vδ1 expression in human postnatal thymus. Images show snap-frozen sections of 
human postnatal thymic tissue (< 17 months-old) stained for Vδ1 (red) and CK19 (green). Topro3 
was used for nuclear staining (blue). A, General view of Vδ1 expression in the human thymus. 
Thymic regions are labeled as; c: cortex; and m: medulla; dotted line: CMJ. Scale bar: 100µm. B, 
C, D, Vδ1 expression at the cortex, CMJ and medulla, respectively. Arrowheads indicate Vδ1 
positive staining. Dotted line: CMJ; h: Hassal’s corpuscle. Scale bars: 50µm. E, Bars graph  
showing the mean +/- SEM absolute number of TCRγδ+ on each anatomic region relative to the 
total number of γδ T cells per field. F, Bar graph shows the mean +/- SEM frequencies of the 
different Vδ subpopulations present in vivo in the human thymus. Data are representative of results 
obtained from N ≥ 10 images (40x) per thymic region and N ≥ 3 different tissue samples. 
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Figure 45. Vδ2 expression in human postnatal thymus. Images show snap-frozen sections of 
human postnatal thymus (< 17 months-old) stained for Vδ2 (red) and CK19 (green). Topro3 was 
used for nuclear staining (blue). A, General view of Vδ2 expression in the human thymus. Thymic 
regions are labeled as; c: cortex; and m: medulla; dotted line: CMJ. Scale bar: 100µm. B, C, D, 
Detailed Vδ2 expression at the cortex, CMJ and medulla, respectively. Arrowheads indicate Vδ2 
positive staining, excluded from panCK+ staining. Dotted line: CMJ; h: Hassal’s corpuscle. Scale 
bars: 50µm. E, Bars graph shows the mean +/- SEM absolute number of γδ T cells on each 
anatomic region relative to the total number of γδ T cells per field. Data were obtained from N ≥ 
10 images (40x) per thymic region and N ≥ 3 different tissue sections. 
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3.4. Intrathymic γδ T cells express Notch1 and Notch3 receptors. 
 
We have previously shown, that Notch receptors are distributed in vivo in different 
thymic niches and expressed by different cell types. Notch1 is mainly expressed by TECs and 
scattered cortical thymocytes, while Notch3 is exclusively expressed by thymocytes at the 
cortex, and by TECs at the medulla. At the cortex, Notch1 and Notch3 receptors may interact 
mostly with the Jag2 Notch ligand expressed on cTECs, which specifically enhance γδ T cell 
generation and impairs αβ development. Recently, it has been shown than differential Notch 
receptor-ligand interactions mediate αβ versus γδ T cell development by inducing differential 
Notch signaling strength and that, particularly Jag2, induces the strongest Notch signal through 
the interaction with the Notch3 receptor (Van de Walle et al., 2013). Despite these findings, 
Notch receptors expression on human intrathymic γδ T cells has not been yet addressed. The in 
vivo localization of immature (CD1a+ DP and/or CD1a+ CD4+) gd T cells at the CMJ, where 
Jag2 and Notch3 expression are maximal, aimed us to investigate Notch1 and Notch3 receptors 
expression in vivo by different γδ T cells subtypes.  
 
Phenotypic analyses of Notch1 and Notch3 expression on human thymocytes showed a 
differential distribution of these receptors on intrathymic γδ T cells, as Notch1 was expressed 
in about 70% of γδ T cells, while low levels of Notch3 were detected in up to 35% of γδ 
thymocytes (Fig. 46A). Multiparameter flow cytometry analyses of the distribution of both 
receptors on distinct γδ T cell subtypes revealed that, as shown for αβ T-lineage cells (Fig. 
46B), Notch1 and Notch3 were expressed by all γδ thymocyte subsets, although at different 
frequencies (Fig. 46C). Notch1 was significantly underrepresented in DN γδ T cells, compared 
with DP γδ thymocytes, which showed the higher frequency of Notch1+ cells, but it was also 
expressed in a considerable proportion of CD4+ and CD8+ SP γδ thymocytes. More 
importantly, Notch3 expression was significantly enriched in DP γδ thymocytes compared to 
all the other γδ T cell subsets (Fig. 46C). Altogether, these findings are compatible with an 
specific role for Notch3 at the immature DP stage of γδ T cell development. 
 
We also found that Notch3 expression, poorly addressed in αβ-lineage thymocytes (Felli 
et al., 1999), was enriched as well in DP αβ-lineage cells. Nevertheless, a similar proportion of 
Notch3+ cells were detected in the upstream thymocyte subset of DN precursors that still lack 
a particular TCR (Fig. 46B). Therefore, Notch3 seems to be selectively downregulated during 
positive selection of SP αβ thymocytes; whereas, as previously shown, Notch1 is early 
downregulated during transition to the DP αβ thymocyte stage (Huang et al., 2003) (Fiorini et 
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al., 2009) (Gonzalez-Garcia et al., 2009). Collectively, these findings concur with our 
observation that Notch3 is strongly expressed in vivo in the hematopoietic population of 
mostly DP thymocytes located at the cortical thymic niche (see Fig. 28D, E), in contrast 
with Notch1 which is early downregulated prior the DP stage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Figure 46. Notch1 and Notch3 receptor expression in human intrathymic γδ T cells 
populations. A. Flow cytometry analysis of Notch1 and Notch3 receptor expression in 
electronically gated human intrathymic γδ T cells. Numbers in histograms show the mean +/- 
SEM frequencies of γδ thymocytes expressing Notch1- or Notch3. B, Bars graph shows the mean 
+/- SEM frequencies of Notch1 and Notch3 expression on CD4/CD8-defined γδ thymocyte 
subsets (DN, CD4+, DP and CD8+). Data are representative of 2 - 4 independent experiments. 
**, p < 0,01; *, p < 0,05.  
  124
Results 
 
3.5. Intrathymic γδ T cell subsets differentially express the CXCR4 chemokine receptor.  
 
The differential distribution of immature and mature γδ T cells within the human 
thymus observed in this study suggests that the developmental maturation of γδ thymocytes 
may be accompanied by a selective migration of immature CD1a+ γδ thymocytes from the CMJ 
to the medulla. Therefore, it was expected that, as reported for thymocytes developing along 
the αβ T cell lineage (Bleul and Boehm, 2000) (Norment and Bevan, 2000) (Annunziato et al., 
2001) (Liu et al., 2006) (Petrie and Zuniga-Pflucker, 2007) expression of chemokine receptors 
could play a crucial role in that process. However, the relationship of γδ T cell differentiation 
and their intrathymic dynamics is less well understood. 
 
Regarding chemokine/chemokine receptor pathways involved in thymocyte 
maturation, it is known that CXCL12 (SDF1) is abundantly expressed at the CMJ, where it is 
involved in thymus seeding by BM-derived progenitors (Aiuti et al., 1999) (Plotkin et al., 
2003). Cortical transmigration is regulated by CCR9-CCL25 (Campbell et al., 1999) (Norment 
et al., 2000), while CCR4 and CCR7, and their respective ligands CCL22 and CCL19/CCL21, 
are abundant at the thymic medulla where they orchestrate cortico-medullary migration of post-
selected DP and CD4+ and CD8+ SP αβ thymocytes (Chantry et al., 1999) (Witt and Robbins, 
2005).  Regarding γδ T cells, studies with CCR7- and CCR9-deficient mice showed that CCR7 
and CCR9 expression was important for γδ T-cell localization within the thymic medulla or 
cortex, respectively (Reinhardt et al., 2014). Of them, CCR9 expression is notably expressed 
in murine γδ thymocytes (Uehara et al., 2002). Based on these grounds, the expression of CCR9 
and CXCR4 was studied by FACS in ex-vivo-isolated human γδ thymocytes, with the aim of 
investigating whether discrete human γδ developmental stages have a differential expression of 
chemokine receptors. In contrast to murine data (Uehara et al., 2002), no CCR9 expression was 
detected in human thymocytes, including γδ thymocytes (Fig. 47A, B, left). Conversely, 
CXCR4 was expressed in a considerable proportion (up to 40%) of total human thymocytes, 
and particularly in DN and DP thymocytes (Fig. 47B, C, right), as reported before in mice 
(Plotkin et al., 2003). Detailed analyses of CXCR4 expression in γδ thymocyte subsets, revealed 
a preferential expression of this chemokine receptor in the DP and CD4 γδ cell subsets with an 
immature CD1a+ phenotype (Fig. 47E,), thus suggesting that CXCR4 downregulation 
parallels cortico-medullary migration and γδ thymocyte maturation.  
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Figure 47. CCR9 and CXCR4 chemokine receptor expression in 
human intrathymic γδ T cell populations. A, Flow cytometry 
analysis of CCR9 and CXCR4 expression on human αβ-lineage 
thymocytes. Numbers in histograms indicate mean +/- SEM 
frecuencies of cells expressing CCR9 or CXCR4. B, Bar graph shows 
the mean +/- SEM frequencies of CXCR4 expression on CD4/CD8-
defined γδ thymocyte subsets (DN, CD4+, DP and CD8+). C, Flow 
cytometry analysis of CCR9 and CXCR4 expression on human 
intrathymic γδ T cells. Numbers in histograms indicate mean +/- SEM 
frecuencies of cells expressing CCR9 or CXCR4. D, Bar graph shows 
the mean +/- SEM frequencies of CXCR4 expression on CD4/CD8-
defined γδ thymocyte subsets (DN, CD4+, DP and CD8+). Data 
shown are representative of 2 - 4 independent experiments. **, p < 
0,01. 
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IV. ROLE OF NOTCH IN THYMIC EPITHELIAL CELL BIOLOGY.  
 
Crosstalk between developing thymocytes and TECs is key to achieve full maturation 
of both cell types (Fig. 5). Several conserved signalling pathways play a capital role in TEC 
development and maturation (see Introduction 3.4), and our studies showing in vivo expression 
of Notch receptors on TECs (see Results 1.4) suggest, although it remains to be formally 
established, that Notch signalling may be one of those crucial pathways for TEC development. 
In order to study the role of Notch signalling in TEC biology, we have undertaken two different 
approaches. First, we performed immunofluorescence studies to analyse the spatio-temporal 
pattern of Notch activation within the thymus in both mouse and human TECs. Then, to further 
dissect Notch function in TEC development and homeostasis. We moved to an in vivo system 
and used a conditional murine model in which Notch signalling was specifically abrogated in 
TECs. 
 
4.1. The Notch signaling pathway is active in TECs. 
 
In order to assess whether Notch signalling is active in vivo in human postnatal TECs, 
we analysed the expression of the well-established Notch activation target Hes1 in human 
postnatal thymus tissue sections. This approach revealed a broad and quite homogeneous 
pattern of Hes1 nuclear expression throughout the thymus, although the thymic medulla 
exhibited higher frequency of Hes1+ cells than the cortex (Fig. 48A). Detailed analyses of 
singular thymic regions, including the subcapsular cortex (SCC), inner cortex (IC) and medulla  
(MED), with the aid of the pancytokeratin (panCK) epithelial cell marker, allowed us to identify 
both Hes1+ cTECs and Hes1+ mTECs in the human thymus (Fig. 48B, C, D); expression 
pattern that was conserved in mice (Fig. 51B, C). Hes1+ cTECs with a strong nuclear staining 
(arrowheads) were found throughout the SCC and IC, and scarce non-epithelial Hes1+ cells, 
likely developing thymocytes, were also found at these locations (arrows) (Fig. 48B, C). Hes1+ 
TECs were quite frequent at the thymic medulla and accumulated in Hassal’s corpuscles (HCs), 
where mTECs displayed the highest Hes1 expression levels (Fig. 48D).  Similar results were 
obtained in murine postnatal thymus (Fig. 51B, C). Collectively, our immunohistochemistry 
analyses of intrathymic Hes1, expression provide the very first evidence of Notch signaling 
activation in human and murine TECs located at the cortical and medullary 
microenvironments. 
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Figure 48. Notch signaling pathway is active in cortical and medullary TECs. Images show 
FFPE sections of human postnatal thymic tissue (< 17 years-old) stained for the Notch target Hes1 
(red) and panCK (green). Topro3 was used for nuclear staining (blue). A, General view of Hes1 
expression in the human thymus. Thymic regions are labeled as c: cortex; and m: medulla. Dotted 
line: CMJ. Scale bar: 100µm. B, C, D, Hes1 expression at the subcapsular cortex (SCC), the inner 
cortex (IC) and the medulla (MED), respectively. Arrowheads indicate Hes1 expression in TECs 
(panCK+). Arrows indicate Hes1 expression in non-epithelial (panCK-) cells. h: Hassal’s 
corspuscles. Scale bars: 50µm. Images shown are representative of results obtained from N ≥ 3 
tissue samples. 
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4.2. Notch1 activation in mTECs increases with age and correlates with thymic involution 
in both humans and mice. 
 
 In order to formally prove that Notch1 signaling is actually activated in Notch1-
expressing cTECs and mTECs (Fig. 28B, C), we directly analyzed the nuclear expression of 
the active form of Notch1 receptor in TECs labeled with a panCK antibody. Conversely to that 
found at the cortex (Fig. 29B, C, D), where ICN1+ cells were exclusively thymocytes and rare 
subcapsular cTECs, ICN1+ cells in the medulla were exclusively mTECs (Fig. 49A). As 
expected from our Hes1 expression results, mTECs surrounding or forming HCs were ICN1+. 
While the role of HCs is still a matter of debate, the observation that their numbers and size 
increase with age, has suggested that they are related with thymic involution. In this context, 
our findings might support a role for Notch signaling in HC formation as well as in mTEC 
terminal differentiation and senescence. In order to test this hypothesis, we next analyzed ICN1 
expression in human involuted thymic tissue in comparison with normal postnatal thymic 
tissue. As shown in Fig. 49B, detailed examination of ICN1-labeled samples revealed a 
frequency of ICN1+ mTECs significantly higher in involuted than in postnatal human thymus. 
Equivalent results were obtained in the murine thymus (not shown). Quantitative analyses of 
ICN1+ mTEC numbers in postnatal (N = 3) and involuted (N = 2) thymic samples (N ≥ 15 
images per sample; 63x) (Fig. 49C), confirmed this observation and revealed that more than 
60% of total mTECs in the involuted thymus display an active Notch1 signaling pathway. 
 
The differences in ICN1+ observed in young and aged human thymus samples, 
prompted us to investigate the kinetics of Notch signaling activation during postnatal life. To 
this end, we analyzed ICN1 expression in mTECs from 0.5, 1.5, 3, 5 and 9 months-old murine 
thymic tissue (N = 3 tissue samples per age). Analysis of at least 15 images per sample (63x) 
showed low frequencies of mTECs expressing active Notch1 in young mice (0.5 and 1.5 
months-old). By 3 months of age, numbers of mTECs expressing ICN1 increase significantly, 
and by 5 and 9 months-old they increase further. Therefore, our results are compatible with 
a role for Notch1 in mTEC homeostasis and/or age-related involution. Whether Notch 
receptors other than Notch1 also contribute to Notch signaling in TECs deserves further studies 
using suitable antibodies currently not available. 
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Figure 49. Notch1 activation at the medulla increases 
with thymic involution. Images show FFPE sections of 
human postnatal (< 17 years-old) and human involuted (> 6 
years-old) thymic tissue stained for the intracellular active 
form of Notch1 (ICN1) (red) and panCK (green). Topro3 was 
used for nuclear staining (blue). A, B, ICN1 expression at the 
medulla, respectively, of the postnatal and involuted human 
thymus. Dotted line: PVS; asterisk: ICN1+ thymic 
endothelium. Scale bar: 50µm. C, Graph shows mean +/- 
SEM frequencies of ICN1+ mTECs in human postnatal and 
involuted thymic medulla. ***; p < 0,0001. D, Graph shows 
mean +/- SEM frequencies of ICN1+ mTECs in the murine 
thymus along time, ranging from postnatal (2 wks-old) to 
involuted (9 months-old) thymi. ***; p < 0,0001. Data were 
obtained by counting total mTECs and ICN1+ mTECs in N ≥ 
10 images (25x) per tissue sample (N = 3). 
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4.3. Conditional inactivation of Notch signaling in epithelial cells.  
 
To better understand the implications of Notch signaling in TEC biology, we developed a 
conditional mouse model of RBPjk deletion in epithelial cells (designated here as RBPjk-KOTEC 
mice) by crossing RBPjkLox/Lox mice with FoxN1-Cre mice (Fig. 50A). In this mice, RBPjk 
deletion is specifically driven by the FoxN1 promoter which allow expression of the Cre 
recombinase in the thymus when FoxN1 is expressed at Ed11,5 of thymic development. In 
order to confirm that Cre recombinase was expressed by TECs, FoxN1-Cre mice were crossed 
with mice carrying the LoxP site-flanqued LacZ allele in homozygosis under the constitutive 
and ubiquitously expressed Rosa26 promoter (Rosa26LoxLacZ+/+). β-galactosidase expression 
was assessed in histologic sections of the resulting Cre-LacZ reporter mice thymi. Positive β-
galactosidase staining was observed at discrete patches in the thymic cortex (Fig. 50B) and the 
thymic medulla (Fig. 50B), thus confirming Cre recombinase expression in cortical and 
medullary TECs. 
 
As detailed at the Introduction, FoxN1 is expressed in epithelial tissues other than the 
thymus, as gut and skin. Accordingly, RBPjκ-KOTEC mice developed macroscopic skin lesions 
and hair defects with age, which were evident around the 8th month of life (Fig. 50D). Aged 
RBPjk-KOTEC mice showed clear signs of disease. Although their average weight was not 
significantly different from that of WT mice (data not shown), they appeared thinner and 
smaller due to a lack of proper hair density. Detailed examination of the RBPjk-KO mice 
revealed rounded lesions at face, ventral, footpad and tail skin (Fig. 50E, F, G and H, 
respectively). Microscopic examination of these lesions showed a clear disorganization of the 
skin that was already appreciable at younger ages and showed signs of inflammation, leukocyte 
infiltration, hair follicle hyperproliferation and keratin cysts (Fig. 50I) coincident with skin 
defects shown before in epithelial Notch-deficient mice (Demehri et al., 2009). Therefore, this 
skin phenotype provides formal proof of Notch deletion in the epithelium in our 
conditional KO model. 
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Figure 50. Murine model for the study of Notch signaling on TECs. A, Up; Cre-LacZ reporter mice 
that express β-galactosidase under the epithelial transcription factor promoter FoxN1 which result from 
crossing FoxN1-Cre+/- with Rosa26LoxLacZ+/+ mice. Down; RBPjκ conditional KO mice resulting from 
crossing FoxN1-Cre+/- with RBPjkLox+/+ mice. In these mice RBPjκ Notch signaling repressor is 
specifically deleted from Foxn1-expressing epithelial cells. In the thymus, RBPjκ is deleted from Ed11,5, 
when Foxn1 is expressed in TECs. B, C, Images show cortical and medullary details, respectively, of β-
galactosidase staining of 3 days-old Foxn1-Cre-LacZ thymus. Arrowheads show Cre-recombinase 
expressing TECs and thus β-galactosidase positive staining (blue). Dotted line: CMJ. Scale bar: 200µm. 
D, General view of aged (9 months-old) WT and RBPjκ-KOTEC mice. E, F, G, H, Images show skin lesions 
(arrowheads) consequence of Notch signaling abrogation in the skin epithelium. I, Hematoxylin/eosin 
staining of tissue slides from footpad skin showing a keratin cysts. 
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Figure 51. Notch signaling is specifically abrogated in RBPjκ-KO TECs. Images show FFPE 
sections of murine postnatal thymic tissue (5 months-old) stained for the Notch target Hes1 (red) and 
panCK (green). Topro3 was used for nuclear staining (blue). A, B, General view of Hes1 expression in 
WT and RBPjκ-KOTEC thymi. Thymic regions are labeled as c: cortex; and m: medulla. Dotted line: 
CMJ. Scale bar: 200µm. B, C, Expression of Hes1 and panCK in WT mice at the thymic cortex and the 
medulla, respectively. D, E, Expression of Hes1 and panCK in RBPjκ-KOTEC mice at the thymic cortex 
and medulla, respectively. Arrowheads indicate nuclear Hes1-positive staining in cTECs and mTECs. 
Arrows indicate Hes1 positive staining in non-epithelial cells (thymocytes). Scale bars: 50µm. 
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4.4. Activation of Notch signaling is impaired in TECs from RBPjκ-KOTEC mice 
 
In order to provide formal proof of RBPjκ deletion in TECs from RBPjκ-KOTEC mice, 
we performed comparative immnunohistological analyses of Hes1 expression in thymic tissue 
samples from RBPjκ-KOTEC and WT mice (Fig. 51). Mice at different ages ranging from 3 to 
11 months were analyzed (N = 8) and consistent results were obtained in terms of Hes1 
expression regardless of their age. The analysis of 5 month-old RBPjκ-KOTEC thymus samples 
(Fig. 51), revealed a drastic decrease of Hes1 staining at the cortex, and especially at the 
medulla, where Hes1+ TECs accumulate in WT animals (Fig. 51A). Detailed examination of 
the cortical niche (Fig. 51B, D), confirmed the abrogation of Hes1 expression in panCK+ 
cTECs; while the minor proportion of Hes1+ cells found in the thymic cortex were panCK-
thymocytes (Fig. 51D), thus confirming the specific deletion of RBPjκ in TECs. Similarly, a 
strong reduction of Hes1+ mTEC numbers was observed in the RBPjκ-KOTEC thymic medulla 
(Fig. 51C, E), although some Hes1+ mTECs that display lower expression levels and different 
morphology than WT mTECs were detected as well (arrowheads). Overall, these data 
confirm that (1) Hes1 is a good marker for studying Notch pathway activation in the 
thymus, and (2) that our model of conditional deletion of RBPjκ in TECs is efficient and 
specific. 
 
 
4.5. Abrogation of Notch signaling in TECs disrupts the medullary thymic 
microenvironment. 
 
Macroscopic examination of RBPjκ-KO thymi revealed no significant differences 
although they were slightly smaller than WT thyme. Several reports have shown that mTECs 
derive from FoxN1+ cTEC and mTEC bipotent progenitors that express cTEC markers (Bleul 
et al., 2006) (Anderson et al., 2009) (Alves et al., 2014). Thymic medulla develops clonally 
from cTEC-derived mTECs islets (Rodewald et al., 2001), that enlarge and fuse at some point 
of development forming an histologically continuous niche. The molecular milieu of signals 
that regulate medullary formation and thus cortico-medulary compartimentalization is still 
partially unveiled (see Introduction 1.2); but our results suggest that Notch signaling could have 
an important role in mTEC biology, at least during postnatal life. To investigate this possibility, 
we performed histomorphometric studies of the thymus aimed to establish a detailed 
comparison of the cortical and medullary areas (ca and ma) of thymus samples from WT and 
RBPjκ-KOTEC mice.  
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Figure 52. Notch signaling abrogation in TECs severely affects the thymic medulla. Figure 
shows the histomorphometric study of corticomedullary compartmentalization in WT and RBPjκ-
KOTEC postnatal and involuted murine thymus. A, Schematic representation of murine thymic lobules 
orientation for consistent histologic preparations. B, Expression of the Notch ligand Jag1 in a WT 
murine thymic lobule showing Jag1 expression confined exclusively to the medulla. Jag1+ stained 
area and total thymic area (Topro3 staining) were used to calculate, cortical area (ca) and medullary 
area (ma) in WT and RBPjκ-KOTEC mice. Scale bar: 200µm. C, D, Jag1 and panCK staining of 3 
months-old WT and RPBjκ-KOTEC mice thymi, respectively showing a significant reduction in medulla 
size in the RBPjκ-KOTEC mice. E, F, Jag1 and panCK staining of 5 months-old WT and RPBjk-KOTEC 
mice thymi, respectively showing equal results as in C and D. Dotted line: CMJ. Scale bars: 200µm. 
G, Bars graph represents cortical area (ca) and medullary area (ma) ratio mean +/- SEM obtained 
from 3 (N = 9), 5 (N = 7), 9 (N = 7) and 12 months-old (N = 8) WT thymic lobules, and 3 (N = 12), 5 
(N = 7), 9 (N = 6) and 12 months-old (N = 3) RBPjκ-KOTEC thymic lobules. *, p < 0,05;  **, p < 0,001. 
H, Bar graph represents cortical area (ca) and medullary area (ma) ratio mean +/- SEM obtained 
from all WT (N = 31) and RBPjκ-KOTEC (N = 28) thymic lobules analyzed. ***, p < 0,0001. 
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The average ratio between cortical and medullary areas (C:M Ratio) could be 
determined from low magnification images (10x) of the thymic tissue stained with cortical 
and/or medullary markers. Since C:M ration may vary depending on the orientation of the 
tissue, all thymic samples were consistently embedded and trimmed with the same orientation 
to allow accurate comparisons (Elmore, 2006). Fig. 52A illustrates murine thymus sampling 
for cortico-medullary compartmentalization studies. These thymus samples were embedded 
longitudinally along its antero-posterior axis and trimmed transversally. Resulting tissue 
sections were stained for the epithelial marker panCK and the Notch ligand Jag1 that, as shown 
in this study, nicely defines the medullary microenvironment (Fig. 52B). Topro3 staining was 
used to calculate total thymic area, from which Jag1-defined medullary area was subtracted to 
obtain the cortical area (Fig. 39B’). Cortical and medullary area measurements were obtained 
from WT and RBPjκ-KOTEC mice at 3 (N = 4), 5 (N = 3), 9 (N = 3) and 11 (N = 2) months of 
age, and two images per mice were acquired (10x). Fig. 52C, D and 52E, F show examples of 
3 and 5 months-old Jag1-stained WT and RBPjκ-KOTEC thymi, respectively, which revealed a 
clear reduction of medulla size in RBPjκ-KOTEC mice. In these animals medullary formation 
and/or homeostasis seems to be affected, as medullary areas are composed by small and discrete 
islets, similar to those observed at early times of thymic development (Rodewald et al., 2001). 
 
Previous reports showing morphometric measurements of histological sections of rat 
thymus (Tryphonas et al., 2004), concluded that the average C:M ratio is around 4,8 in up to 3 
months-old WT rats (Pearse, 2006). The average C:M ratios calculated for WT mice were 
similar to that value, as 3 months-old WT mice showed a ratio of 3.93 +/- 0.5, thus supporting  
the suitability of this histomorphometric method. Conversely, RBPjκ-KOTEC mice showed C:M 
ratios above 10, which formally prove that Notch signaling abrogation in TECs significantly 
affect the size of the medullary compartment (Fig. 52G). Given that no significant differences 
were observed between age groups of mice, mean values of final C:M ratios were calculated 
considering all mice analyzed regardless their age (Fig. 52H). In summary, 
histomorphometric measurements of cortical and medullary thymic compartments 
demonstrate that selective abrogation of Notch signaling in TECs severely affects the size 
of the medullary niche. 
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4.6. RBPjk-KOTEC thymi host B cells. 
 
Next, we wanted to assess the functional implications of the disturbed medulla in 
RBPjκ-KOTEC mice. To this end, thymocyte cell suspensions from WT (N = 7) and RBPjκ-
KOTEC mice (N = 10) were analyzed by FACS for expression of T, B and myeloid cell markers. 
RBPjκ-KOTEC mice had a significantly higher proportion of thymic non-T cells than WT mice 
(**, p = 0,0093) (Fig. 53A, left). In order to identify the nature of this non-T cell population, 
cells were stained with the B cell markers CD19 and B220, and the myeloid markers CD11b 
and Gr1. Electronic gating of the Thy1-negative non-T cell population confirmed that indeed 
they were B cells, and significantly more abundant within the non-T cell thymic subset of 
RBPjκ-KOTEC than WT mice (**, p = 0,0011); but no significant differences were found in the 
proportions of intrathymic myeloid cells (data not shown). Importantly, RBPjκ-KOTEC thymi 
that host a significant population of B cells showed a significant reduction (**, p = 0,0053) in 
the frequency of DP thymocytes (Fig. 53C). In summary, conditional deletion of Notch 
signaling in TECs has substantial implications for thymus function, that result in the 
appearance of an important population of intrathymic B cells and the simultaneous 
reduction of the DP thymocytes compartment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 53. Flow cytometry analysis 
of WT and RBPjκ-KOTEC thymocyte 
populations. Mice analyzed were 
ranging from 3 to 11 months-old. A, 
Left, Thy1- and Thy1+ mean +/- SEM 
cell frequencies in WT and RBPκ-
KOTEC mice. Right, Flow cytometry 
analysis on electronically gated 
Thy1- cells stained for the B cell 
markers CD19 and B220 and, T cell 
markers CD8 and CD3. B, Graph 
representis mean +/- SEM cell 
frequences of  B cells in the thymus 
of WT and RBPjk-KOTEC mice. *, p < 
0,05. C, Flow cytometry analysis on 
electronically gated Thy1+ cells 
stained for CD4 and CD8 T cell 
markers, and the B cell marker B220. 
Numbers in quadrants show the 
mean cell frequency (cell %) +/- SEM 
(WT, N = 7; RBPjκ-KOTEC, N = 10). 
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Notch ligands and receptors are differentially distributed in the human thymus, defining 
specific and dynamic niches. 
 
Cellular differentiation is a process imposed by the environment rather than an 
intrinsic feature of a certain stem or multipotent progenitor cell. In the T-cell lineage, the 
development of progenitors derived from hematopoietic stem cells resident in the BM is 
regulated by an specific niche, which is exclusively provided by the thymus. The thymus is an 
evolutionary conserved organ with a singular microenvironment specialized in generating and 
“educating” T cells. The understanding of the molecular cues provided by the TME is crucial 
for developing in vitro protocols of T cell generation, and to gain insight on how deregulation 
of this process can generate hematopoietic malignancies such as T cell leukemia. Most studies 
on the TME have traditionally focused on TECs, as they are the essential and non-redundant 
component of the thymic stroma responsible for T cell development (van Ewijk et al., 1994) 
(Boyd et al., 1993). In mice homozygous for the nude mutation (Flanagan, 1966), the thymic 
epithelial rudiment is unable to further develop into mature cTECs and mTECs (Mori et al., 
2010) (Tsukamoto et al., 2005) and, in consequence, these animals lack thymocytes and 
thymus-derived cells (Wortis et al., 1971) (Vigliano et al., 2011). These data highlight the 
importance of the signals provided by these highly specialized epithelial cells; but TEC 
biology is still poorly understood. TEC characterization has been hampered by the fact that 
TECs are difficult to isolate due to their low numbers and the lack of niche-specific markers. 
This is crucial since intrathymic T cell development involves the migration of thymocytes 
throughout different thymic niches composed of particular TEC populations (Petrie and 
Zuniga-Pflucker, 2007). Additionally, isolation methods destroy the 3D configuration of 
TECs, which results in the downregulation of specific T-cell inductive signals such as Dll4, 
and the impairment of TEC function (Mohtashami and Zuniga-Pflucker, 2006). Due to these 
limitations, we have focused our efforts in characterizing the functional signals provided by 
TECs and other cell types of the TME in the intact human thymus. The use of 
immunohistological techniques and confocal microscopy allowed us to identify in situ 
particular intrathymic niches that undergo relevant modifications throughout life, from early 
ontogeny to postnatal life and later on to age-related involution. Considering the importance 
of Notch signaling in T cell development, we aimed at characterizing which components of 
the Notch signaling pathway are expressed by thymic stroma, in order to assess their function 
at particular T-cell developmental stages. We found that Notch ligands and receptors are 
differentially distributed in particular niches and are dynamically regulated in a spatio-
temporal manner in different stromal cell types, which may explain the complexity of T cell 
development and the observed age-related changes in T cell output. We show here that certain 
ligands and receptors define specific niches, such as Jag1 and Notch4, which are exclusively 
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expressed at the medulla, or Jag2 and Notch3, which are highly expressed at the thymic 
cortex.  However we have discovered some intriguing facts. It is known that the murine 
thymic cortex hosts 5 of the 6 main T-cell developmental stages (Ladi et al., 2006) (Petrie and 
Zuniga-Pflucker, 2007), as all immature thymocyte subsets are located in the cortex, while 
only mature thymocytes reside in the medulla (Lobach and Haynes, 1987). Consequently, the 
cortex should provide particular niches different enough to support specific developmental 
steps. Such specificity has been related to the expression of Dll4 (Hozumi et al., 2008); but, 
surprisingly, Dll4 expression was undetectable in the cortical epithelium of the human 
postnatal thymus, a finding that concurs with previous data using an alternative experimental 
approach (Van de Walle et al., 2011). Notch ligands other than Dll4, such as Jag2, are 
expressed in cTECs, particularly in the CMJ, although the rest of the cortex including the IC 
and the SCC areas display low expression levels of Jag2 and Dll1. Low Notch ligand 
expression in the outer cortex is also owed to the low numbers of TECs in this area 
(Bruijntjes et al., 1993). Therefore, a major cortical area of the human postnatal thymus 
expresses very low density of Notch ligands.  
 
The scarce expression of Dll4 compared to Jag2 in cTECs may generate some doubts 
about which ligand induces T cell specification in the human postnatal thymus. In this regard 
we found that cortical Dll4 expression is restricted to the capillary endothelium, as previously 
reported (Shutter et al., 2000), and rare subcapsular TECs and thymocytes. This endothelial 
Dll4 expression may rather suggest that Notch-dependent T-cell commitment is a very early 
event in human T-cell development occurring prior to, or immediately during, thymus 
colonization, which is known to happen at the CMJ in the vascularized thymus. The 
corticomedullary microenvironment includes mesenchymal (MCs) and endothelial cells 
(ECs), which express virtually all four Notch ligands, especially Dll4. Considering that BM-
derived progenitors enter the thymus by leukocyte extravasation through the vascular 
endothelium (Springer, 1994) of corticomedulary blood vessels, they must encounter Dll4 
ligands during this process. Then, endothelial transmigration would localize thymus-seeding 
progenitors in the perivascular mesenchymal niche, which expresses high Dll4 levels in the 
human postnatal thymus. Accordingly, we have found ICN1+ hematopoietic cells, likely 
corresponding with intrathymic progenitors in the human postnatal PVS (data not shown). 
Likewise CD117+ murine hematopoietic progenitors have been shown to stay in the PVS 
before entering the thymic parenchyma, indicating that the PVS is the gate from which HPCs 
enter into the thymus (Mori et al., 2007) and the first thymic tissue they encounter after their 
egress from the BM. Likewise, early in thymus organogenesis fetal HPCs encounter the 
mesenchymal microenvironment as soon as they reach the avascular thymic anlage, as they 
must migrate through the thick mesenchymal capsule surrounding the thymic epithelial 
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parenchyma (Itoi et al., 2001). The capital importance of the thymic mesenchyme for both T-
cell development and TEC differentiation has been extensively studied (Jenkinson et al., 
2003) (Itoi et al., 2007), but its function in the postnatal vascularized thymus is still 
controversial. In addition to the important developmental role of thymic MCs, recent findings 
showing Dll4 expression in BM MCs points to the BM niche as the first microenvironment 
presenting Dll4 to thymus-seeding and T-cell lineage priming prior to thymus entry (Yu et al., 
2015). Besides Dll4, Jag1 is also expressed in the BM microenvironment (Li et al., 1998) 
(Karanu et al., 2000), but none of these ligands trigger T-cell development in the BM under 
normal conditions. In the case of Jag1, this may be due to an intrinsic defect of this ligand to 
trigger T-cell commitment of very early human HPCs from BM and CB, as shown in vitro 
(Van de Walle et al., 2009), although it supports T-cell development from ETPs (Van de 
Walle et al., 2013). In addition, the capacity of HPCs to respond to particular Notch-ligands 
may depend on the regulation of specific Notch receptor expression, as ETPs express mostly 
Notch1, while BM HPCs predominantly express Notch2, and Notch2-Delta interactions do 
not allow for T-cell maturation beyond the DN3 (CD25+) stage (Porritt et al., 2004) 
(Varnum-Finney et al., 1998) (Besseyrias et al., 2007). In this scenario, T-cell specification 
driven by Dll4 at extrathymic sites could target a particular population of Notch1+ 
progenitors that differ from bona fide BM HPCs and have already egressed from the BM. 
Sustained Notch1-Dll4 signaling provided during endothelial transmigration and transient 
residence in the PVS, would then favor thymus colonization and could likely override the 
lack of Dll4 in the postnatal human thymic parenquima. Intriguingly, this scenario could be 
different in the human fetal thymus were Dll4 is extensively expressed by cTECs. In fact, our 
data confirm that Dll4 is downregulated in cTECs in the adult human thymus, as it has been 
shown in mice (Fiorini et al., 2008), although this downregulation occurs prior to birth in 
humans, but in the adult thymus (8 weeks-old) in mice. As Dll4 downregulation seems to be 
mediated by cTEC-DP thymocyte crosstalk (Fiorini et al., 2008), it is possible that the role of 
Dll4+ cTECs during human thymus ontogeny is restricted to the first third of development, 
when the full T-cell repertoire and the definitive postnatal thymic configuration are 
established following colonization at 8.2 weeks (Haynes and Heinly, 1995). Conversely, in 
the murine thymus all these processes appear to be delayed (Mohtashami and Zuniga-
Pflucker, 2006), and Dll4 expression although downregulated, is maintained in postnatal life. 
 
Once Dll4 has induced T-cell fate, alternative signals could support T-lineage 
progression. Progression of DN2 progenitors to the DP CD3- stage, which is Notch ligand-
independent in vitro for human DN2-like cells (Taghon et al., 2009), occurs in vivo during 
migration throughout the IC, which displays minor Notch ligand expression. Therefore, as 
proposed before (Van de Walle et al., 2009), it is possible that decreased Notch signaling is 
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an early and obligatory event required for appropriate T-cell developmental progression, at 
least in humans. In this scenario, it can be suggested that the human thymus provides two 
specific cortical niches, CMJ and IC, distinct enough to support separate cell functions. First, 
early in development, Notch signaling induced by high expression levels of Notch ligands 
(likely Dll4) at the thymus entry site (PVS and CMJ) would ensure T-cell commitment of 
multipotent thymus-seeding progenitors. Later, once T-cell commitment is induced, a 
decrease in Notch signaling would allow developmental progression of human thymocytes 
along the αβ T cell lineage; while sustained Notch1 signaling may instead favor γδ T cell 
development, as shown in vitro (Garcia-Peydro et al., 2003) (Van de Walle et al., 2013). In 
contrast, cortical transmigration of murine thymocytes after T cell fate specification may 
involve Dll4 signaling continuously provided throughout the IC up to the SCC (Fig. 54). 
Accordingly, murine αβ T cell development is highly dependent on Notch signaling both in 
vitro and in vivo, while such a strong dependence is not seen in humans. The proposed 
downregulation of Notch activation during human T-cell development may be transient, as 
Notch signaling is mandatory for β-selection. This occurs at the SCC niche (Ciofani et al., 
2004) (Petrie and Zuniga-Pflucker, 2007), where cTECs expressing Dll4 and Jag2, and more 
significantly Dll1, may fulfill Notch activation requirements of DN3-like developing 
thymocytes. Accordingly, we found that human thymocytes with active Notch1 accumulate at 
the CMJ and SCC, while the IC hosts lower numbers of ICN1+ cells. Notably, gene 
expression studies of microdissected tissue have shown that CMJ and SCC regions in mouse 
thymus show a unique stromal gene expression profile, suggesting that the IC region may just 
regulate the trafficking of developing progenitors between those two inductive 
microenvironments (Griffith et al., 2009). Particularly, Notch activation at the CMJ may 
control progenitor migration up to the SSC (Maerki et al., 2006) (Mirandola et al., 2012) 
(Krishnamoorthy et al., 2015), through the IC, and back down into the IC area following β-
selection. Apart from Dll4 expression in cTECs, we have seen in the murine thymus a Jag2 
expression gradient that is established in the opposite orientation than in the human thymus, 
with maximal expression levels at the SCC. This differential distribution of Dll4 and Jag2 in 
murine and human thymus may support the differential requirements of Notch signaling 
observed for αβ/γδ T cell development between both species, and suggests that specialized 
populations of cTECs with interspecific characteristics (De Souza et al., 1993) may 
differentially regulate Notch signaling components in the SCC, IC and CMJ niches (Fig. 54).  
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In striking contrast with the low density and diversity of Notch ligands expressed at 
the thymic cortex, our data pointed to the human thymic medulla as a rich Notch ligand-
expressing microenvironment. Jag1 and Dll1 are highly expressed by mTECs, the later mostly 
by those forming HCs. Importantly, some medullary Dll4-expressing CD11c+ myeloid cells 
can be found at the CMJ, thus myeloid cells provide an important source of Dll4 at the CMJ, 
where additionally, high Jag2 is highly expressed by cTECs. Therefore, following Notch 
activation induced by Dll4-expressing endothelium and PVS, Notch signaling could be  
 
 
 
 
 
 
 
 
 
 
 
In striking contrast with the low density and diversity of Notch ligands expressed at 
the thymic cortex, our data pointed to the human thymic medulla as a rich Notch ligand-
expressing microenvironment. Jag1 and Dll1 are highly expressed by mTECs, the later mostly 
by those forming HCs. Importantly, some medullary Dll4-expressing CD11c+ myeloid cells 
can be found at the CMJ (Fig. 20). Thus myeloid cells provide an important source of Dll4 at 
the CMJ, where additionally, Jag2 is highly expressed by cTECs. Therefore, following Notch 
activation induced by Dll4-expressing endothelium and PVS, Notch signaling could be 
further sustained at the CMJ by Jag2-expressing cTECs and Dll4-expresing myeloid cells. 
Figure 54. Model of Notch ligand patterning at the postnatal thymic cortex. Left shows and 
schematic representation of the right confocal image showing myeloid cells and cTECs staining. 
Human thymus: Myeloid cells (green) mainly express Dll4 and Dll1. cTECs (red) express Jag2 and 
Dll1. As Jag2 expression levels are maximal at corticomedulary cTECs, high levels of Jag2 and Dll4 
expression are focused on the narrow region of the CMJ in Jag2-expressing cTECs and Dll4-
expressing myeloid cells. Mouse thymus: Myeloid cells (green) are also located at the medulla and 
some at the CMJ. Murine cTECs (red) express Dll1 and Jag2, mostly at the SCC, but they also 
express Dll4, thus high Noch ligands expression is sustained all along the thymic cortex. 
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 Additionally, our study reveals that postnatal configuration of the human TME is not 
steady. Many events as age, pregnancy, infections, stress, may influence the TME and thus 
modify the T cell outcome, but age is the main trait to battle against when facing poor 
immune function in healthy individuals. It has been long thought that the aged thymus loses 
its ability to generate T cells. However it has been shown that the remaining thymic 
parenchyma is normally functional in the involuted thymus (Flores et al., 1999). Undoubtedly 
age-related histologic changes, like PVS enlargement and adipose tissue deposition, are the 
main remodelers of intrathymic niches as both diminish the volume of functional 
parenchyma. But we have found that aged TECs actively regulate Notch ligand expression in 
particular thymic niches, similarly to what has been described in the fetal thymus. We found 
that Jag1 is specifically upregulated at the SCC, and Jag2 downregulates is particularly 
enriched expression at the CMJ. This active remodeling might be viewed as one of the causes 
of poor T cell generation in the aged thymus, but it can also be view as a compensatory 
mechanism that arises in the remaining functional parenchyma when thymic structure is lost. 
Altogether, our expression data demonstrate that Notch ligands and Notch receptor 
expression is dynamically regulated in a spatio-temporal manner in human TECs. This 
regulation fulfills the sequential Notch signaling requirements of developing thymocytes, 
although such requirements vary between mice and humans according to the 
interspecific diversity of TME. 
 
Notch ligands differentially influence αβ and γδ T cell development. 
 
Notch ligands differentially regulate cell fate decisions in diverse developmental 
systems. In the hematopoietic system, Delta ligands are involved in T cell commitment and T 
lymphocyte peripheral maturation, while Jagged ligands are involved in γδ and NK 
lymphocytes development and peripheral functional T cell differentiation (de La Coste and 
Freitas, 2006). Likewise, it is well established that Notch signaling regulates the αβ versus 
γδ T cell lineage choice (Ciofani and Zuniga-Pflucker, 2010) (Kreslavsky et al., 2010) 
(Taghon et al., 2012), besides the contradictory results between mice and humans found 
regarding the signal strength required for such developmental decision (Washburn et al., 
1997) (De Smedt et al., 2002) (Garcia-Peydro et al., 2003) (Garbe and von Boehmer, 2007) 
(Van de Walle et al., 2009). The identity of the Notch ligands regulating this developmental 
choice in vivo remained unclear. Here we demonstrate that differential Notch ligand-induced 
signaling control human αβ and γδ T cell development and, show that Jag2 has an unique 
ability in promoting almost exclusively the γδ T cell lineage at the expense of the αβ lineage, 
which is only supported by Dll1, Dll4 and Jag1 ligands. Conversely, Jag1 is equally efficient 
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in generating cells of both, αβ or γδ T cell lineages, with a clear impairment of the γδ T cell 
lineage when compared with Jag2, which acts similarly as Delta ligands in γδ T cell 
specification, as previously suggested to occur for T cell fate specification on human CD34+ 
CB progenitors (Van de Walle et al., 2011) and later confirmed for αβ/γδ-lineage 
specification on ETPs during the development of this thesis (Van de Walle et al., 2013).  
 
Although confirming a differential role for Notch ligands in αβ and γδ T cell 
development, the data obtained by in vitro co-cultures coming from bulk populations, cannot 
discriminate whether differential Notch signaling directly influence the αβ/γδ T-cell fate 
decision in uncommitted progenitors, or rather it affects the survival and expansion of 
lineage-restricted pre-committed thymocyte populations, or both. Taghon and colleagues 
(Van de Walle et al., 2013) approached this issue by single cell co-culture of human 
intrathymic progenitors onto the different OP9 ligand-expressing stromas. These clonal 
analysis allowed them to conclude that Notch ligands differentially influence αβ/γδ cell fate 
decision, as Dll4-seeded wells recovered both αβ and γδ lineages, whereas Jag1-seeded wells 
almost exclusively yield αβ T cells and Jag2 mainly recovered γδ T cells. Nevertheless, in 
order to avoid Notch ligand-mediated effects in T cell commitment, the progenitors used in 
these clonal experiments were CD34+ CD1a+, corresponding with late DN2-like progenitors 
in which αβ/γδ T cell commitment may have been occurred already, as illustrated by several 
references (Prinz et al., 2006) (Rothenberg, 2014) (Res and Spits, 1999). Thus clonal analysis 
using early DN2-like lymphoid progenitors, in which T but not αβ/γδ cell fate has been 
specified, as the CD34+ CD1a- cells used in our experiments, would be useful to evaluate the 
putative instructive role of Notch ligands in αβ/γδ T cell fate determination. In this line of 
arguments, further analysis of the mechanisms involved in αβ T cell generation in our 
cultures, showed that Jag2 promotion of the γδ T cell fate at the expense of the αβ T cell fate, 
was due in part, to the specific impairment of the generation of a icTCRβ+ thymocyte 
population. Taghon and colleagues (Van de Walle et al., 2013), easily approached the 
question whether Jag2 negatively impact αβ lineage decision or affect the survival and/or 
expansion of the icTCRβ+ population, by transducing a TCRβ chain into intrathymic 
hematopoietic progenitors later co-cultured in the presence of Jag2. TCRβ transgene rescued 
the Jag2-mediated impairment of the αβ T cell linage, thus demonstrating that Jag2 is not 
affecting the survival and/or expansion of icTCRβ+ αβ-lineage cells, but specifically 
impairing its generation by blocking TCRβ chain expression. We decided to approach the 
issue of an inductive versus selective role of Notch ligands in αβ/γδ lineage commitment by 
gene expression analyses on T cell committed αβ/γδ uncommitted DN2-like progenitors 
“primed” during 6 days of co-culture with the different Notch ligands. During those 6 days of 
  146
Discussion 
 
co-culture, T cell progenitors did not acquired TCR expression, neither intracellular nor at the 
cell membrane. We assayed a narrow set of 7 known αβ/γδ lineage-specific genes, and non of 
them were specifically expressed by γδ T cells and regulated under differential Notch 
signaling, thus suggesting that Jag2 specific promotion of the γδ T cell lineage is not 
specifically mediated by known γδ-specific transcription factors such as Sox13 or Etv5 
(Melichar et al., 2007) (Jojic et al., 2013) (Malhotra et al., 2013). However, these results do 
not exclude the possibility of an inductive role of Jag2 by other transcription factors not yet 
characterized.  Precisely, the characterization of human αβ/γδ lineage-specific transcription 
factors involves certain difficulties. Several studies in mice (Jojic et al., 2013) (Mingueneau et 
al., 2013) have shown that almost all the factors known to provide crucial functions for αβ or 
γδ lineage specification, are also vital for early T cell commitment. Nonetheless, some factors 
are specifically maintained by each lineage after T cell fate specification (Novershtern et al., 
2011). Conversely, similar studies conducted on human HPCs found a substantial mixed use 
of factors by αβ and γδ lineages, thus hampering the characterization of a single factor 
responsible for αβ or γδ T cell fate determination (Novershtern et al., 2011). Nevertheless, our 
data show that TOX2 expression was significantly increased by Jag2 and Dll4 ligands, which 
both induce strong Notch signaling activation needed for γδ T cell fate specification (Van de 
Walle et al., 2009). Tox2 is a transcriptional activator member of the thymocyte selection-
associated high mobility group box protein family. Its cognate member family, Tox1 has been 
shown to play key roles in the development of lymphoid tissue inducer cells (LTi), CD4 T 
cells and NK cells (Aliahmad and Kaye, 2008) (Aliahmad et al., 2010), and Tox2 has been 
shown to control NK development from CB-derived HPCs by regulation of T-bet expression 
(Vong et al., 2014), a transcription factor involved in γδ T cell functional maturation (Ribot et 
al., 2014). Thus TOX2 might be involved in early γδ T cell differentiation although later 
downregulated upon TCRγδ expression.  In order to shed light about other mechanism/s 
responsible for the differential role of Jag2 in γδ T cell development, we studied intrathymic 
gd T cell differentiation ex vivo and in vitro with the four different Notch ligand-expressing 
OP9 cells. As detailed at the introduction, human but not murine γδ T cells may follow a DP 
developmental pathway. DN, DP and CD4+ and CD8+ SP γδ T cell populations can be found 
in the human thymus. Additionally, we may divide γδ thymocytes in three populations 
according to their different expression levels of CD1a (high, dim and negative). CD1a+ γδ 
thymocytes express RAG-1 recombinase and do not respond to TCR engagement, thus 
constitute an immature population exclusively found in the thymus (Offner et al., 1997) 
which exclusively corresponds with the DP and CD4+ phenotypes in vivo and in vitro, thus 
positioning the DP and CD4+ γδ thymocyte populations prior the DN and CD8+ ones. A 
minor population of CD1a+ DN γδ thymocytes (less than 10% of total DN γδ thymocytes) can 
be also found, which may correspond with γδ T cell progenitors as previously suggested (Van 
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Coppernolle et al., 2012). Intriguingly, the frequency of the CD1a+ DP γδ population, 
underrepresented in vivo, was the most abundant γδ population obtained in vitro, specially in 
OP9-Jag2 and OP9-Dll4 co-cultures, thus suggesting a role for strong sustained Notch 
activation in the generation of these immature γδ T cell populations. Indeed, one of the 
mechanisms responsible for Jag2 support of the γδ T cell lineage, was the specific promotion 
of immature γδ populations. This singular ability of Jag2 in promoting the generation of 
CD1a+ γδ thymocytes in vitro was not unique of Jag2, as under Dll1 and Dll4 signaling, DP 
and CD4+ γδ T cells were also promoted when compared with Jag1, but much less efficiently 
than with Jag2. It is quite intriguing that in mice γδ T cells do not follow a DP pathway, 
although they also follow different maturation stages defined by CD24. This may lead to 
think that human DP and CD4+ γδ T phenotypes might be αβ-lineage thymocytes that were 
switched to the γδ-lineage by an early strong TCR or preTCR signal, as predicted by the 
“signal strength” model of αβ/γδ lineage determination. To investigate this possibility, 
intracellular expression of the TCRβ chain was analyzed in DP and CD4+ γδ T cells 
generated in vitro with the different Notch ligands. We found no expression of the TCRβ 
chain by any TCRγδ+ cell in any culture condition, result supported by icTCRβ expression 
analyses in the bulk population. Thus CD4+ and DP human γδ developmental stages are true 
γδ-lineage thymocytes. Opposing to Jag2, Jag1 was clearly impairing the generation of these 
two immature populations of γδ thymocytes, although it was the only ligand allowing CD1a 
downregulation in the DN and CD8+ γδ populations. It has been shown that absence of Notch 
signaling drives CD1a+ DN γδ progenitors towards the CD1a- DN or CD8+ stage without 
passing through the CD4 and/or DP stage (Van Coppernolle et al., 2012), thus we cannot 
account for CD1a downregulation as an specific inductive effect of the Jag1 ligand, or just a 
consequence of its weak ability in activating Notch signaling in thymocytes. In this way, Jag1 
signaling might not be strong enough to drive γδ T cell progenitors towards the DP 
differentiation pathway thus allowing a straightforward generation of DN and CD8+ γδ T 
cells from the γδ progenitor and/or favoring the maturation of CD1a+ DP / CD4+ γδ 
thymocytes. In order to clarify this issue, and confirm the progenitor-progeny relationship of 
CD1a+ and CD1a- gd thymocytes, in vitro γδ T cell differentiation assays were performed 
using ex-vivo isolated human CD1ahi γδ thymocytes, which included CD4+, DP and a minor 
population of DN γδ T cell progenitors. This assays confirmed two opposite roles for Jag1 and 
Jag2 in γδ T cell development, as Jag1 allowed CD1a+ γδ thymocytes maturation towards a 
CD1a- stage, in a similar way as absence of Notch signaling (OP9-GFP) does, although 
maintaining a small population of CD1a+ γδ T cell thymocytes that may correspond with 
CD1a+ DN γδ T cell progenitors. Conversely, Jag2-mediated Notch signaling constituted a 
strong proliferative signal for CD1a+ γδ thymocytes which inhibited their differentiation 
towards the CD1a- developmental stage. In this way, Jag2 was less efficient than Jag1 in 
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generating CD1a- mature γδ thymocytes, as Jag2 co-culture generated 4 times more γδ T cells 
than Jag1 but yield equal number of mature CD1a- γδ T cells, thus confirming previous 
findings suggesting that generation of CD1a- DN / CD8+ γδ T cells is independent of Notch 
signaling (Van Coppernolle et al., 2012), and suggesting that CD1a- γδ T cells generated on 
OP9-Jag2 co-cultures derive from cells that initially might have escaped from Jag2 ligand 
engagement. Jag2-mediated effect on immature CD1a+ γδ thymocytes perfectly illustrates 
that proliferation and differentiation are mutually exclusive processes. In this regard, Jag2 
resembles a typical positive selection signal that induces proliferation and survival of a 
certain population TCR-expressing thymocytes. We know that αβ-lineage cells follow two 
successive checkpoints that result in programmed cell death if not fulfilled. The fist one, β-
selection, is a process in which productive rearrangements of the TCRB locus and subsequent 
membrane pre-TCR expression results in extensive proliferation, differentiation into DP 
CD3+ preT cells and creates TCR diversity, as each daughter cell generates an unique TCR-α 
chain, resulting in daughter cells that each contains a different αβ-TCR despite sharing the 
same TCR-β chain. This process has not been observed in γδ T cells, which express both TCR 
chains at the same time. Next, TCRαβ-expressing DP thymocytes are engaged by low affinity 
interactions with self-MHC complexes that rescue them from apoptosis and induce again their 
survival and proliferation. But the developmental checkpoint in which successful γδ T cell 
receptor (TCR) gene rearrangements and/or MHC-self affinity are controlled during γδ T cell 
development are poorly characterized in humans. Studies in mice have shown that after 
TCRgd expression some DN3 γδ thymocytes selectively express CD27, which is upregulated 
in αβ-lineage thymocytes after β-selection (Taghon et al., 2006). Additionally, TCRb-/- mice 
have shown several DN thymocyte subsets enritched with in-frame TCRδ rearrangements, 
thus suggesting that cells with TCRδ in-frame rearrangements have a selective advantage, 
although there is no evidence of the involvement of a “preTγ” chain in this process. 
Nevertheless, TCRg expression do not results in proliferation, although is absolutely required 
for the generation of DP CD3- thymocytes (Passoni et al., 1997). Conversely, signaling 
through the γδ TCR induce a discrete proliferative phase of much less extend to that induced 
by the preTCR  (Taghon et al., 2006) (Prinz et al., 2006). Interestingly, LAT-deficient mice 
are not able to generate mature γδ T cell (Nunez-Cruz et al., 2003) (Prinz et al., 2006), thus 
suggesting that some TCRγδ-mediated mechanism of positive selection is needed for normal 
T cell development (Wells et al., 1993). In this regard, Jag2-mediated signaling may act 
cooperatively with the γδ TCR on immature thymocytes inducing proliferation and thus 
allowing the expansion of positively selected immature γδ thymocytes. The differential signal 
strength delivered by the different Notch receptor - Notch  ligand pairs may explain the 
differential outcome observed in γδ T cell development, as proposed for αβ/γδ T cell 
specification (Abe et al., 2010) (Van de Walle et al., 2013). Jag2 induces the strongest Notch 
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signal in human intrathymic progenitors, but not in CB HPCs. This was explained because the 
strongest Notch activation in CB HPCs is mediated through Notch1-Dll4 pair (Van de Walle 
et al., 2011), while on intrathymic progenitors the strongest signal is mediated through the 
Notch3-Jag2 receptor pair (Van de Walle et al., 2013). Likewise, it has been proposed that 
Notch1-Jag1 signaling do not favor γδ T cell development because the resulting Notch1 
activation is not strong enough to upregulate the Notch1 target gene NOTCH3 and thus avoid 
further strong Notch3-Jag2 γδ-inductive signal. But this argument opposes several findings as 
in vivo, T cell lineage specification occurs by Dll4, a strong activator of the Notch1 receptor. 
Additionally, our in vivo expression data show broad Notch3 expression in cortical αβ-lineage 
thymocytes finding consistent with Notch3 rapid upregulation in thymocytes after Notch1-
Dll4- mediated T cell commitment (Felli et al., 1999) (Van de Walle et al., 2009). Thus or 
data suggest that Notch1 activation accomplished in vivo on ab/gd uncommitted intrathymic 
progenitors is strong enough to upregulate Notch3 expression in subsequent developmental 
stages. Likewise, we show that Notch1 is active in CD34+ intrathymic progenitors and that 
Notch1 receptor is the most prominent receptor expressed by human γδ thymocytes, 
specifically at the DP stage, a finding in line with previous data from our laboratory and 
others (Van de Walle et al., 2009) (Martin-Gayo, E. et al. submmited). Altogether, these data 
suggest that Notch1 might play an important role in ab/gd T cell fate determination. Anyhow, 
additional regulatory mechanism to that proposed by Thagon and collegues might be acting in 
vivo in the human thymus, as a model based in specific Notch receptors – Notch ligands 
interactions may be too simplistic. There are many regulators that may act in the human 
thymus to modulate Notch signaling strength. Notch signal strength has been traditionally 
estimated by the level of transcriptional activation of Notch target genes (Van de Walle et al., 
2009) (Gonzalez-Garcia et al., 2012), which may be a direct consequence of three things: (1) 
the number of intracellular Notch domain molecules (ICN) cleaved; (2) the number of ICN 
molecules reaching the nucleus, and (3) the half-life of ICN-RBPjk-MAML-DNA complexes 
(Liu et al., 2015). These factors may vary, for example, by ubiquitination of ICN or Fringe-
mediated glycosylation of Notch receptors, which potentiate Notch1 signaling through Delta 
ligands and Jag2, but not through Jag1 (Van de Walle et al., 2011). Additionally, other 
morphogenetic signaling pathways, as the Wnt pathway, might be operating in the thymus in 
specific TMEs (data not shown). For example, it has been demonstrated that secreted frizzled-
related proteins (SFRPs) may bind ADAM10/17 metalloproteases and downregulate its 
activity, thus interfering with Notch signaling pathway activation (Esteve et al., 2011). 
Additionally, ligand lateral mobility, orientation and density modulate receptor activation 
levels, as limiting the lateral mobility of Dll4 displayed on lipid bilayers, enhances Notch1 
activation (Narui and Salaita, 2013). Thus the expression of the same ligand in different cell 
types does not necessarily must account the same Notch activation threshold in the 
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responding cell. However, and based in our findings, we can grade Notch ligand-induced 
signals delivered to DN2-like progenitors in the following order: Jag2, Dll4, Dll1 and Jag1, 
and we can say that the opposite functional outcomes of Jag2 and Jag1 ligands correlates with 
their opposite location in two different functional thymic niches, the cortex and the medulla, 
respectively. Thus our findings establish that the equilibrium between two Notch ligands 
with distinct spatial expression patterns in vivo, and opposing functional roles in vitro, 
may regulate γδ T cell development, in a similar way to that described for other Notch-
dependent tissues (Benedito et al., 2009). 
 
Role of Notch signaling in functional differentiation γδ T cells. 
 
 
At the light of recent findings indicating that γδ T cell maturation occurs in the 
murine thymus (Narayan et al., 2012), we decided to investigate if human γδ T cell functional 
maturation equally occurs at the TME and if its influenced by differential Notch signaling. In 
mice, numerous reports point to Notch signaling as a molecular cue involved in the 
development of IL-17-secreting γδ T cells (Shibata et al., 2008) (Ribot et al., 2009) (Michel et 
al., 2012) (Mukherjee et al., 2009), while INFγ-secreting cells are generated after TCRγδ 
engagement (Jensen et al., 2008). We were not able to detect a significant population of IL17-
secreting γδ T cells neither on PMA/ionomycin-stimulated ex-vivo-isolated human γδ T cells 
nor in γδ T cells generated in our co-cultures with OP9 Notch ligand-expressing cells (data 
not shown), thus discarding the idea of finding naturally occurring γδ Th17 cells in the human 
thymus. Nevertheless, differential Notch signaling provided by the TME may regulate the 
generation of different functionally pre-programmed γδ T cell subpopulations. Thus in vitro 
generated γδ T cells were activated with plate bound anti-CD3 and IL-2. Although regular αβ 
Th17 cells were easily detected in human peripheral blood samples, thus discarding possible 
experimental issues during cytokine labeling, IL17 γδ T cells were not detected. We cannot 
discard the possibility that our activation conditions skewed Th17 potential, as IL2 is a typical 
IFNg-polarizing cytokine (Manel et al., 2008). Conversely to γδ IL17 cells, we were able to 
detect an efficient generation of INFγ gδ-secreting cells, especially in OP9-Jag1 co-cultures. It 
has been shown that IFNγ-secreting cell mostly correspond with the Vδ2Vγ9 peripheral blood 
phenotype, while IL-17-secreting γδ T cells correspond with tissue Vδ1 subsets. Therefore the 
favored generation of IFNγ+ γδ cells in relative terms obtained in Jag1 co-cultures, might be 
the consequence of the defective support of CD1a+ immature Vδ1 and Vδ1-/Vδ2- γδ subsets, 
which are both efficiently supported by Jag2 and Delta ligands. The identity of those Vδ1-
/Vδ2- γδ T cells remains obscure as no suitable antibodies have been developed yet to detect 
the up to 6 putative Vδ chains identified in humans. Another interesting possibility is they 
may correspond with γδ T regulatory cells, as Vδ1+ PB γδ T cells when stimulated in vitro 
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with anti-Vδ1 acquire regulatory features as Foxp3, CTLA-4 and TNFR expression and 
produce TGFb1 (Hua et al., 2013).  Further characterization of these γδ T cell populations 
with T regulatory cell markers such as Foxp3, Galectin1, CTLA-4 or GARP (Roncarolo and 
Gregori, 2008) (Battaglia and Roncarolo, 2009) would be useful. Nevertheless, the 
information obtained about the molecular cues involved in the regulation of human γδ T cell 
development, is extremely valuable for implementing new protocols of in vitro γδ T cells 
generation. Only one reference in the literature address the generation of γδ T cells in vitro 
from human HPCs (Groh et al., 1991), and recent approaches of large scale generation of 
human γδ T cells in vitro have been focused in expansion of peripheral blood γδ T cells which 
are mostly of the Vδ2Vγ9 subtype. Conversely, our data show that co-culture of intrathymic 
human hematopoietic progenitors with genetically-modified stromal cells for the expression 
of Notch ligands, specially Jag2, generate great numbers of diverse Vδ γδ T cell subsets. A 
single DN2-like progenitor may give rise about 300 γδ T cells showing the same Vδ diversity 
as found in vivo in the human thymus. Unfortunately, likewise within the thymus, only 10% 
of those γδ T cells are mature, as the precise mechanism exerted by Jag2 consists in 
promoting the proliferation of immature CD1a+ DP and CD4+ intermediate gd T cell 
differentiation stages. These immature γδ T cells are not functional as they do not proliferate 
after TCR engagement (Offner et al., 1997). But maturation efficiency can be boosted by 
sequential Notch signaling deprivation and TCR engagement with plate bound anti-CD3 
antibodies and polarizing cytokines, obtaining mature CD1a- DN/CD8+ γδ T cells which are 
diverse regarding Vδ expression and fully functional as they secrete INFγ. Thus, the in vitro 
co-culture system describe here may serve for large-scale generation of human γδ T cells 
and overcomes the limitations of current protocols of γδ T cell generation for adoptive 
transfer of ex-vivo isolated in-vitro expanded peripheral blood human γδ T cells. New 
xeno-free in vitro approaches, as Jag2-rich hydrogels, could be the ultimate approach to 
large-scale generate in vitro functionally diverse populations of γδ T cells suitable for the 
clinic.  
 
Gamma-delta T cell intrathymic dynamics. 
 
 
In contrast to the well-defined sequential migration that αβ-lineage cells follow 
within the TME, intrathymic dynamics of γδ T cells are poorly understood. We have found 
that human γδ T cells are more abundant at the cortex, where they preferentially accumulates 
at the CMJ. Previous studies (Groh et al., 1989) (Falini et al., 1989) reported that γδ T cells 
are more abundant at the medulla than the cortex, but this discrepancy can be explained by a 
miss definition of the cortico-medulary boundary in the absence of epithelial markers.  The 
differential distribution of immature and mature γδ T cells found in the cortex and the 
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medulla, suggests that developmental progression of γδ thymocytes from the cortical 
immature CD1a+ to the medullary mature CD1a- stage might be accompanied by cortico-
medulary transmigration and thus membrane expression regulation of chemokine receptors. 
Nevertheless, this possibility do not exclude that a proportion of mature CD1a- γδ T cells may 
be generated directly at the thymic medulla by the Notch-independent pathway described by 
Vandekerckhove and colleagues (Van Coppernolle et al., 2012), and observed in our γδ T cell 
co-cultures. As previously reported (Ueno et al., 2004) (Misslitz et al., 2004), cortico-
medulary transmigration may be regulated by CCR7, as medullary TECs express the CCL19 
and CCL21 chemokines. Lack of a suitable CCR7 antibody frustrated our effort in detecting 
CCR7 in γδ thymocytes, although we cannot exclude the possibility that density gradient 
preparations (Ficoll) of thymocyte suspensions decreased chemokine receptors expression as 
previously demonstrated (Nieto et al., 2012) (Berhanu et al., 2003). Due to this inconvenient, 
transwell migration analyses with CD1a+ and CD1a- γδ thymocytes would be capital to 
properly assess differential regulation of chemokine receptors expression in both γδ T cell 
populations. Despite these limitations, we were able to detect CXCR4 expression in αβ-
lineage and γδ thymocytes. CXCR4 was specifically expressed in DP and CD4 immature γδ 
thymocytes, suggesting that location of immature γδ thymocytes at the CMJ, might be 
mediated by the CXCR4 chemokine receptor. Nevertheless, only 50% and 30% of DP and 
CD4+ γδ thymocytes expressed CXCR4, respectively. These differences on CXCR4 
expression within both populations suggest that DP and CD4 γδ thymocytes may regulate 
CXCR4 expression in a certain point of development as a consequence of events like positive 
selection, as demonstrated for CCR9, which is up-regulated in CD69+ DP αβ post-selected 
thymocytes (Uehara et al., 2002). Indeed, in αβ T cells positive selection correlates with 
cortico-medulary transmigration of positively selected thymocytes into the medulla, while 
non-selected DP αβ-lineage thymocytes remains moving randomly at the cortex where they 
die by neglect. Similarly, CXCR4 acts as a co-stimulator during β-selection of αβ-lineage 
cells by regulating the steady-state localization of immature thymocytes at the SCC, thus 
facilitating delivery of pre-TCR-induced survival and proliferation signals (Trampont et al., 
2010). In this line of arguments, and as discussed earlier, Jag2-mediated Notch signaling may 
be acting cooperatively with the γδ TCR during a putative positive selection checkpoint at the 
CMJ and, in a similar way to αβ T cells, γδ T cell positive selection may induce the migration 
cortical immature CD1a+ γδ thymocytes into the medulla, thus avoiding putative 
overproliferation by sustained Jag2 signaling at the CMJ. In summary, intrathymic 
progenitors receiving the T cell commitment signal by Dll4 at extraparenchymal sites, 
such as the endothelium or the PVS, and/or by Jag2 at the CMJ, rapidly move upwards 
the cortex, where low Notch ligands density allow αβ-lineage progression. Conversely, 
sustained Jag2 signaling at the CMJ would favor γδ T cell generation by selective 
  153
Discussion 
 
induction of γδ-lineage commitment and specific support of intermediate immature γδ 
populations. The time length that an immature γδ thymocyte stays at the CMJ must be 
strictly limited to avoid the overproduction of immature γδ T cells mediated by Jag2. 
This mechanism may involve a γδ positive selection like process which regulate the 
CXCR4 receptor expression, thus allowing cortico-medulary migration into the thymic 
medulla (Fig. 55). Nevertheless this scenario may have an objection derived from the fact 
that there is no other phenotypic marker than the TCRγδ itself for tracking γδ lineage-
committed thymocytes. Consequently, it is impossible to characterize early intermediate 
stages of γδ T cell differentiation between the uncommitted DN2-like progenitor and the γδ-
committed thymocyte. Thus γδ T cell stages prior TCRγδ expression cannot be characterized 
neither located in vivo. Because of this, we cannot exclude that cortical immature CD1a+ γδ T 
cell progenitors, after γδ T cell commitment and prior TCRγδ receptor expression, migrate 
from the CMJ to the SCC and acquire CD4, CD8 expression on their way up to the SCC in a 
similar ways as αβ T cells do. Upward migration from the CMJ to the SCC might serve as 
well as a mechanism for avoidance of Jag2-induced γδ T cell progenitor proliferation at the 
CMJ. Nevertheless, migration to the to the medulla is more likely, as Jag2 is much less 
expressed there than at the cortex, and because γδ T cells do not follow a β-selection-like 
process as αβ T cells do (Passoni et al., 1997). In order to avoid this technical limitation in the 
detection of early steps of γδ-lineage determination, the group of Malissen developed a mouse 
model expressing the GFP reporter gene knocked into the TCRD constant region gene (Prinz 
et al., 2006). They found that the TCRD locus becomes transcriptionally active at late DN1 
stage; unfortunately they do not show the in vivo location of those late DN1 GFP+ cells. 
Nevertheless, transcriptional activation of the TCRD gene do not necessarily means γδ T cell 
commitment, which has been defined to occur at late DN2 stage (Rothenberg, 2014). 
Additionally, considering that (1) human γδ T cells follow a DP differentiation pathway while 
murine γδ T cells do not, and (2) the differences between the murine and human TMEs 
exposed in this work, we can not assume similar human and murine γδ T cell dynamics. The 
ultimate assessment of γδ T cell dynamics would be performing real time imaging of human 
intrathymic progenitors transduced with ICN1 on FTOC or intact human thymic lobules, as 
ICN1-expressing human intrathymic progenitors adopt the γδ T cell fate in FTOC (Garcia-
Peydro et al., 2003). 
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Notch signaling in intrathymic crosstalk: the role of Notch in TEC biology. 
 
 
TECs are the stromal component of the thymus specialized in T cell development 
support. They are divided in two specialized subsets, which differ in their anatomical 
location, cellular morphology and functional properties. Both mTECs and cTECs express 
common markers but can be distinguished by differential expression of cytokeratins and other 
markers (Gray et al., 2006). Despite their differences, cTECs and mTECs originate from a 
common epithelial cell progenitor (TEPC) (Rossi et al., 2006) that persists in the postnatal 
thymus (Bleul et al., 2006) and contribute to the maintenance of the steady-state thymus, at 
least in mice. The existence of this bipotent epithelial progenitor in the human postnatal 
thymus is pending to be determined, mainly due to the absence of specific markers to 
unequivocally characterize these progenitors. TEC development is divided in two phases: an 
early thymocyte-independent differentiation stage, which drives the initial specification of the 
bipotent TEPC into the cTEC and mTEC lineages; and a late thymocyte-dependent phase, 
initiated in later phases of gestation, involving terminal differentiation of cTECs and mTECs. 
Several signaling pathways, as TNFR and LFβR, have been shown to be involved in the 
second thymocyte-dependent phase of TEC development (Boehm et al., 2003) (Rossi et al., 
2007) (Akiyama et al., 2008) (Hikosaka et al., 2008). However, the signaling requirements for 
Figure 56. Model of γδ T cell intrathymic dynamics. Schematic representation of αβ (grey) and γδ-
lineage (colored) T cell intrathymic dynamics. Colored ligand legends indicate: red: impairment (-); 
green: promotion (+). Colored bars at the left indicate chemokine receptors (and corresponding 
ligands) gradients according to literature. Right grey boxes indicate Notch signaling activation 
according to Notch ligands expression levels and density. TLMP: Thymic lymphomyeloid progenitor; 
ETP: Early thymic progenitor; pDN γδ: double-negative γδ T cell progenitor. 
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the early phase remain obscure. Foxn1 is an essential factor during this early thymocyte-
independent phase of TEC development (Klug et al., 2002) (Jenkinson et al., 2005), and 
continuous expression of FoxN1 is required throughout adulthood to maintain the functional 
capacity of TECs (Chen et al., 2009) (Cheng et al., 2010) (Tsukamoto et al., 2005). 
Interestingly, in the skin Foxn1 is needed for Notch1 receptor expression and hair shaft 
differentiation (Cai et al., 2009), but no such relationship of Notch1 and Foxn1 have been 
found in TECs. Nevertheless, TECs express Notch ligands and Notch receptors from very 
early in development in mice and humans, thus TECs may provide each other Notch signaling 
cues. Two capital checkpoints of TEC biology could be regulated by Notch according the two 
phases of TEC development accounted earlier: (1) maintenance and renewal of the TEC 
progenitor cells (TEPCs) and cTEC versus mTEC fate specification, and (2) terminal TEC 
differentiation, homeostasis and senescence during postnatal life. Only one report (Masuda et 
al., 2009) has indirectly addressed the role of Notch in the first checkpoint. They found that B 
cells overexpressing Dll1 induce the development of well differentiated cortical an medullary 
microenvironments in dGuo-treated FTOC lobes, proposing a model in which TECs and 
thymocytes support each other through bi-directional Notch signaling. Nevertheless, they do 
not provide solid evidence of Dll1-induced Notch signaling activation on TECs. Conversely, 
our data provide the first in vivo evidence of Notch signaling activation in murine, and more 
importantly, human TECs. Nevertheless, further study of Notch signaling activation in human 
fetal TECs is compulsory to confirm the role of Notch in the early steps of human TEC 
development. However, previous data showing Notch1 activation in murine fetal TECs 
support the involvement of Notch1 in TEC ontogeny (Del Monte et al., 2007). Additionally, 
the strong expression of the canonical Notch target gene Hes1 in postnatal TECs, as well as 
the specific activation of Notch1 in mTECs and scTECs, but not in cTECs, suggest that Notch 
signaling activation is mediated by different Notch receptors in cTECs and mTECs. This is 
not a surprising finding as scTECs are developmentally related and phylogenetically more 
similar to mTECs than to cTECs (McFarland et al., 1984) (Haynes et al., 1984). This would 
also explain our previous findings regarding the specific upregulation of Jag1 and Jag2 by 
subcapsular cTECs in the involuted thymus, meaning that with thymic involution scTECs 
acquire the phenotypic characteristics of their medullary counterparts. Evidences of the 
involvement of Notch signaling in the second phase of TEC development are equally scarce, 
as only one report suggested the involvement of Notch signaling in postnatal TECs 
homeostasis and thymic involution (Beverly et al., 2006). Nevertheless, we found that Notch 
signaling activation in mTECs increases with age, supporting the role for Notch in thymic 
involution. A kinetic study in postnatal murine thymus allowed us to identify the precise 
time-point on which Notch1 activation significantly increases in mTECs, corresponding with 
the age of 3 months-old. As human thymus developmental kinetics are faster than murine, in 
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humans this point might correspond with the neonatal thymus or even the late stages of fetal 
thymic development, thus human fetal ICN1 staining are again necessary to define at which 
point Notch1 signaling is upregulated in TECs.  
 
In order to specifically dissect the role of Notch in TEC development, we established 
a conditional mouse model in which Notch signaling is specifically abrogated in epithelial 
cells. The resulting RBPjκ-KOTEC mice were phenotypically normal during their first 7 
months of age, but aged mice presented defects in hair growth and developed skin lesions as 
previously described (Demehri et al., 2008) (Demehri et al., 2009) (Dumortier et al., 2010). 
Histological analysis of the lesions showed a granulomatous-like skin disease. In the thymus, 
Hes1 staining provided evidence of specific Notch signaling abrogation in RBPjk-KO TECs, 
although we observed differences in Hes1 expression levels between different KO mice (data 
not shown), implying that deletion efficiency may vary from different individuals. Anyhow, 
in vivo immunohistochemical Hes1 staining provided a powerful tool to assess Notch 
signaling activation in vivo. A solid implication of Notch in TEC development was provided 
by cortico-medulary compartmentalization analyses of RBPjk-KO thymi, which showed a 
clear defect in the medullary microenvironment size; result double-checked by FACS analysis 
of cTEC and mTEC populations (data not shown). The choose of a medullary marker for this 
analyses was not trivial, specially when studying medullary size in old age animals where 
thymic involution may have already disorganized the thymic microenvironment and 
deregulated the expression of several epithelial markers such as cytokeratins, MHC and more 
importantly Notch ligands expression (Ortman et al., 2002) (Aw et al., 2008) (Aw et al., 
2009) (Fiorini et al., 2008). However, we found no differences in Notch ligand expression in 
mTEC in the involuted thymus except for Dll1, which was upregulated in terminally 
differentiated mTECs including HCs. Nevertheless, we have to consider that Notch signaling 
regulates the expression of the elements of its own pathway, as for example NOTCH1 and 
NOTCH3 genes (Ikawa et al., 2006) (Del Monte et al., 2007) (Van de Walle et al., 2009), thus 
when abrogating Notch signaling in our conditional RBPjk-KOTEC mice, we could be 
disrupting the Notch signaling positive feedback loop that may also regulate Notch ligands 
expression in TECs. Indeed, this fact would explain the observed ectopic appearance of B 
cells in the thymus. Indeed, it has been demonstrated that Notch signaling regulates Dll1 and 
Jag2 expression; being the later a direct target of c-myc (Yustein et al., 2010) (Fiaschetti et 
al., 2014), which in turn is a well-known target of Notch1 (Palomero et al., 2006). In this line 
of arguments we could not exclude the possibility that the observed reduction of Jag1+ 
stained area in RBPjk-KOTEC thymi could be due not to a reduction in medulla size, 
understood as less number of mTECs, but to a reduced expression levels of Jag1. However, 
this scenario is unlikely since: (1) FACS analysis of TEC populations in WT and RBPjk-
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KOTEC mice corroborate the histomorphometric results as RBPjk-KOTEC mice showed less 
frequency (%) of mTECs than WT mice, (2) there are no evidences in the literature reporting 
Jag1 as target of the Notch signaling pathway; (3) independently to a putative regulation of 
Jag1 expression by Notch signaling, Jag1 is expressed in medullary-exclusive non-epithelial 
cells, as 30% of CD11c+ myeloid cells and some perivascular cells express Jag1, both cell 
types per se defining the medullary microenvironment; (4) the medulla is not only defined by 
medullary specific markers but also by its differential histology with the cortex. Even without 
a medullary marker, the thymic medulla can be defined attending to low cellular density 
observed by Topro3 staining; (5) regular Jag1+ staining in mTECs was observed in every 
remaining medullary areas of the RBPjk-KOTEC thymi, data altogether confirming that Jag1 is 
a good thymic medullary marker. Nevertheless, numerous questions remains unanswered 
regarding the role of Notch signaling in thymic compartimentalization and medulla formation. 
Two possibilities may account medulla size reduction in RBPjk-KO mice: (1) Notch regulates 
the senescence process inducing mTEC apoptosis in the involuted thymus, as suggested by 
Capobianco et al. (Beverly et al., 2006). (2) There is a defect in mTEC fate specification and 
thus medulla formation during development, which would be supported by the fact that the 
medullary patches observed in our RBPjk-KO mice mimic the clonal mTEC islets from 
which medulla derives during thymus ontogeny (Rodewald et al., 2001).   
 
An interesting observation derived from our in vivo immunohistological studies in 
mice and human thymus is that highest Notch signaling activation (Hes1 or ICN1) 
corresponded with mTECs forming the HCs. The role of the HCs in thymus biology is still a 
matter of debate. Traditionally, HCs has been considered senescent structures formed by 
terminally differentiated mTECs. But mTECs forming HCs are connected to one another by 
desmosomes and exhibit long cytoplasmic processes that directly contact thymic T 
lymphocytes and accessory antigen presenting cells (Bodey and Kaiser, 1997). mTECs 
forming the outer layer of Hassal’s bodies, as well as scTECs and terminally differentiated 
mTECs, are very similar to the basal layer of epidermis, as they exhibit close antigenic 
similarity with skin epithelial cells (Kampinga et al., 1989) and all the classical characteristics 
of an epithelium: they are polarized, form hemidesmosomes and highly express cytokeratins 
(Petrie, 2002), thus resembling to a finally differentiated epithelial cell similar to the stratum 
corneum keratinocytes (Haynes, 1984) (Schmitt et al., 1987), which, by the way, efficiently 
supports T cell development (Clark et al., 2005). It has been shown that p53 is active in 
scTECs and HC mTECs of the normal human thymus (Jablonska-Mestanova et al., 2013), a 
protein well known by its anti-apoptotic and tumor suppression function in the skin. Further 
inmunohistochemical studies of p53 and other pro-apoptotic proteins such as Bcl2 and 
survivin in RBPjk-KOTEC thymi, as well as in the human thymus, would give additional 
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valuable hits about the putative role of Notch in TEC senescence and homeostasis. 
Additionally, RBPjk-KOTEC thymi hosted a great proportion of B cells and showed a 
significant reduction in the frequency of DP thymocytes. As suggested earlier, B cell 
appearance in this KO thyme might be due to Notch ligand expression downregulation, and 
an abnormal DP thymocyte compartment could be the cause of the defective medulla size, as 
DP thymocytes are needed for terminal mTEC differentiation. It is interesting to observe that 
RBPjκ-KOTEC mice show an increased proportion in DP B220+ Thy1+ thymocytes, being the 
B220 marker associated in T cells with the apoptotic process (Renno et al., 1998), thus 
suggesting that DP thymocytes are subjected to higher rates of apoptosis in RBPjk-KOTEC 
than in WT mice; annexinV expression analysis would shed light into this issue. 
Nevertheless, as sampling population is mainly composed by aged mice, we cannot exclude 
that the DP defective population may be attributable to age-related stress or to the systemic 
illness derived from Notch signaling abrogation in the skin and other epithelial organs. It has 
been shown that Notch signaling abrogation in the skin cause a systemic inflammatory and 
lymphoproliferative disease mostly driven by the cytokine TSLP secreted by skin 
keratinocytes (Demehri et al., 2008) (Dumortier et al., 2010). TSLP secretion acts as a tumor 
suppressor in the skin somehow compensating the loss of Notch (Di Piazza et al., 2012), 
which has been described to be tumorigenic (Demehri et al., 2009). Interestingly, one of the 
main and well-established functions of the HCs, is TSLP secretion. Thus, we cannot exclude 
the possibility that the observed defect in the DP compartment and B cell appearance in the 
thymus might be the consequence of increased TSLP secretion in the within the thymus from 
Notch-deficient HC mTECs, as it has been demonstrated that TSLP induces human B cell 
proliferation and differentiation (Scheeren et al., 2010). Interestingly, the molecular structure 
of TSLP is very similar to IL7, a cytokine essential for T cell development, as both cytokines 
binds the IL-7Rα chain. Indeed, the phenotype found in our RBPjk-KOTEC mice is very 
similar to that observed in IL7-Tg mice (Rich et al., 1993), which show marked reduction of 
DP thymocytes and also develop a progressive cutaneous disorder involving dermal lymphoid 
infiltrates resulting in progressive alopecia, hyperkeratosis, and exfoliation. Additionally, IL7 
transgene also provokes the development of a lymphoproliferative disorder that induces B and 
T cell lymphomas. In summary, our data confirms that the relevance of Notch signaling in the 
thymus can be extended from the T cell compartment to the main thymic stromal 
compartment, the TECs, as Notch signaling abrogation modifies thymic architecture and 
thymocyte populations, by a mechanisms still unknown but that may involve defective 
regulation of apoptosis and secretion of TSLP by mTECs. Thus a Notch signaling crosstalk 
may exists between TECs and thymocytes, or between TECs themselves, as reciprocal 
Notch signaling interactions are required to achieve complete maturation of both cell 
types as well as homeostasis of the whole thymus during postnatal life. 
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1. Notch ligands and receptors are differentially expressed throughout the thymus, 
thus defining specific niches that vary during thymus ontogeny and age-related 
thymic involution, and differ from human to mice. 
 
2. Dll4, the essential Notch ligand for T cell development, is early downregulated 
from cortical TECs during human thymus ontogeny. 
 
3. Vascular endothelium as well as perivascular cells and myeloid cells at the CMJ 
provide an important source of Dll4 ligands to progenitors entering the human 
thymus, suggesting that Dll4 may contribute to Notch activation at very early T 
cell developmental stages. 
 
4. Notch1 is active in vivo in human CD34+ progenitors located at the CMJ and in a 
minute population of CD34- cortical thymocytes, indicating that Notch1 
signalling is transiently induced early in human T cell development. 
 
5. Jag1 and Jag2 Notch ligands define reciprocal medullar and cortical niches, 
respectively, in the human thymus and exhibit opposite roles in the generation of 
αβ versus γδ T cells, but they do not seem to impact the transcriptional priming 
of the γδ T cell lineage, at least before acquisition of the TCRγδ.  
 
6. Jag2 signaling impairs the generation of αβ-lineage cells at the β-selection check-
point, but efficiently supports γδ T cell development and selectively promotes the 
expansion of γδ T cells at the CD1a+ immature CD4+ and DP developmental 
stages.  
 
7.  Jag1 is the most efficient Notch ligand at supporting the developmental 
progression of CD1a+ γδ T cells and the generation of mature CD1a- DN and 
CD8+ γδ T cells with functional potential.  
 
8. Two distinct human thymus niches, the CMJ and the medulla, host γδ  
thymocytes with different expression levels of the CXCR4 chemokine receptor, 
which are placed at sequential CD1a+ and CD1a-/lo γδ T cell developmental 
stages. Therefore, final maturation of cortical CD1a+ γδ thymocytes may involve 
their migration into the thymus medulla. 
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9. Notch1 signaling is active in cortical and medullary TECs, and selectively 
increases with age in the latter, in both mouse and human, suggesting a role for 
Notch1 in medullary TEC homeostasis and age-related thymus involution.  
 
10. Selective abrogation of Notch signaling in mouse TECs in vivo, disturbs the 
architecture of the thymus medulla and impacts thymus function by impairing DP 
thymocyte development while inducing the aberrant generation of intrathymic B 
cells. 
 
 
Conclusiones 
 
1. Los ligandos y receptores de Notch se expresan diferencialmente en el timo,  
definiendo nichos específicos que varían durante su ontogenia e involución 
asociada a la edad, y que difieren en humanos y ratón.   
 
2. Dll4, el ligando de Notch1 esencial para el desarrollo de los linfocitos T,   
disminuye sus niveles de expresión en las TEC corticales en estadios tempranos 
de la ontogenia tímica humana.   
 
3. El endotelio vascular, así como las células perivasculares y las células mieloides de  
 la CMJ, proporcionan una fuente importante de ligando Dll4 a los progenitores que  
 colonizan el timo humano, lo que sugiere que Dll4 puede contribuir a la activación  
 de Notch en etapas muy tempranas del desarrollo T.   
 
4. Notch1 se activa in vivo en progenitores intratímicos tempranos CD34+ situados  
en la CMJ y también en una mínima población de timocitos corticales CD34-, lo 
que indica que la señalización por Notch1 se induce tempranamente y de forma 
transitoria durante el desarrollo de las células T humanas.   
 
5. Los ligandos de Notch Jag1 y Jag2 definen nichos recíprocos, medular y cortical,  
respectivamente, en el timo humano, y desempeñan funciones opuestas en la 
generación de células T de los linajes αβ versus γδ, pero no parecen afectar el 
programa transcripcional específico del linaje T γδ , al menos antes de la 
adquisición del TCRγδ.   
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6. La señalización mediada por Jag2 afecta negativamente a la generación de células  
del linaje αβ en el punto de control de la selección β, pero favorece el desarrollo de 
las células T γδ y promueve selectivamente la expansión de los timocitos γδ en 
estadios immaduros CD1a+ CD4 + y CD1a+ DP del desarrollo intratímico..   
 
7. Jag1 es el ligando de Notch más eficiente en inducir la progresión de las células γδ  
immaduras CD1a+ y la generación de células T γδ CD1a- DN y CD8+ 
funcionalmente maduras.  
 
8. La unión corticomedular y la médula, definen dos nichos en el timo humano que  
albergan timocitos γδ con diferentes niveles de expresión del receptor de 
quimioquinas CXCR4 y de CD1a, siendo los timocitos γδ corticales los que 
expresan mayores niveles de ambos marcadores, por lo que la maduración final de 
los timocitos γδ corticales inmaduros CD1a+ implicaría su migración a la médula 
del timo.   
 
9. Notch1 señaliza en TECs corticales y medulares y su activación aumenta  
selectivamente en estas últimas con la edad, tanto en humanos como en ratón, lo que 
sugiere la implicación de Notch1 en la homeostasis de las TEC medulares y en la 
involución del timo relacionada con la edad.   
 
10. El bloqueo selectivo de la señalización por Notch en las TECs de ratones  
condicionales deficientes perturba la arquitectura del nicho medular, y altera la 
función tímica, impidiendo la generación de timocitos DP e induciendo la 
generación aberrante de células B intratímicas. 
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Figure S1. Notch ligands and panCK control staining in the murine and human thymus. 
Images show FFPE sections of murine postnatal (< 16 week-old; upper panel) and human postnatal 
thymic tissue (< 17 months-old; lower panel) stained in the absence of primary antibodies. Topro3 
was used for nuclear staining (blue). Thymic regions are labeled as c: cortex; m: medulla; dotted line: 
CMJ. Scale bar: 100µm. Images shown are representative of results obtained in N ≥ 3 tissue 
samples per ligand. 
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Figure S2. Notch ligands and stromal markers CK19, CD11c and CD34 control staining in the 
human thymus. Images show FFPE sections of human postnatal thymic tissue (< 17 months-old) 
stained in the absence of primary antibodies. Topro3 was used for nuclear staining (blue). Thymic 
regions are labeled as c: cortex; m: medulla; dotted line: CMJ. Upper panel scale bar: 100µm. Lower 
panel scale bar: 50µm; Images shown are representative of results obtained in N ≥ 3 tissue samples 
per ligand. 
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Figure S3. Notch ligands and panCK 
control staining in the fetal and 
involuted human thymus. Images show 
FFPE sections of human postnatal (< 17 
months-old; upper panel) and human 
involuted (> 6 years-old; lower panel) 
thymic tissue stained in the absence of 
primary antibodies. Topro3 was used for 
nuclear staining (blue). Thymic regions are 
labeled as c: cortex; m: medulla; dotted 
line: CMJ. Scale bars: 100µm. Images 
shown are representative of results 
obtained in N ≥ 3 different tissue samples 
per ligand. 
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Figure S4. Notch receptors and panCK control staining in the human thymus. Images show 
FFPE sections of human postnatal (< 17 months-old) thymic tissue stained in the absence of 
primary antibodies. Topro3 was used for nuclear staining (blue). Thymic regions are labeled as c: 
cortex; m: medulla; dotted line: CMJ. Scale bars: 50µm; Images shown are representative of 
results obtained in N ≥ 3 different tissue samples per receptor. 
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Figure S5. Intracelullar Notch1 and cortical CD34 and CK19 control staining in the human 
thymus. Images show FFPE sections of human postnatal (< 17 months-old) thymic tissue 
stained in the absence of primary antibodies. Topro3 was used for nuclear staining (blue). 
Thymic regions are labeled as c: cortex; m: medulla; dotted line: CMJ. Upper panel scale bar: 
100µm. Lower panel scale bars: 50µm; Images shown are representative of results obtained in 
N ≥ 3 different tissue samples per ligand. 
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Figure S6. TCRγδ and CK19 control staining in the human thymus. Images show snap-frozen 
sections of human postnatal (< 17 months-old) thymic tissue in the absence of primary antibodies. 
Topro3 was used for nuclear staining (blue). Thymic regions are labeled as c: cortex; m: medulla; 
dotted line: CMJ. Left panel scale bar: 100µm. Right panel sacale bar: 50µm; Images shown are 
representative of results obtained in N ≥ 3 tissue samples per ligand. 
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Figure S7. Vδ1, Vδ2  and CK19 control staining in the corticomedulary and medullary 
microenvironments of the human thymus. Images show snap-frozen sections of human 
postnatal (< 17 months-old) thymic tissue stained in the absence of primary antibodies. Topro3 was 
used for nuclear staining (blue). h: Hassal’s corpuscle. Scale bars: 50µm; Images shown are 
representative of results obtained in N ≥ 3 different tissue samples per ligand. 
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Figure S8. Hes1 and medulary intracellular Notch1 and panCK control staining in the human 
thymus. Images show FFPE sections of human postnatal (< 17 months-old) thymic tissue stained 
in the absence of primary antibodies. Topro3 was used for nuclear staining (blue). Thymic regions 
are labeled as c: cortex; m: medulla; dotted line: CMJ. Left panel scale bar: 100µm. Right panel 
scale bars: 50µm; Images shown are representative of results obtained in N ≥ 3 different tissue 
samples per ligand. 
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Figure S9. Hes1, Jag1 and panCK control staining in 
WT and RBPjk-KOTEC mice thymi. Images show FFPE 
sections of murine postnatal (3 months-old) thymic tissue 
stained in the absence of primary antibodies. Topro3 was 
used for nuclear staining (blue). Dotted line: CMJ. Upper 
panel scale bar: 50µm. Lower panel scale bars: 200µm; 
Images shown are representative of results obtained in N 
≥ 7 different tissue samples. 
 
